date generated: 2023-08-30
Mitch performs unidimensional and multidimensional gene set enrichment analysis. The concept behind this dates to work by Cox and Mann (https://doi.org/10.1186/1471-2105-13-S16-S12). This implementation is suited to R based workflows of multi-omics datasets. This software was developed by Antony Kaspi and Mark Ziemann. Learn more about Mitch at the website: https://github.com/markziemann/Mitch
Here is the first few lines of the input profile.
x | |
---|---|
0610009B22Rik | -1.1332185 |
0610009E02Rik | -0.3290659 |
0610009L18Rik | 0.1306738 |
0610010K14Rik | -0.3126674 |
0610012G03Rik | -0.2034285 |
0610030E20Rik | -0.5747514 |
Here are some metrics about the input data profile:
Profile metrics | |
---|---|
num_genesets | 1604 |
num_genes_in_profile | 17372 |
duplicated_genes_present | 0 |
num_profile_genes_in_sets | 8443 |
num_profile_genes_not_in_sets | 8929 |
Here is a plot of the input profiles. Note the dynamic ranges.
Here is the contour plot of the profile including all detected genes.
Here are some metrics about the gene sets used:
GMT file of genesets: mouse_msigdb_reactome_2022-02-16.gmtGene sets metrics | |
---|---|
num_genesets | 1604 |
num_genesets_excluded | 425 |
num_genesets_included | 1179 |
Significance is calculated by -log10(p-value). All points shown are FDR<0.05.
Significance is calculated by -log10(p-value). Top N sets shown irrespective of FDR.
Top N= 50 gene sets
## Warning in kable_styling(., "hover", full_width = FALSE): Please specify format
## in kable. kableExtra can customize either HTML or LaTeX outputs. See
## https://haozhu233.github.io/kableExtra/ for details.
set | setSize | pANOVA | s.dist | p.adjustANOVA |
---|---|---|---|---|
REGULATION OF RUNX1 EXPRESSION AND ACTIVITY | 17 | 1.27e-05 | 0.611 | 5.57e-04 |
ERYTHROCYTES TAKE UP CARBON DIOXIDE AND RELEASE OXYGEN | 10 | 1.98e-03 | -0.565 | 2.21e-02 |
NOTCH2 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | 11 | 3.97e-03 | 0.502 | 3.77e-02 |
TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | 11 | 4.70e-03 | -0.492 | 4.29e-02 |
ADENYLATE CYCLASE ACTIVATING PATHWAY | 10 | 7.94e-03 | 0.485 | 6.24e-02 |
NOTCH4 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | 20 | 2.38e-04 | 0.475 | 5.02e-03 |
ACETYLCHOLINE REGULATES INSULIN SECRETION | 10 | 9.56e-03 | 0.473 | 7.12e-02 |
A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | 26 | 6.90e-05 | 0.451 | 2.09e-03 |
RUNX3 REGULATES NOTCH SIGNALING | 13 | 4.89e-03 | 0.451 | 4.40e-02 |
DEFECTIVE B4GALT7 CAUSES EDS PROGEROID TYPE | 20 | 5.61e-04 | 0.446 | 8.99e-03 |
NOTCH HLH TRANSCRIPTION PATHWAY | 28 | 5.01e-05 | 0.443 | 1.64e-03 |
REGULATION OF COMMISSURAL AXON PATHFINDING BY SLIT AND ROBO | 10 | 1.70e-02 | 0.436 | 1.02e-01 |
NOTCH3 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | 23 | 3.47e-04 | 0.431 | 6.45e-03 |
MITOCHONDRIAL TRANSLATION | 93 | 7.30e-13 | -0.430 | 4.30e-10 |
SYNTHESIS OF ACTIVE UBIQUITIN ROLES OF E1 AND E2 ENZYMES | 29 | 6.19e-05 | -0.430 | 1.92e-03 |
P75NTR REGULATES AXONOGENESIS | 10 | 1.96e-02 | -0.426 | 1.13e-01 |
TRANSCRIPTIONAL REGULATION OF PLURIPOTENT STEM CELLS | 19 | 1.33e-03 | 0.425 | 1.65e-02 |
YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | 12 | 1.41e-02 | 0.409 | 9.16e-02 |
CRISTAE FORMATION | 31 | 8.21e-05 | -0.409 | 2.31e-03 |
REGULATION OF GENE EXPRESSION IN LATE STAGE BRANCHING MORPHOGENESIS PANCREATIC BUD PRECURSOR CELLS | 15 | 6.28e-03 | 0.408 | 5.33e-02 |
FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | 19 | 2.53e-03 | -0.400 | 2.69e-02 |
SIGNALING BY LEPTIN | 10 | 2.84e-02 | 0.400 | 1.43e-01 |
NR1H2 AND NR1H3 MEDIATED SIGNALING | 38 | 2.41e-05 | 0.396 | 9.48e-04 |
NR1H3 NR1H2 REGULATE GENE EXPRESSION LINKED TO CHOLESTEROL TRANSPORT AND EFFLUX | 32 | 1.18e-04 | 0.393 | 3.17e-03 |
INTERLEUKIN 6 SIGNALING | 10 | 3.18e-02 | 0.392 | 1.51e-01 |
FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | 18 | 4.08e-03 | -0.391 | 3.84e-02 |
APOPTOSIS INDUCED DNA FRAGMENTATION | 10 | 3.48e-02 | -0.386 | 1.56e-01 |
E2F MEDIATED REGULATION OF DNA REPLICATION | 20 | 3.10e-03 | -0.382 | 3.12e-02 |
RESPIRATORY ELECTRON TRANSPORT | 102 | 2.96e-11 | -0.381 | 8.73e-09 |
CHK1 CHK2 CDS1 MEDIATED INACTIVATION OF CYCLIN B CDK1 COMPLEX | 11 | 2.90e-02 | -0.380 | 1.45e-01 |
ASPARTATE AND ASPARAGINE METABOLISM | 11 | 2.92e-02 | -0.380 | 1.45e-01 |
PHASE 2 PLATEAU PHASE | 12 | 2.28e-02 | 0.380 | 1.22e-01 |
COOPERATION OF PREFOLDIN AND TRIC CCT IN ACTIN AND TUBULIN FOLDING | 26 | 9.80e-04 | -0.373 | 1.33e-02 |
COMPLEX I BIOGENESIS | 56 | 1.98e-06 | -0.367 | 1.17e-04 |
DEFECTIVE EXT2 CAUSES EXOSTOSES 2 | 14 | 1.75e-02 | 0.367 | 1.03e-01 |
ACTIVATION OF SMO | 16 | 1.13e-02 | 0.366 | 7.88e-02 |
TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | 13 | 2.28e-02 | 0.365 | 1.22e-01 |
INTERACTION BETWEEN L1 AND ANKYRINS | 27 | 1.04e-03 | 0.365 | 1.37e-02 |
NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | 15 | 1.51e-02 | 0.362 | 9.54e-02 |
RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | 125 | 2.83e-12 | -0.362 | 1.11e-09 |
CITRIC ACID CYCLE TCA CYCLE | 22 | 3.40e-03 | -0.361 | 3.31e-02 |
MITOCHONDRIAL PROTEIN IMPORT | 63 | 7.97e-07 | -0.360 | 6.26e-05 |
ORGANIC CATION ANION ZWITTERION TRANSPORT | 12 | 3.22e-02 | 0.357 | 1.52e-01 |
CHOLESTEROL BIOSYNTHESIS | 24 | 2.49e-03 | -0.357 | 2.67e-02 |
TNFR1 INDUCED PROAPOPTOTIC SIGNALING | 12 | 3.30e-02 | 0.356 | 1.53e-01 |
SIGNALING BY NOTCH1 HD DOMAIN MUTANTS IN CANCER | 15 | 1.73e-02 | 0.355 | 1.03e-01 |
AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | 27 | 1.52e-03 | 0.353 | 1.81e-02 |
PENTOSE PHOSPHATE PATHWAY | 13 | 2.85e-02 | -0.351 | 1.43e-01 |
PKA ACTIVATION IN GLUCAGON SIGNALLING | 16 | 1.52e-02 | 0.351 | 9.54e-02 |
ADENYLATE CYCLASE INHIBITORY PATHWAY | 13 | 2.92e-02 | 0.349 | 1.45e-01 |
set | setSize | pANOVA | s.dist | p.adjustANOVA |
---|---|---|---|---|
REGULATION OF RUNX1 EXPRESSION AND ACTIVITY | 17 | 1.27e-05 | 6.11e-01 | 5.57e-04 |
ERYTHROCYTES TAKE UP CARBON DIOXIDE AND RELEASE OXYGEN | 10 | 1.98e-03 | -5.65e-01 | 2.21e-02 |
NOTCH2 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | 11 | 3.97e-03 | 5.02e-01 | 3.77e-02 |
TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | 11 | 4.70e-03 | -4.92e-01 | 4.29e-02 |
ADENYLATE CYCLASE ACTIVATING PATHWAY | 10 | 7.94e-03 | 4.85e-01 | 6.24e-02 |
NOTCH4 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | 20 | 2.38e-04 | 4.75e-01 | 5.02e-03 |
ACETYLCHOLINE REGULATES INSULIN SECRETION | 10 | 9.56e-03 | 4.73e-01 | 7.12e-02 |
A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | 26 | 6.90e-05 | 4.51e-01 | 2.09e-03 |
RUNX3 REGULATES NOTCH SIGNALING | 13 | 4.89e-03 | 4.51e-01 | 4.40e-02 |
DEFECTIVE B4GALT7 CAUSES EDS PROGEROID TYPE | 20 | 5.61e-04 | 4.46e-01 | 8.99e-03 |
NOTCH HLH TRANSCRIPTION PATHWAY | 28 | 5.01e-05 | 4.43e-01 | 1.64e-03 |
REGULATION OF COMMISSURAL AXON PATHFINDING BY SLIT AND ROBO | 10 | 1.70e-02 | 4.36e-01 | 1.02e-01 |
NOTCH3 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | 23 | 3.47e-04 | 4.31e-01 | 6.45e-03 |
MITOCHONDRIAL TRANSLATION | 93 | 7.30e-13 | -4.30e-01 | 4.30e-10 |
SYNTHESIS OF ACTIVE UBIQUITIN ROLES OF E1 AND E2 ENZYMES | 29 | 6.19e-05 | -4.30e-01 | 1.92e-03 |
P75NTR REGULATES AXONOGENESIS | 10 | 1.96e-02 | -4.26e-01 | 1.13e-01 |
TRANSCRIPTIONAL REGULATION OF PLURIPOTENT STEM CELLS | 19 | 1.33e-03 | 4.25e-01 | 1.65e-02 |
YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | 12 | 1.41e-02 | 4.09e-01 | 9.16e-02 |
CRISTAE FORMATION | 31 | 8.21e-05 | -4.09e-01 | 2.31e-03 |
REGULATION OF GENE EXPRESSION IN LATE STAGE BRANCHING MORPHOGENESIS PANCREATIC BUD PRECURSOR CELLS | 15 | 6.28e-03 | 4.08e-01 | 5.33e-02 |
FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | 19 | 2.53e-03 | -4.00e-01 | 2.69e-02 |
SIGNALING BY LEPTIN | 10 | 2.84e-02 | 4.00e-01 | 1.43e-01 |
NR1H2 AND NR1H3 MEDIATED SIGNALING | 38 | 2.41e-05 | 3.96e-01 | 9.48e-04 |
NR1H3 NR1H2 REGULATE GENE EXPRESSION LINKED TO CHOLESTEROL TRANSPORT AND EFFLUX | 32 | 1.18e-04 | 3.93e-01 | 3.17e-03 |
INTERLEUKIN 6 SIGNALING | 10 | 3.18e-02 | 3.92e-01 | 1.51e-01 |
FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | 18 | 4.08e-03 | -3.91e-01 | 3.84e-02 |
APOPTOSIS INDUCED DNA FRAGMENTATION | 10 | 3.48e-02 | -3.86e-01 | 1.56e-01 |
E2F MEDIATED REGULATION OF DNA REPLICATION | 20 | 3.10e-03 | -3.82e-01 | 3.12e-02 |
RESPIRATORY ELECTRON TRANSPORT | 102 | 2.96e-11 | -3.81e-01 | 8.73e-09 |
CHK1 CHK2 CDS1 MEDIATED INACTIVATION OF CYCLIN B CDK1 COMPLEX | 11 | 2.90e-02 | -3.80e-01 | 1.45e-01 |
ASPARTATE AND ASPARAGINE METABOLISM | 11 | 2.92e-02 | -3.80e-01 | 1.45e-01 |
PHASE 2 PLATEAU PHASE | 12 | 2.28e-02 | 3.80e-01 | 1.22e-01 |
COOPERATION OF PREFOLDIN AND TRIC CCT IN ACTIN AND TUBULIN FOLDING | 26 | 9.80e-04 | -3.73e-01 | 1.33e-02 |
COMPLEX I BIOGENESIS | 56 | 1.98e-06 | -3.67e-01 | 1.17e-04 |
DEFECTIVE EXT2 CAUSES EXOSTOSES 2 | 14 | 1.75e-02 | 3.67e-01 | 1.03e-01 |
ACTIVATION OF SMO | 16 | 1.13e-02 | 3.66e-01 | 7.88e-02 |
TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | 13 | 2.28e-02 | 3.65e-01 | 1.22e-01 |
INTERACTION BETWEEN L1 AND ANKYRINS | 27 | 1.04e-03 | 3.65e-01 | 1.37e-02 |
NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | 15 | 1.51e-02 | 3.62e-01 | 9.54e-02 |
RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | 125 | 2.83e-12 | -3.62e-01 | 1.11e-09 |
CITRIC ACID CYCLE TCA CYCLE | 22 | 3.40e-03 | -3.61e-01 | 3.31e-02 |
MITOCHONDRIAL PROTEIN IMPORT | 63 | 7.97e-07 | -3.60e-01 | 6.26e-05 |
ORGANIC CATION ANION ZWITTERION TRANSPORT | 12 | 3.22e-02 | 3.57e-01 | 1.52e-01 |
CHOLESTEROL BIOSYNTHESIS | 24 | 2.49e-03 | -3.57e-01 | 2.67e-02 |
TNFR1 INDUCED PROAPOPTOTIC SIGNALING | 12 | 3.30e-02 | 3.56e-01 | 1.53e-01 |
SIGNALING BY NOTCH1 HD DOMAIN MUTANTS IN CANCER | 15 | 1.73e-02 | 3.55e-01 | 1.03e-01 |
AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | 27 | 1.52e-03 | 3.53e-01 | 1.81e-02 |
PENTOSE PHOSPHATE PATHWAY | 13 | 2.85e-02 | -3.51e-01 | 1.43e-01 |
PKA ACTIVATION IN GLUCAGON SIGNALLING | 16 | 1.52e-02 | 3.51e-01 | 9.54e-02 |
ADENYLATE CYCLASE INHIBITORY PATHWAY | 13 | 2.92e-02 | 3.49e-01 | 1.45e-01 |
LGI ADAM INTERACTIONS | 14 | 2.38e-02 | 3.49e-01 | 1.26e-01 |
FGFR2 LIGAND BINDING AND ACTIVATION | 13 | 3.07e-02 | -3.46e-01 | 1.49e-01 |
EARLY PHASE OF HIV LIFE CYCLE | 13 | 3.15e-02 | -3.44e-01 | 1.50e-01 |
CS DS DEGRADATION | 14 | 2.73e-02 | 3.41e-01 | 1.38e-01 |
SIGNAL REGULATORY PROTEIN FAMILY INTERACTIONS | 11 | 5.49e-02 | 3.34e-01 | 2.08e-01 |
RORA ACTIVATES GENE EXPRESSION | 18 | 1.41e-02 | 3.34e-01 | 9.16e-02 |
THE CITRIC ACID TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT | 172 | 4.36e-14 | -3.34e-01 | 5.15e-11 |
CLASS I PEROXISOMAL MEMBRANE PROTEIN IMPORT | 20 | 9.82e-03 | -3.34e-01 | 7.15e-02 |
SCAVENGING OF HEME FROM PLASMA | 10 | 6.92e-02 | -3.32e-01 | 2.44e-01 |
GENE AND PROTEIN EXPRESSION BY JAK STAT SIGNALING AFTER INTERLEUKIN 12 STIMULATION | 31 | 1.41e-03 | -3.31e-01 | 1.70e-02 |
ACTIVATION OF THE AP 1 FAMILY OF TRANSCRIPTION FACTORS | 10 | 7.04e-02 | -3.30e-01 | 2.44e-01 |
PROCESSING OF SMDT1 | 16 | 2.23e-02 | -3.30e-01 | 1.22e-01 |
DISEASES ASSOCIATED WITH GLYCOSAMINOGLYCAN METABOLISM | 40 | 3.45e-04 | 3.27e-01 | 6.45e-03 |
ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | 10 | 7.41e-02 | 3.26e-01 | 2.52e-01 |
HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | 10 | 7.41e-02 | 3.26e-01 | 2.52e-01 |
SYNAPTIC ADHESION LIKE MOLECULES | 21 | 1.12e-02 | 3.20e-01 | 7.88e-02 |
ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | 17 | 2.42e-02 | 3.16e-01 | 1.27e-01 |
FOXO MEDIATED TRANSCRIPTION OF CELL DEATH GENES | 15 | 3.44e-02 | 3.16e-01 | 1.56e-01 |
ORC1 REMOVAL FROM CHROMATIN | 69 | 5.97e-06 | -3.15e-01 | 3.20e-04 |
NF KB ACTIVATION THROUGH FADD RIP 1 PATHWAY MEDIATED BY CASPASE 8 AND 10 | 11 | 7.06e-02 | 3.15e-01 | 2.44e-01 |
TNFS BIND THEIR PHYSIOLOGICAL RECEPTORS | 14 | 4.17e-02 | 3.14e-01 | 1.74e-01 |
ACTIVATION OF PPARGC1A PGC 1ALPHA BY PHOSPHORYLATION | 10 | 8.69e-02 | -3.13e-01 | 2.71e-01 |
RRNA PROCESSING IN THE MITOCHONDRION | 10 | 8.77e-02 | -3.12e-01 | 2.71e-01 |
SWITCHING OF ORIGINS TO A POST REPLICATIVE STATE | 88 | 4.77e-07 | -3.11e-01 | 4.32e-05 |
PRESYNAPTIC DEPOLARIZATION AND CALCIUM CHANNEL OPENING | 11 | 7.45e-02 | 3.11e-01 | 2.52e-01 |
MITOCHONDRIAL IRON SULFUR CLUSTER BIOGENESIS | 13 | 5.27e-02 | -3.10e-01 | 2.06e-01 |
PHOSPHOLIPASE C MEDIATED CASCADE FGFR2 | 12 | 6.39e-02 | -3.09e-01 | 2.32e-01 |
SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | 20 | 1.68e-02 | -3.09e-01 | 1.02e-01 |
METALLOPROTEASE DUBS | 25 | 7.73e-03 | -3.08e-01 | 6.16e-02 |
BIOTIN TRANSPORT AND METABOLISM | 11 | 7.83e-02 | 3.07e-01 | 2.57e-01 |
APC C MEDIATED DEGRADATION OF CELL CYCLE PROTEINS | 84 | 1.66e-06 | -3.02e-01 | 1.03e-04 |
SYNTHESIS OF IP3 AND IP4 IN THE CYTOSOL | 25 | 9.30e-03 | 3.01e-01 | 6.99e-02 |
MOLECULES ASSOCIATED WITH ELASTIC FIBRES | 32 | 3.35e-03 | 3.00e-01 | 3.29e-02 |
SCF SKP2 MEDIATED DEGRADATION OF P27 P21 | 59 | 8.24e-05 | -2.96e-01 | 2.31e-03 |
INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | 19 | 2.54e-02 | -2.96e-01 | 1.30e-01 |
INTERLEUKIN 7 SIGNALING | 19 | 2.57e-02 | 2.96e-01 | 1.30e-01 |
ASSEMBLY OF THE PRE REPLICATIVE COMPLEX | 66 | 3.70e-05 | -2.94e-01 | 1.36e-03 |
NEGATIVE REGULATION OF NOTCH4 SIGNALING | 54 | 1.95e-04 | -2.93e-01 | 4.34e-03 |
ZINC INFLUX INTO CELLS BY THE SLC39 GENE FAMILY | 10 | 1.09e-01 | 2.93e-01 | 3.13e-01 |
REGULATION OF MECP2 EXPRESSION AND ACTIVITY | 30 | 6.20e-03 | 2.89e-01 | 5.30e-02 |
APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | 72 | 2.58e-05 | -2.87e-01 | 9.81e-04 |
FREE FATTY ACIDS REGULATE INSULIN SECRETION | 10 | 1.16e-01 | 2.87e-01 | 3.25e-01 |
FGFR2 MUTANT RECEPTOR ACTIVATION | 27 | 1.03e-02 | -2.85e-01 | 7.44e-02 |
THE ROLE OF GTSE1 IN G2 M PROGRESSION AFTER G2 CHECKPOINT | 69 | 4.33e-05 | -2.85e-01 | 1.55e-03 |
SIGNALING BY NOTCH3 | 48 | 6.66e-04 | 2.84e-01 | 9.85e-03 |
DNA REPLICATION PRE INITIATION | 81 | 1.02e-05 | -2.84e-01 | 4.60e-04 |
ACTIVATION OF AMPK DOWNSTREAM OF NMDARS | 21 | 2.48e-02 | -2.83e-01 | 1.29e-01 |
HIV TRANSCRIPTION INITIATION | 45 | 1.05e-03 | -2.82e-01 | 1.38e-02 |
TNFR1 INDUCED NFKAPPAB SIGNALING PATHWAY | 29 | 8.84e-03 | 2.81e-01 | 6.68e-02 |
CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | 48 | 8.05e-04 | -2.80e-01 | 1.13e-02 |
METABOLISM OF POLYAMINES | 59 | 2.04e-04 | -2.80e-01 | 4.45e-03 |
GOLGI CISTERNAE PERICENTRIOLAR STACK REORGANIZATION | 12 | 9.37e-02 | -2.79e-01 | 2.84e-01 |
ELASTIC FIBRE FORMATION | 38 | 3.01e-03 | 2.78e-01 | 3.06e-02 |
G PROTEIN ACTIVATION | 23 | 2.11e-02 | 2.78e-01 | 1.19e-01 |
INTERLEUKIN 12 SIGNALING | 36 | 3.93e-03 | -2.78e-01 | 3.77e-02 |
PHOSPHORYLATION OF THE APC C | 18 | 4.15e-02 | -2.78e-01 | 1.74e-01 |
PROCESSING OF INTRONLESS PRE MRNAS | 19 | 3.74e-02 | -2.76e-01 | 1.63e-01 |
RECEPTOR MEDIATED MITOPHAGY | 11 | 1.13e-01 | -2.76e-01 | 3.21e-01 |
MET ACTIVATES RAP1 AND RAC1 | 10 | 1.33e-01 | -2.75e-01 | 3.50e-01 |
HOMOLOGOUS DNA PAIRING AND STRAND EXCHANGE | 41 | 2.40e-03 | -2.74e-01 | 2.59e-02 |
DEGRADATION OF DVL | 57 | 3.55e-04 | -2.74e-01 | 6.45e-03 |
TIGHT JUNCTION INTERACTIONS | 17 | 5.11e-02 | -2.73e-01 | 2.03e-01 |
CRMPS IN SEMA3A SIGNALING | 16 | 5.97e-02 | 2.72e-01 | 2.21e-01 |
REGULATION OF HMOX1 EXPRESSION AND ACTIVITY | 65 | 1.55e-04 | -2.71e-01 | 3.73e-03 |
SIGNALING BY NTRK3 TRKC | 17 | 5.39e-02 | 2.70e-01 | 2.07e-01 |
PLASMA LIPOPROTEIN ASSEMBLY | 11 | 1.22e-01 | 2.70e-01 | 3.36e-01 |
AUF1 HNRNP D0 BINDS AND DESTABILIZES MRNA | 55 | 5.72e-04 | -2.69e-01 | 8.99e-03 |
DNA REPLICATION | 123 | 2.79e-07 | -2.68e-01 | 2.99e-05 |
REGULATION OF TLR BY ENDOGENOUS LIGAND | 14 | 8.22e-02 | -2.68e-01 | 2.62e-01 |
G1 S DNA DAMAGE CHECKPOINTS | 67 | 1.50e-04 | -2.68e-01 | 3.70e-03 |
REGULATION OF IFNA SIGNALING | 12 | 1.09e-01 | 2.67e-01 | 3.14e-01 |
ACTIVATION OF THE PRE REPLICATIVE COMPLEX | 29 | 1.31e-02 | -2.66e-01 | 8.68e-02 |
TRANSFERRIN ENDOCYTOSIS AND RECYCLING | 26 | 1.91e-02 | -2.66e-01 | 1.11e-01 |
PROTEIN UBIQUITINATION | 70 | 1.24e-04 | -2.65e-01 | 3.25e-03 |
SIGNALING BY NOTCH2 | 33 | 8.37e-03 | 2.65e-01 | 6.49e-02 |
DECTIN 1 MEDIATED NONCANONICAL NF KB SIGNALING | 61 | 3.53e-04 | -2.65e-01 | 6.45e-03 |
REPRESSION OF WNT TARGET GENES | 14 | 8.67e-02 | 2.64e-01 | 2.71e-01 |
ABERRANT REGULATION OF MITOTIC EXIT IN CANCER DUE TO RB1 DEFECTS | 19 | 4.76e-02 | -2.63e-01 | 1.93e-01 |
DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | 80 | 4.94e-05 | -2.63e-01 | 1.64e-03 |
STABILIZATION OF P53 | 56 | 7.10e-04 | -2.62e-01 | 1.01e-02 |
ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | 32 | 1.05e-02 | 2.61e-01 | 7.54e-02 |
N GLYCAN ANTENNAE ELONGATION | 15 | 7.99e-02 | 2.61e-01 | 2.59e-01 |
NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | 17 | 6.24e-02 | 2.61e-01 | 2.29e-01 |
REGULATION OF TNFR1 SIGNALING | 34 | 8.48e-03 | 2.61e-01 | 6.50e-02 |
CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | 48 | 1.87e-03 | 2.60e-01 | 2.14e-02 |
PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | 51 | 1.36e-03 | -2.59e-01 | 1.66e-02 |
FCERI MEDIATED NF KB ACTIVATION | 78 | 7.53e-05 | -2.59e-01 | 2.22e-03 |
REGULATION OF RUNX2 EXPRESSION AND ACTIVITY | 71 | 1.63e-04 | -2.59e-01 | 3.77e-03 |
SEROTONIN NEUROTRANSMITTER RELEASE CYCLE | 18 | 5.77e-02 | 2.58e-01 | 2.16e-01 |
S PHASE | 155 | 2.87e-08 | -2.58e-01 | 3.77e-06 |
CYCLIN A B1 B2 ASSOCIATED EVENTS DURING G2 M TRANSITION | 22 | 3.63e-02 | -2.58e-01 | 1.62e-01 |
P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | 12 | 1.24e-01 | 2.57e-01 | 3.39e-01 |
CYCLIN A CDK2 ASSOCIATED EVENTS AT S PHASE ENTRY | 84 | 4.82e-05 | -2.57e-01 | 1.64e-03 |
CELLULAR RESPONSE TO HYPOXIA | 74 | 1.47e-04 | -2.55e-01 | 3.69e-03 |
REGULATION OF TP53 ACTIVITY THROUGH ASSOCIATION WITH CO FACTORS | 14 | 1.01e-01 | 2.53e-01 | 2.98e-01 |
BETA OXIDATION OF VERY LONG CHAIN FATTY ACIDS | 11 | 1.46e-01 | 2.53e-01 | 3.74e-01 |
PIWI INTERACTING RNA PIRNA BIOGENESIS | 19 | 5.71e-02 | -2.52e-01 | 2.15e-01 |
MITOCHONDRIAL CALCIUM ION TRANSPORT | 23 | 3.65e-02 | -2.52e-01 | 1.62e-01 |
FGFRL1 MODULATION OF FGFR1 SIGNALING | 10 | 1.68e-01 | -2.52e-01 | 3.98e-01 |
HYALURONAN METABOLISM | 15 | 9.16e-02 | 2.52e-01 | 2.79e-01 |
APC CDC20 MEDIATED DEGRADATION OF NEK2A | 24 | 3.30e-02 | -2.51e-01 | 1.53e-01 |
CYTOSOLIC TRNA AMINOACYLATION | 24 | 3.36e-02 | -2.51e-01 | 1.54e-01 |
INTERLEUKIN RECEPTOR SHC SIGNALING | 20 | 5.46e-02 | 2.48e-01 | 2.08e-01 |
IRE1ALPHA ACTIVATES CHAPERONES | 50 | 2.56e-03 | 2.47e-01 | 2.69e-02 |
COHESIN LOADING ONTO CHROMATIN | 10 | 1.77e-01 | -2.47e-01 | 4.13e-01 |
CD28 DEPENDENT VAV1 PATHWAY | 11 | 1.59e-01 | -2.45e-01 | 3.88e-01 |
APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B | 22 | 4.68e-02 | -2.45e-01 | 1.91e-01 |
RAB GERANYLGERANYLATION | 58 | 1.26e-03 | -2.45e-01 | 1.59e-02 |
G2 M DNA DAMAGE CHECKPOINT | 66 | 6.16e-04 | -2.44e-01 | 9.43e-03 |
DEGRADATION OF GLI1 BY THE PROTEASOME | 59 | 1.23e-03 | -2.43e-01 | 1.56e-02 |
FGFR1 LIGAND BINDING AND ACTIVATION | 10 | 1.85e-01 | -2.42e-01 | 4.22e-01 |
G2 M CHECKPOINTS | 135 | 1.19e-06 | -2.42e-01 | 8.22e-05 |
REGULATION OF TP53 ACTIVITY THROUGH ACETYLATION | 30 | 2.19e-02 | 2.42e-01 | 1.22e-01 |
ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | 30 | 2.23e-02 | -2.41e-01 | 1.22e-01 |
INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | 13 | 1.33e-01 | -2.41e-01 | 3.50e-01 |
NEPHRIN FAMILY INTERACTIONS | 23 | 4.57e-02 | 2.41e-01 | 1.88e-01 |
PEXOPHAGY | 11 | 1.67e-01 | 2.40e-01 | 3.98e-01 |
REGULATION OF BACH1 ACTIVITY | 11 | 1.68e-01 | -2.40e-01 | 3.98e-01 |
PI 3K CASCADE FGFR2 | 17 | 8.74e-02 | -2.40e-01 | 2.71e-01 |
PYRUVATE METABOLISM | 27 | 3.30e-02 | -2.37e-01 | 1.53e-01 |
PROTEIN LOCALIZATION | 157 | 3.24e-07 | -2.36e-01 | 3.18e-05 |
DCC MEDIATED ATTRACTIVE SIGNALING | 14 | 1.26e-01 | 2.36e-01 | 3.43e-01 |
CYTOCHROME C MEDIATED APOPTOTIC RESPONSE | 12 | 1.56e-01 | -2.36e-01 | 3.87e-01 |
DEGRADATION OF AXIN | 55 | 2.71e-03 | -2.34e-01 | 2.83e-02 |
DEACTIVATION OF THE BETA CATENIN TRANSACTIVATING COMPLEX | 41 | 9.62e-03 | 2.34e-01 | 7.12e-02 |
FRS MEDIATED FGFR2 SIGNALING | 19 | 7.79e-02 | -2.34e-01 | 2.57e-01 |
INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | 29 | 2.96e-02 | -2.33e-01 | 1.46e-01 |
NEGATIVE REGULATION OF TCF DEPENDENT SIGNALING BY WNT LIGAND ANTAGONISTS | 11 | 1.81e-01 | 2.33e-01 | 4.18e-01 |
RND2 GTPASE CYCLE | 39 | 1.19e-02 | 2.33e-01 | 8.09e-02 |
EPHRIN SIGNALING | 19 | 8.08e-02 | 2.31e-01 | 2.60e-01 |
HDMS DEMETHYLATE HISTONES | 26 | 4.12e-02 | 2.31e-01 | 1.74e-01 |
E3 UBIQUITIN LIGASES UBIQUITINATE TARGET PROTEINS | 51 | 4.31e-03 | -2.31e-01 | 4.00e-02 |
DEGRADATION OF CYSTEINE AND HOMOCYSTEINE | 13 | 1.50e-01 | -2.30e-01 | 3.79e-01 |
TRISTETRAPROLIN TTP ZFP36 BINDS AND DESTABILIZES MRNA | 16 | 1.12e-01 | -2.30e-01 | 3.18e-01 |
FORMATION OF APOPTOSOME | 10 | 2.09e-01 | -2.30e-01 | 4.59e-01 |
CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | 19 | 8.36e-02 | -2.29e-01 | 2.65e-01 |
ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | 33 | 2.27e-02 | -2.29e-01 | 1.22e-01 |
SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | 14 | 1.38e-01 | 2.29e-01 | 3.57e-01 |
RND3 GTPASE CYCLE | 38 | 1.45e-02 | 2.29e-01 | 9.30e-02 |
RESOLUTION OF D LOOP STRUCTURES THROUGH SYNTHESIS DEPENDENT STRAND ANNEALING SDSA | 25 | 4.76e-02 | -2.29e-01 | 1.93e-01 |
PROCESSING AND ACTIVATION OF SUMO | 10 | 2.10e-01 | -2.29e-01 | 4.61e-01 |
GLUTATHIONE CONJUGATION | 29 | 3.33e-02 | -2.28e-01 | 1.53e-01 |
SIGNALING BY NOTCH1 | 75 | 6.68e-04 | 2.27e-01 | 9.85e-03 |
MITOTIC G1 PHASE AND G1 S TRANSITION | 141 | 3.44e-06 | -2.27e-01 | 1.93e-04 |
TRANSLESION SYNTHESIS BY POLK | 17 | 1.06e-01 | -2.26e-01 | 3.09e-01 |
CA2 PATHWAY | 58 | 2.87e-03 | 2.26e-01 | 2.94e-02 |
PROTEIN METHYLATION | 17 | 1.06e-01 | -2.26e-01 | 3.09e-01 |
MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | 15 | 1.29e-01 | -2.26e-01 | 3.49e-01 |
RUNX1 INTERACTS WITH CO FACTORS WHOSE PRECISE EFFECT ON RUNX1 TARGETS IS NOT KNOWN | 37 | 1.74e-02 | 2.26e-01 | 1.03e-01 |
RHOB GTPASE CYCLE | 69 | 1.23e-03 | 2.25e-01 | 1.56e-02 |
RHOC GTPASE CYCLE | 74 | 8.54e-04 | 2.24e-01 | 1.17e-02 |
MAPK TARGETS NUCLEAR EVENTS MEDIATED BY MAP KINASES | 31 | 3.11e-02 | -2.24e-01 | 1.50e-01 |
CLEC7A DECTIN 1 SIGNALING | 96 | 1.61e-04 | -2.23e-01 | 3.77e-03 |
SEPARATION OF SISTER CHROMATIDS | 169 | 6.23e-07 | -2.22e-01 | 5.25e-05 |
REGULATION OF RUNX3 EXPRESSION AND ACTIVITY | 53 | 5.24e-03 | -2.22e-01 | 4.61e-02 |
BRANCHED CHAIN AMINO ACID CATABOLISM | 21 | 7.92e-02 | -2.21e-01 | 2.58e-01 |
GLUCAGON SIGNALING IN METABOLIC REGULATION | 30 | 3.66e-02 | 2.20e-01 | 1.62e-01 |
INSULIN RECEPTOR RECYCLING | 20 | 8.80e-02 | -2.20e-01 | 2.71e-01 |
CELL CYCLE CHECKPOINTS | 245 | 2.95e-09 | -2.20e-01 | 6.95e-07 |
REGULATION OF INSULIN SECRETION | 72 | 1.23e-03 | 2.20e-01 | 1.56e-02 |
PROCESSING OF DNA DOUBLE STRAND BREAK ENDS | 70 | 1.60e-03 | -2.18e-01 | 1.88e-02 |
GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTEGRINS | 12 | 1.92e-01 | 2.17e-01 | 4.34e-01 |
TRANSLATION OF REPLICASE AND ASSEMBLY OF THE REPLICATION TRANSCRIPTION COMPLEX | 12 | 1.92e-01 | -2.17e-01 | 4.34e-01 |
PERK REGULATES GENE EXPRESSION | 28 | 4.78e-02 | -2.16e-01 | 1.94e-01 |
SUPPRESSION OF PHAGOSOMAL MATURATION | 12 | 1.96e-01 | -2.16e-01 | 4.39e-01 |
SIGNALING BY NOTCH1 PEST DOMAIN MUTANTS IN CANCER | 59 | 4.28e-03 | 2.15e-01 | 4.00e-02 |
SIGNALING BY FGFR2 IN DISEASE | 37 | 2.39e-02 | -2.15e-01 | 1.26e-01 |
CELLULAR HEXOSE TRANSPORT | 11 | 2.18e-01 | 2.14e-01 | 4.74e-01 |
THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | 23 | 7.59e-02 | 2.14e-01 | 2.54e-01 |
TNF SIGNALING | 43 | 1.53e-02 | 2.14e-01 | 9.54e-02 |
MUCOPOLYSACCHARIDOSES | 11 | 2.21e-01 | 2.13e-01 | 4.74e-01 |
GLUTATHIONE SYNTHESIS AND RECYCLING | 11 | 2.21e-01 | -2.13e-01 | 4.74e-01 |
DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | 23 | 7.66e-02 | 2.13e-01 | 2.55e-01 |
GP1B IX V ACTIVATION SIGNALLING | 11 | 2.21e-01 | 2.13e-01 | 4.74e-01 |
ACTIVATION OF GENE EXPRESSION BY SREBF SREBP | 43 | 1.57e-02 | 2.13e-01 | 9.72e-02 |
NRAGE SIGNALS DEATH THROUGH JNK | 56 | 5.85e-03 | 2.13e-01 | 5.07e-02 |
RMTS METHYLATE HISTONE ARGININES | 42 | 1.71e-02 | 2.13e-01 | 1.02e-01 |
G ALPHA 12 13 SIGNALLING EVENTS | 76 | 1.36e-03 | 2.13e-01 | 1.66e-02 |
INTERLEUKIN 12 FAMILY SIGNALING | 43 | 1.60e-02 | -2.12e-01 | 9.80e-02 |
PYRIMIDINE CATABOLISM | 10 | 2.47e-01 | -2.12e-01 | 5.03e-01 |
BLOOD GROUP SYSTEMS BIOSYNTHESIS | 14 | 1.72e-01 | -2.11e-01 | 4.03e-01 |
INTEGRATION OF ENERGY METABOLISM | 100 | 2.76e-04 | 2.11e-01 | 5.52e-03 |
RHO GTPASES ACTIVATE NADPH OXIDASES | 22 | 8.77e-02 | -2.10e-01 | 2.71e-01 |
DERMATAN SULFATE BIOSYNTHESIS | 11 | 2.29e-01 | 2.10e-01 | 4.80e-01 |
PKA MEDIATED PHOSPHORYLATION OF CREB | 19 | 1.14e-01 | 2.09e-01 | 3.22e-01 |
MRNA CAPPING | 29 | 5.18e-02 | -2.09e-01 | 2.04e-01 |
TRAF6 MEDIATED IRF7 ACTIVATION | 15 | 1.63e-01 | 2.08e-01 | 3.92e-01 |
ROLE OF SECOND MESSENGERS IN NETRIN 1 SIGNALING | 10 | 2.55e-01 | 2.08e-01 | 5.14e-01 |
HSP90 CHAPERONE CYCLE FOR STEROID HORMONE RECEPTORS SHR | 48 | 1.29e-02 | -2.08e-01 | 8.61e-02 |
SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | 16 | 1.51e-01 | -2.07e-01 | 3.79e-01 |
DARPP 32 EVENTS | 23 | 8.62e-02 | -2.07e-01 | 2.70e-01 |
CDC42 GTPASE CYCLE | 155 | 9.19e-06 | 2.07e-01 | 4.36e-04 |
RUNX1 REGULATES GENES INVOLVED IN MEGAKARYOCYTE DIFFERENTIATION AND PLATELET FUNCTION | 49 | 1.28e-02 | 2.06e-01 | 8.61e-02 |
GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | 19 | 1.23e-01 | 2.05e-01 | 3.38e-01 |
HDR THROUGH SINGLE STRAND ANNEALING SSA | 37 | 3.14e-02 | -2.04e-01 | 1.50e-01 |
G0 AND EARLY G1 | 25 | 7.71e-02 | -2.04e-01 | 2.55e-01 |
SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | 18 | 1.36e-01 | -2.03e-01 | 3.54e-01 |
NEUROTRANSMITTER RELEASE CYCLE | 49 | 1.40e-02 | 2.03e-01 | 9.16e-02 |
G1 S SPECIFIC TRANSCRIPTION | 27 | 7.02e-02 | -2.01e-01 | 2.44e-01 |
NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | 48 | 1.59e-02 | 2.01e-01 | 9.79e-02 |
DEFECTIVE CFTR CAUSES CYSTIC FIBROSIS | 61 | 6.58e-03 | -2.01e-01 | 5.42e-02 |
INTERLEUKIN 15 SIGNALING | 13 | 2.10e-01 | 2.01e-01 | 4.61e-01 |
RUNX2 REGULATES BONE DEVELOPMENT | 29 | 6.24e-02 | 2.00e-01 | 2.29e-01 |
NEUREXINS AND NEUROLIGINS | 54 | 1.12e-02 | 2.00e-01 | 7.88e-02 |
RET SIGNALING | 36 | 3.86e-02 | 1.99e-01 | 1.66e-01 |
INTEGRIN SIGNALING | 24 | 9.16e-02 | 1.99e-01 | 2.79e-01 |
OTHER SEMAPHORIN INTERACTIONS | 19 | 1.33e-01 | 1.99e-01 | 3.50e-01 |
G ALPHA S SIGNALLING EVENTS | 109 | 3.54e-04 | 1.98e-01 | 6.45e-03 |
C TYPE LECTIN RECEPTORS CLRS | 115 | 2.47e-04 | -1.98e-01 | 5.02e-03 |
FORMATION OF INCISION COMPLEX IN GG NER | 43 | 2.49e-02 | -1.98e-01 | 1.29e-01 |
INTERLEUKIN 20 FAMILY SIGNALING | 14 | 2.01e-01 | 1.98e-01 | 4.48e-01 |
PRE NOTCH PROCESSING IN GOLGI | 17 | 1.59e-01 | 1.97e-01 | 3.88e-01 |
CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | 12 | 2.38e-01 | 1.97e-01 | 4.94e-01 |
RA BIOSYNTHESIS PATHWAY | 14 | 2.03e-01 | -1.97e-01 | 4.52e-01 |
HDR THROUGH HOMOLOGOUS RECOMBINATION HRR | 63 | 7.02e-03 | -1.96e-01 | 5.75e-02 |
RESOLUTION OF D LOOP STRUCTURES | 31 | 5.85e-02 | -1.96e-01 | 2.18e-01 |
MITOTIC TELOPHASE CYTOKINESIS | 13 | 2.21e-01 | -1.96e-01 | 4.74e-01 |
METABOLIC DISORDERS OF BIOLOGICAL OXIDATION ENZYMES | 20 | 1.30e-01 | -1.96e-01 | 3.49e-01 |
REGULATION OF PTEN STABILITY AND ACTIVITY | 69 | 4.95e-03 | -1.96e-01 | 4.42e-02 |
PLASMA LIPOPROTEIN REMODELING | 13 | 2.22e-01 | 1.95e-01 | 4.74e-01 |
RECOGNITION OF DNA DAMAGE BY PCNA CONTAINING REPLICATION COMPLEX | 28 | 7.36e-02 | -1.95e-01 | 2.51e-01 |
TRAFFICKING OF AMPA RECEPTORS | 31 | 5.99e-02 | 1.95e-01 | 2.21e-01 |
DISEASES ASSOCIATED WITH O GLYCOSYLATION OF PROTEINS | 52 | 1.52e-02 | 1.95e-01 | 9.54e-02 |
ADRENALINE NORADRENALINE INHIBITS INSULIN SECRETION | 27 | 8.04e-02 | 1.94e-01 | 2.60e-01 |
PRE NOTCH EXPRESSION AND PROCESSING | 62 | 8.19e-03 | 1.94e-01 | 6.40e-02 |
LYSOSPHINGOLIPID AND LPA RECEPTORS | 13 | 2.25e-01 | 1.94e-01 | 4.78e-01 |
CHONDROITIN SULFATE BIOSYNTHESIS | 18 | 1.55e-01 | 1.94e-01 | 3.85e-01 |
HS GAG DEGRADATION | 22 | 1.16e-01 | 1.93e-01 | 3.25e-01 |
MITOTIC METAPHASE AND ANAPHASE | 210 | 1.41e-06 | -1.93e-01 | 9.21e-05 |
REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | 86 | 1.98e-03 | -1.93e-01 | 2.21e-02 |
RHOV GTPASE CYCLE | 33 | 5.51e-02 | 1.93e-01 | 2.08e-01 |
VEGFR2 MEDIATED CELL PROLIFERATION | 19 | 1.46e-01 | -1.93e-01 | 3.73e-01 |
TRANSLATION | 287 | 2.17e-08 | -1.92e-01 | 3.66e-06 |
RHOBTB3 ATPASE CYCLE | 10 | 2.94e-01 | -1.92e-01 | 5.60e-01 |
INTERLEUKIN 37 SIGNALING | 18 | 1.59e-01 | 1.92e-01 | 3.88e-01 |
PROCESSING OF CAPPED INTRONLESS PRE MRNA | 28 | 7.93e-02 | -1.92e-01 | 2.58e-01 |
RHOU GTPASE CYCLE | 34 | 5.33e-02 | 1.92e-01 | 2.07e-01 |
ADP SIGNALLING THROUGH P2Y PURINOCEPTOR 1 | 24 | 1.05e-01 | 1.91e-01 | 3.07e-01 |
BUTYRATE RESPONSE FACTOR 1 BRF1 BINDS AND DESTABILIZES MRNA | 16 | 1.86e-01 | -1.91e-01 | 4.24e-01 |
REGULATION OF RAS BY GAPS | 68 | 6.48e-03 | -1.91e-01 | 5.39e-02 |
MITOCHONDRIAL FATTY ACID BETA OXIDATION | 34 | 5.41e-02 | -1.91e-01 | 2.07e-01 |
APOPTOTIC FACTOR MEDIATED RESPONSE | 18 | 1.62e-01 | -1.90e-01 | 3.91e-01 |
SIGNALING BY FGFR2 IIIA TM | 19 | 1.51e-01 | -1.90e-01 | 3.79e-01 |
N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | 24 | 1.07e-01 | 1.90e-01 | 3.09e-01 |
TCR SIGNALING | 104 | 8.30e-04 | -1.90e-01 | 1.15e-02 |
FORMATION OF TC NER PRE INCISION COMPLEX | 53 | 1.71e-02 | -1.89e-01 | 1.02e-01 |
FOXO MEDIATED TRANSCRIPTION OF OXIDATIVE STRESS METABOLIC AND NEURONAL GENES | 25 | 1.01e-01 | 1.89e-01 | 2.98e-01 |
GABA B RECEPTOR ACTIVATION | 40 | 3.83e-02 | 1.89e-01 | 1.66e-01 |
METHYLATION | 11 | 2.78e-01 | -1.89e-01 | 5.46e-01 |
THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | 28 | 8.43e-02 | 1.89e-01 | 2.66e-01 |
PHASE II CONJUGATION OF COMPOUNDS | 63 | 9.72e-03 | -1.88e-01 | 7.12e-02 |
ION TRANSPORT BY P TYPE ATPASES | 49 | 2.33e-02 | 1.87e-01 | 1.24e-01 |
RHOA GTPASE CYCLE | 144 | 1.06e-04 | 1.87e-01 | 2.90e-03 |
INTERLEUKIN 2 FAMILY SIGNALING | 33 | 6.27e-02 | 1.87e-01 | 2.29e-01 |
COLLAGEN CHAIN TRIMERIZATION | 41 | 3.91e-02 | -1.86e-01 | 1.68e-01 |
IRON UPTAKE AND TRANSPORT | 52 | 2.03e-02 | -1.86e-01 | 1.16e-01 |
SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | 11 | 2.86e-01 | -1.86e-01 | 5.54e-01 |
TRAF6 MEDIATED NF KB ACTIVATION | 22 | 1.31e-01 | 1.86e-01 | 3.49e-01 |
CYTOPROTECTION BY HMOX1 | 120 | 4.59e-04 | -1.85e-01 | 8.07e-03 |
ONCOGENE INDUCED SENESCENCE | 32 | 6.99e-02 | 1.85e-01 | 2.44e-01 |
SULFUR AMINO ACID METABOLISM | 23 | 1.29e-01 | -1.83e-01 | 3.49e-01 |
IRAK4 DEFICIENCY TLR2 4 | 15 | 2.22e-01 | -1.82e-01 | 4.74e-01 |
DISEASES OF MITOTIC CELL CYCLE | 37 | 5.55e-02 | -1.82e-01 | 2.09e-01 |
MITOTIC G2 G2 M PHASES | 187 | 1.84e-05 | -1.82e-01 | 7.48e-04 |
BBSOME MEDIATED CARGO TARGETING TO CILIUM | 23 | 1.31e-01 | -1.82e-01 | 3.49e-01 |
DOWNSTREAM SIGNAL TRANSDUCTION | 29 | 9.12e-02 | 1.81e-01 | 2.79e-01 |
HOST INTERACTIONS OF HIV FACTORS | 128 | 4.03e-04 | -1.81e-01 | 7.21e-03 |
PHASE 0 RAPID DEPOLARISATION | 28 | 9.75e-02 | 1.81e-01 | 2.92e-01 |
NOTCH2 ACTIVATION AND TRANSMISSION OF SIGNAL TO THE NUCLEUS | 23 | 1.33e-01 | 1.81e-01 | 3.50e-01 |
GLYCOSPHINGOLIPID METABOLISM | 38 | 5.42e-02 | -1.81e-01 | 2.07e-01 |
POST CHAPERONIN TUBULIN FOLDING PATHWAY | 17 | 1.98e-01 | -1.80e-01 | 4.44e-01 |
METABOLISM OF PORPHYRINS | 19 | 1.75e-01 | -1.80e-01 | 4.09e-01 |
FC EPSILON RECEPTOR FCERI SIGNALING | 125 | 5.20e-04 | -1.80e-01 | 8.75e-03 |
GLUCAGON LIKE PEPTIDE 1 GLP1 REGULATES INSULIN SECRETION | 39 | 5.20e-02 | 1.80e-01 | 2.04e-01 |
NEGATIVE REGULATION OF FGFR2 SIGNALING | 28 | 9.96e-02 | -1.80e-01 | 2.96e-01 |
RESOLUTION OF SISTER CHROMATID COHESION | 103 | 1.67e-03 | -1.79e-01 | 1.94e-02 |
HDR THROUGH MMEJ ALT NHEJ | 10 | 3.26e-01 | -1.79e-01 | 5.92e-01 |
METABOLISM OF STEROID HORMONES | 21 | 1.56e-01 | -1.79e-01 | 3.86e-01 |
TP53 REGULATES TRANSCRIPTION OF CASPASE ACTIVATORS AND CASPASES | 11 | 3.04e-01 | -1.79e-01 | 5.70e-01 |
FCGR3A MEDIATED IL10 SYNTHESIS | 33 | 7.55e-02 | 1.79e-01 | 2.54e-01 |
NOTCH3 ACTIVATION AND TRANSMISSION OF SIGNAL TO THE NUCLEUS | 26 | 1.15e-01 | 1.79e-01 | 3.24e-01 |
EGR2 AND SOX10 MEDIATED INITIATION OF SCHWANN CELL MYELINATION | 27 | 1.08e-01 | 1.79e-01 | 3.13e-01 |
DEGRADATION OF BETA CATENIN BY THE DESTRUCTION COMPLEX | 84 | 4.73e-03 | -1.78e-01 | 4.29e-02 |
MITOTIC SPINDLE CHECKPOINT | 98 | 2.29e-03 | -1.78e-01 | 2.50e-02 |
DISEASES ASSOCIATED WITH N GLYCOSYLATION OF PROTEINS | 17 | 2.06e-01 | -1.77e-01 | 4.55e-01 |
INTERLEUKIN 6 FAMILY SIGNALING | 21 | 1.61e-01 | 1.77e-01 | 3.91e-01 |
PROTEIN PROTEIN INTERACTIONS AT SYNAPSES | 85 | 4.99e-03 | 1.76e-01 | 4.42e-02 |
REGULATION OF KIT SIGNALING | 16 | 2.22e-01 | 1.76e-01 | 4.74e-01 |
PYROPTOSIS | 21 | 1.62e-01 | -1.76e-01 | 3.91e-01 |
INTERLEUKIN 3 INTERLEUKIN 5 AND GM CSF SIGNALING | 41 | 5.15e-02 | 1.76e-01 | 2.04e-01 |
ECM PROTEOGLYCANS | 66 | 1.36e-02 | 1.76e-01 | 8.98e-02 |
CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | 12 | 2.96e-01 | 1.74e-01 | 5.61e-01 |
PRESYNAPTIC FUNCTION OF KAINATE RECEPTORS | 20 | 1.78e-01 | 1.74e-01 | 4.13e-01 |
SIGNALING BY CTNNB1 PHOSPHO SITE MUTANTS | 15 | 2.46e-01 | -1.73e-01 | 5.03e-01 |
TRANSCRIPTION OF E2F TARGETS UNDER NEGATIVE CONTROL BY DREAM COMPLEX | 17 | 2.17e-01 | -1.73e-01 | 4.72e-01 |
CELLULAR RESPONSE TO CHEMICAL STRESS | 153 | 2.35e-04 | -1.72e-01 | 5.02e-03 |
LOSS OF FUNCTION OF MECP2 IN RETT SYNDROME | 13 | 2.82e-01 | 1.72e-01 | 5.50e-01 |
HIV INFECTION | 224 | 9.25e-06 | -1.72e-01 | 4.36e-04 |
PCNA DEPENDENT LONG PATCH BASE EXCISION REPAIR | 20 | 1.83e-01 | -1.72e-01 | 4.21e-01 |
BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN GENE EXPRESSION | 26 | 1.30e-01 | 1.72e-01 | 3.49e-01 |
ALPHA LINOLENIC OMEGA3 AND LINOLEIC OMEGA6 ACID METABOLISM | 12 | 3.05e-01 | 1.71e-01 | 5.71e-01 |
PECAM1 INTERACTIONS | 12 | 3.06e-01 | 1.71e-01 | 5.71e-01 |
TRANSPORT OF BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS | 71 | 1.29e-02 | 1.71e-01 | 8.61e-02 |
SEALING OF THE NUCLEAR ENVELOPE NE BY ESCRT III | 23 | 1.57e-01 | -1.70e-01 | 3.87e-01 |
REGULATION OF TP53 ACTIVITY THROUGH PHOSPHORYLATION | 89 | 5.62e-03 | -1.70e-01 | 4.91e-02 |
ELEVATION OF CYTOSOLIC CA2 LEVELS | 14 | 2.72e-01 | 1.70e-01 | 5.40e-01 |
SIGNALING BY THE B CELL RECEPTOR BCR | 105 | 2.74e-03 | -1.69e-01 | 2.84e-02 |
VASOPRESSIN REGULATES RENAL WATER HOMEOSTASIS VIA AQUAPORINS | 38 | 7.18e-02 | 1.69e-01 | 2.47e-01 |
FORMATION OF THE BETA CATENIN TCF TRANSACTIVATING COMPLEX | 45 | 5.03e-02 | 1.69e-01 | 2.01e-01 |
TRANSPORT OF CONNEXONS TO THE PLASMA MEMBRANE | 13 | 2.93e-01 | -1.68e-01 | 5.60e-01 |
BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | 76 | 1.13e-02 | -1.68e-01 | 7.88e-02 |
RHOBTB1 GTPASE CYCLE | 23 | 1.63e-01 | -1.68e-01 | 3.92e-01 |
SYNTHESIS SECRETION AND INACTIVATION OF GLUCAGON LIKE PEPTIDE 1 GLP 1 | 13 | 2.96e-01 | -1.67e-01 | 5.61e-01 |
DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | 37 | 7.92e-02 | -1.67e-01 | 2.58e-01 |
MAPK6 MAPK4 SIGNALING | 86 | 7.70e-03 | -1.66e-01 | 6.16e-02 |
HEPARAN SULFATE HEPARIN HS GAG METABOLISM | 54 | 3.48e-02 | 1.66e-01 | 1.56e-01 |
HEDGEHOG LIGAND BIOGENESIS | 63 | 2.29e-02 | -1.66e-01 | 1.22e-01 |
HSF1 ACTIVATION | 26 | 1.44e-01 | -1.66e-01 | 3.72e-01 |
HOMOLOGY DIRECTED REPAIR | 106 | 3.28e-03 | -1.65e-01 | 3.25e-02 |
ANTI INFLAMMATORY RESPONSE FAVOURING LEISHMANIA PARASITE INFECTION | 122 | 1.79e-03 | 1.64e-01 | 2.07e-02 |
PEROXISOMAL LIPID METABOLISM | 26 | 1.48e-01 | -1.64e-01 | 3.77e-01 |
HDACS DEACETYLATE HISTONES | 45 | 5.82e-02 | 1.63e-01 | 2.17e-01 |
CLASS B 2 SECRETIN FAMILY RECEPTORS | 69 | 1.93e-02 | 1.63e-01 | 1.11e-01 |
SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | 12 | 3.30e-01 | 1.62e-01 | 5.94e-01 |
TRANSCRIPTIONAL REGULATION OF GRANULOPOIESIS | 43 | 6.58e-02 | 1.62e-01 | 2.37e-01 |
NCAM SIGNALING FOR NEURITE OUT GROWTH | 60 | 3.04e-02 | 1.62e-01 | 1.49e-01 |
MECP2 REGULATES NEURONAL RECEPTORS AND CHANNELS | 18 | 2.38e-01 | 1.61e-01 | 4.94e-01 |
BUDDING AND MATURATION OF HIV VIRION | 27 | 1.49e-01 | -1.60e-01 | 3.78e-01 |
TRNA PROCESSING IN THE NUCLEUS | 56 | 3.85e-02 | -1.60e-01 | 1.66e-01 |
NEGATIVE REGULATION OF MAPK PATHWAY | 42 | 7.45e-02 | -1.59e-01 | 2.52e-01 |
COPI INDEPENDENT GOLGI TO ER RETROGRADE TRAFFIC | 44 | 6.84e-02 | -1.59e-01 | 2.42e-01 |
NCAM1 INTERACTIONS | 40 | 8.24e-02 | 1.59e-01 | 2.62e-01 |
GLYCOSAMINOGLYCAN METABOLISM | 116 | 3.22e-03 | 1.58e-01 | 3.21e-02 |
TRANSCRIPTIONAL REGULATION BY MECP2 | 60 | 3.39e-02 | 1.58e-01 | 1.55e-01 |
ADORA2B MEDIATED ANTI INFLAMMATORY CYTOKINES PRODUCTION | 96 | 7.46e-03 | 1.58e-01 | 6.02e-02 |
NEUROTOXICITY OF CLOSTRIDIUM TOXINS | 10 | 3.88e-01 | 1.58e-01 | 6.44e-01 |
G ALPHA Q SIGNALLING EVENTS | 161 | 5.70e-04 | 1.57e-01 | 8.99e-03 |
DAG AND IP3 SIGNALING | 40 | 8.49e-02 | 1.57e-01 | 2.67e-01 |
METABOLISM OF FAT SOLUBLE VITAMINS | 32 | 1.24e-01 | 1.57e-01 | 3.40e-01 |
SHC MEDIATED CASCADE FGFR1 | 16 | 2.78e-01 | -1.57e-01 | 5.46e-01 |
SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | 20 | 2.25e-01 | 1.57e-01 | 4.78e-01 |
IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | 10 | 3.94e-01 | 1.56e-01 | 6.51e-01 |
NONHOMOLOGOUS END JOINING NHEJ | 42 | 8.13e-02 | -1.56e-01 | 2.60e-01 |
AMINE LIGAND BINDING RECEPTORS | 28 | 1.55e-01 | 1.55e-01 | 3.85e-01 |
HEME BIOSYNTHESIS | 13 | 3.32e-01 | -1.55e-01 | 5.95e-01 |
TRANSCRIPTIONAL REGULATION BY E2F6 | 34 | 1.17e-01 | -1.55e-01 | 3.26e-01 |
MITOCHONDRIAL BIOGENESIS | 93 | 9.70e-03 | -1.55e-01 | 7.12e-02 |
RAS PROCESSING | 24 | 1.88e-01 | -1.55e-01 | 4.29e-01 |
REGULATION OF BETA CELL DEVELOPMENT | 29 | 1.49e-01 | 1.55e-01 | 3.77e-01 |
INTERFERON ALPHA BETA SIGNALING | 57 | 4.32e-02 | 1.55e-01 | 1.79e-01 |
PTK6 REGULATES RHO GTPASES RAS GTPASE AND MAP KINASES | 13 | 3.34e-01 | -1.55e-01 | 5.96e-01 |
METAL ION SLC TRANSPORTERS | 25 | 1.81e-01 | 1.55e-01 | 4.18e-01 |
PROLONGED ERK ACTIVATION EVENTS | 14 | 3.17e-01 | -1.55e-01 | 5.83e-01 |
TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | 87 | 1.28e-02 | 1.55e-01 | 8.61e-02 |
REGULATION OF CHOLESTEROL BIOSYNTHESIS BY SREBP SREBF | 56 | 4.64e-02 | 1.54e-01 | 1.90e-01 |
SENSORY PROCESSING OF SOUND BY OUTER HAIR CELLS OF THE COCHLEA | 41 | 8.82e-02 | 1.54e-01 | 2.71e-01 |
ATF4 ACTIVATES GENES IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 23 | 2.03e-01 | -1.53e-01 | 4.52e-01 |
M PHASE | 342 | 1.17e-06 | -1.53e-01 | 8.22e-05 |
TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | 74 | 2.28e-02 | 1.53e-01 | 1.22e-01 |
TRANSLOCATION OF SLC2A4 GLUT4 TO THE PLASMA MEMBRANE | 64 | 3.42e-02 | -1.53e-01 | 1.56e-01 |
GPCR LIGAND BINDING | 273 | 1.39e-05 | 1.53e-01 | 5.84e-04 |
SHC1 EVENTS IN ERBB4 SIGNALING | 13 | 3.43e-01 | -1.52e-01 | 6.02e-01 |
THE NLRP3 INFLAMMASOME | 14 | 3.29e-01 | -1.51e-01 | 5.94e-01 |
TP53 REGULATES TRANSCRIPTION OF GENES INVOLVED IN G1 CELL CYCLE ARREST | 13 | 3.47e-01 | -1.51e-01 | 6.06e-01 |
RHOBTB2 GTPASE CYCLE | 23 | 2.11e-01 | -1.51e-01 | 4.61e-01 |
PURINERGIC SIGNALING IN LEISHMANIASIS INFECTION | 22 | 2.22e-01 | -1.50e-01 | 4.74e-01 |
MATURATION OF SARS COV 2 SPIKE PROTEIN | 29 | 1.61e-01 | 1.50e-01 | 3.91e-01 |
PINK1 PRKN MEDIATED MITOPHAGY | 22 | 2.23e-01 | -1.50e-01 | 4.75e-01 |
STAT5 ACTIVATION DOWNSTREAM OF FLT3 ITD MUTANTS | 10 | 4.12e-01 | 1.50e-01 | 6.69e-01 |
RNA POLYMERASE I PROMOTER ESCAPE | 46 | 7.95e-02 | -1.49e-01 | 2.58e-01 |
CHROMATIN MODIFYING ENZYMES | 219 | 1.41e-04 | 1.49e-01 | 3.62e-03 |
SIGNAL AMPLIFICATION | 31 | 1.50e-01 | 1.49e-01 | 3.79e-01 |
DETOXIFICATION OF REACTIVE OXYGEN SPECIES | 34 | 1.33e-01 | -1.49e-01 | 3.50e-01 |
MATURATION OF NUCLEOPROTEIN | 10 | 4.15e-01 | -1.49e-01 | 6.72e-01 |
GAB1 SIGNALOSOME | 14 | 3.36e-01 | 1.49e-01 | 5.97e-01 |
DISASSEMBLY OF THE DESTRUCTION COMPLEX AND RECRUITMENT OF AXIN TO THE MEMBRANE | 26 | 1.90e-01 | 1.48e-01 | 4.31e-01 |
GAP JUNCTION ASSEMBLY | 21 | 2.40e-01 | -1.48e-01 | 4.98e-01 |
TP53 REGULATES TRANSCRIPTION OF ADDITIONAL CELL CYCLE GENES WHOSE EXACT ROLE IN THE P53 PATHWAY REMAIN UNCERTAIN | 20 | 2.53e-01 | -1.48e-01 | 5.12e-01 |
ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING | 29 | 1.70e-01 | 1.47e-01 | 4.00e-01 |
ANTIGEN PROCESSING CROSS PRESENTATION | 101 | 1.05e-02 | -1.47e-01 | 7.54e-02 |
MITOTIC PROMETAPHASE | 178 | 7.08e-04 | -1.47e-01 | 1.01e-02 |
TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR TC NER | 77 | 2.55e-02 | -1.47e-01 | 1.30e-01 |
G PROTEIN MEDIATED EVENTS | 52 | 6.65e-02 | 1.47e-01 | 2.38e-01 |
SIGNALING BY GPCR | 490 | 2.78e-08 | 1.47e-01 | 3.77e-06 |
CLASS A 1 RHODOPSIN LIKE RECEPTORS | 192 | 4.68e-04 | 1.47e-01 | 8.12e-03 |
NEDDYLATION | 221 | 1.78e-04 | -1.46e-01 | 4.04e-03 |
FORMATION OF SENESCENCE ASSOCIATED HETEROCHROMATIN FOCI SAHF | 13 | 3.61e-01 | 1.46e-01 | 6.17e-01 |
FLT3 SIGNALING | 36 | 1.29e-01 | 1.46e-01 | 3.49e-01 |
ABERRANT REGULATION OF MITOTIC G1 S TRANSITION IN CANCER DUE TO RB1 DEFECTS | 17 | 2.97e-01 | -1.46e-01 | 5.61e-01 |
ERK MAPK TARGETS | 22 | 2.37e-01 | -1.46e-01 | 4.93e-01 |
SIALIC ACID METABOLISM | 32 | 1.54e-01 | -1.46e-01 | 3.84e-01 |
ROLE OF PHOSPHOLIPIDS IN PHAGOCYTOSIS | 23 | 2.26e-01 | 1.46e-01 | 4.78e-01 |
TRANSCRIPTION OF THE HIV GENOME | 67 | 3.98e-02 | -1.45e-01 | 1.69e-01 |
TRANSCRIPTION OF E2F TARGETS UNDER NEGATIVE CONTROL BY P107 RBL1 AND P130 RBL2 IN COMPLEX WITH HDAC1 | 16 | 3.15e-01 | -1.45e-01 | 5.81e-01 |
SYNTHESIS OF PE | 13 | 3.68e-01 | 1.44e-01 | 6.26e-01 |
NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | 20 | 2.64e-01 | 1.44e-01 | 5.27e-01 |
GROWTH HORMONE RECEPTOR SIGNALING | 21 | 2.55e-01 | 1.44e-01 | 5.14e-01 |
DISEASES ASSOCIATED WITH GLYCOSYLATION PRECURSOR BIOSYNTHESIS | 18 | 2.92e-01 | -1.44e-01 | 5.59e-01 |
PEPTIDE LIGAND BINDING RECEPTORS | 115 | 7.90e-03 | 1.43e-01 | 6.24e-02 |
CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | 74 | 3.31e-02 | 1.43e-01 | 1.53e-01 |
CASPASE ACTIVATION VIA DEPENDENCE RECEPTORS IN THE ABSENCE OF LIGAND | 10 | 4.33e-01 | 1.43e-01 | 6.90e-01 |
REGULATION OF HSF1 MEDIATED HEAT SHOCK RESPONSE | 76 | 3.10e-02 | -1.43e-01 | 1.50e-01 |
RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | 24 | 2.27e-01 | -1.43e-01 | 4.78e-01 |
TP53 REGULATES METABOLIC GENES | 87 | 2.18e-02 | -1.42e-01 | 1.22e-01 |
RHO GTPASES ACTIVATE FORMINS | 120 | 7.13e-03 | -1.42e-01 | 5.80e-02 |
RNA POLYMERASE I TRANSCRIPTION TERMINATION | 31 | 1.71e-01 | -1.42e-01 | 4.02e-01 |
RUNX1 REGULATES TRANSCRIPTION OF GENES INVOLVED IN DIFFERENTIATION OF HSCS | 84 | 2.54e-02 | -1.41e-01 | 1.30e-01 |
CYCLIN D ASSOCIATED EVENTS IN G1 | 45 | 1.02e-01 | -1.41e-01 | 2.99e-01 |
INOSITOL PHOSPHATE METABOLISM | 46 | 9.89e-02 | 1.41e-01 | 2.94e-01 |
SLC MEDIATED TRANSMEMBRANE TRANSPORT | 196 | 7.00e-04 | 1.41e-01 | 1.01e-02 |
REGULATION OF INSULIN LIKE GROWTH FACTOR IGF TRANSPORT AND UPTAKE BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | 90 | 2.13e-02 | 1.41e-01 | 1.20e-01 |
ADHERENS JUNCTIONS INTERACTIONS | 30 | 1.83e-01 | 1.40e-01 | 4.21e-01 |
SPHINGOLIPID METABOLISM | 79 | 3.19e-02 | -1.40e-01 | 1.51e-01 |
ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | 29 | 1.94e-01 | -1.39e-01 | 4.37e-01 |
SIGNALING BY INSULIN RECEPTOR | 64 | 5.41e-02 | -1.39e-01 | 2.07e-01 |
PLASMA LIPOPROTEIN ASSEMBLY REMODELING AND CLEARANCE | 48 | 9.63e-02 | 1.39e-01 | 2.90e-01 |
ACTIVATION OF BAD AND TRANSLOCATION TO MITOCHONDRIA | 15 | 3.53e-01 | -1.39e-01 | 6.08e-01 |
CELL CYCLE MITOTIC | 476 | 2.59e-07 | -1.38e-01 | 2.99e-05 |
TICAM1 RIP1 MEDIATED IKK COMPLEX RECRUITMENT | 18 | 3.11e-01 | -1.38e-01 | 5.76e-01 |
INTERLEUKIN 10 SIGNALING | 21 | 2.77e-01 | 1.37e-01 | 5.46e-01 |
RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | 79 | 3.58e-02 | -1.37e-01 | 1.60e-01 |
CHROMOSOME MAINTENANCE | 101 | 1.78e-02 | -1.37e-01 | 1.04e-01 |
RAF ACTIVATION | 34 | 1.69e-01 | -1.36e-01 | 3.99e-01 |
CELL CYCLE | 594 | 1.65e-08 | -1.36e-01 | 3.25e-06 |
DISEASES OF GLYCOSYLATION | 126 | 8.46e-03 | 1.36e-01 | 6.50e-02 |
NF KB IS ACTIVATED AND SIGNALS SURVIVAL | 13 | 3.97e-01 | 1.36e-01 | 6.55e-01 |
RHO GTPASES ACTIVATE KTN1 | 11 | 4.35e-01 | -1.36e-01 | 6.91e-01 |
MITOPHAGY | 29 | 2.06e-01 | -1.36e-01 | 4.55e-01 |
ANTIMICROBIAL PEPTIDES | 17 | 3.33e-01 | -1.36e-01 | 5.95e-01 |
FATTY ACYL COA BIOSYNTHESIS | 32 | 1.84e-01 | -1.36e-01 | 4.22e-01 |
INTERLEUKIN 1 SIGNALING | 98 | 2.05e-02 | -1.35e-01 | 1.17e-01 |
TRNA PROCESSING | 105 | 1.70e-02 | -1.35e-01 | 1.02e-01 |
SENSORY PROCESSING OF SOUND | 61 | 6.90e-02 | 1.35e-01 | 2.44e-01 |
FLT3 SIGNALING IN DISEASE | 28 | 2.19e-01 | 1.34e-01 | 4.74e-01 |
RAC1 GTPASE CYCLE | 180 | 1.97e-03 | 1.34e-01 | 2.21e-02 |
ASSEMBLY OF COLLAGEN FIBRILS AND OTHER MULTIMERIC STRUCTURES | 53 | 9.32e-02 | -1.33e-01 | 2.83e-01 |
KINESINS | 48 | 1.10e-01 | 1.33e-01 | 3.16e-01 |
GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR GG NER | 83 | 3.62e-02 | -1.33e-01 | 1.61e-01 |
DNA DAMAGE BYPASS | 45 | 1.23e-01 | -1.33e-01 | 3.38e-01 |
SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | 62 | 7.03e-02 | -1.33e-01 | 2.44e-01 |
VISUAL PHOTOTRANSDUCTION | 59 | 7.75e-02 | 1.33e-01 | 2.56e-01 |
RHO GTPASES ACTIVATE WASPS AND WAVES | 36 | 1.68e-01 | -1.33e-01 | 3.98e-01 |
PKMTS METHYLATE HISTONE LYSINES | 47 | 1.15e-01 | 1.33e-01 | 3.24e-01 |
MHC CLASS II ANTIGEN PRESENTATION | 102 | 2.07e-02 | -1.33e-01 | 1.17e-01 |
PEROXISOMAL PROTEIN IMPORT | 58 | 8.11e-02 | -1.32e-01 | 2.60e-01 |
HIV LIFE CYCLE | 142 | 6.49e-03 | -1.32e-01 | 5.39e-02 |
ATTENUATION PHASE | 24 | 2.62e-01 | -1.32e-01 | 5.24e-01 |
G ALPHA Z SIGNALLING EVENTS | 44 | 1.29e-01 | 1.32e-01 | 3.49e-01 |
ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | 59 | 8.13e-02 | -1.31e-01 | 2.60e-01 |
TICAM1 TRAF6 DEPENDENT INDUCTION OF TAK1 COMPLEX | 11 | 4.51e-01 | -1.31e-01 | 7.06e-01 |
ONCOGENIC MAPK SIGNALING | 76 | 4.87e-02 | 1.31e-01 | 1.96e-01 |
ASYMMETRIC LOCALIZATION OF PCP PROTEINS | 64 | 7.07e-02 | -1.31e-01 | 2.44e-01 |
REGULATION OF GLYCOLYSIS BY FRUCTOSE 2 6 BISPHOSPHATE METABOLISM | 11 | 4.55e-01 | -1.30e-01 | 7.08e-01 |
RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | 86 | 3.73e-02 | -1.30e-01 | 1.63e-01 |
SYNTHESIS OF PA | 29 | 2.26e-01 | 1.30e-01 | 4.78e-01 |
SIGNALING BY FLT3 FUSION PROTEINS | 19 | 3.28e-01 | 1.30e-01 | 5.94e-01 |
BETA CATENIN PHOSPHORYLATION CASCADE | 16 | 3.70e-01 | -1.29e-01 | 6.29e-01 |
TRANSLESION SYNTHESIS BY POLH | 19 | 3.31e-01 | -1.29e-01 | 5.94e-01 |
EFFECTS OF PIP2 HYDROLYSIS | 27 | 2.46e-01 | 1.29e-01 | 5.03e-01 |
SIRT1 NEGATIVELY REGULATES RRNA EXPRESSION | 23 | 2.85e-01 | -1.29e-01 | 5.53e-01 |
REGULATION OF PLK1 ACTIVITY AT G2 M TRANSITION | 85 | 4.02e-02 | -1.29e-01 | 1.71e-01 |
ACYL CHAIN REMODELLING OF PG | 10 | 4.82e-01 | -1.28e-01 | 7.34e-01 |
SIGNALING BY EGFR | 47 | 1.30e-01 | 1.28e-01 | 3.49e-01 |
UPTAKE AND FUNCTION OF ANTHRAX TOXINS | 11 | 4.64e-01 | 1.27e-01 | 7.17e-01 |
FRS MEDIATED FGFR1 SIGNALING | 18 | 3.50e-01 | -1.27e-01 | 6.08e-01 |
RHO GTPASES ACTIVATE IQGAPS | 24 | 2.81e-01 | -1.27e-01 | 5.50e-01 |
ZBP1 DAI MEDIATED INDUCTION OF TYPE I IFNS | 18 | 3.56e-01 | 1.26e-01 | 6.10e-01 |
GLUCONEOGENESIS | 27 | 2.59e-01 | -1.25e-01 | 5.21e-01 |
ABC TRANSPORTER DISORDERS | 71 | 6.76e-02 | -1.25e-01 | 2.40e-01 |
DOWNSTREAM SIGNALING OF ACTIVATED FGFR2 | 24 | 2.88e-01 | -1.25e-01 | 5.55e-01 |
DUAL INCISION IN TC NER | 64 | 8.43e-02 | -1.25e-01 | 2.66e-01 |
O GLYCOSYLATION OF TSR DOMAIN CONTAINING PROTEINS | 37 | 1.91e-01 | 1.24e-01 | 4.32e-01 |
DEFECTS IN COBALAMIN B12 METABOLISM | 13 | 4.39e-01 | -1.24e-01 | 6.94e-01 |
IRS MEDIATED SIGNALLING | 40 | 1.78e-01 | -1.23e-01 | 4.13e-01 |
MTORC1 MEDIATED SIGNALLING | 24 | 2.97e-01 | -1.23e-01 | 5.61e-01 |
DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | 13 | 4.43e-01 | 1.23e-01 | 6.99e-01 |
AURKA ACTIVATION BY TPX2 | 72 | 7.23e-02 | -1.23e-01 | 2.48e-01 |
NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | 17 | 3.82e-01 | -1.22e-01 | 6.39e-01 |
TRANSMISSION ACROSS CHEMICAL SYNAPSES | 245 | 1.00e-03 | 1.22e-01 | 1.34e-02 |
SIGNALING BY BMP | 25 | 2.91e-01 | 1.22e-01 | 5.59e-01 |
DNA DOUBLE STRAND BREAK REPAIR | 135 | 1.49e-02 | -1.21e-01 | 9.51e-02 |
NEURONAL SYSTEM | 373 | 5.94e-05 | 1.21e-01 | 1.89e-03 |
ERCC6 CSB AND EHMT2 G9A POSITIVELY REGULATE RRNA EXPRESSION | 31 | 2.43e-01 | 1.21e-01 | 5.00e-01 |
NUCLEAR ENVELOPE NE REASSEMBLY | 64 | 9.42e-02 | -1.21e-01 | 2.85e-01 |
SIGNALING BY BRAF AND RAF FUSIONS | 60 | 1.06e-01 | 1.21e-01 | 3.09e-01 |
FATTY ACID METABOLISM | 147 | 1.16e-02 | -1.21e-01 | 8.01e-02 |
OTHER INTERLEUKIN SIGNALING | 20 | 3.51e-01 | 1.20e-01 | 6.08e-01 |
PI 3K CASCADE FGFR1 | 16 | 4.05e-01 | -1.20e-01 | 6.63e-01 |
ERKS ARE INACTIVATED | 13 | 4.53e-01 | -1.20e-01 | 7.06e-01 |
SENSORY PERCEPTION | 149 | 1.15e-02 | 1.20e-01 | 8.01e-02 |
GLYCEROPHOSPHOLIPID BIOSYNTHESIS | 109 | 3.06e-02 | 1.20e-01 | 1.49e-01 |
PROGRAMMED CELL DEATH | 189 | 4.70e-03 | -1.19e-01 | 4.29e-02 |
NETRIN 1 SIGNALING | 50 | 1.45e-01 | 1.19e-01 | 3.72e-01 |
SYNDECAN INTERACTIONS | 26 | 2.93e-01 | 1.19e-01 | 5.60e-01 |
SIGNALING BY ERYTHROPOIETIN | 24 | 3.14e-01 | 1.19e-01 | 5.79e-01 |
REGULATED NECROSIS | 46 | 1.63e-01 | -1.19e-01 | 3.92e-01 |
DEATH RECEPTOR SIGNALLING | 134 | 1.77e-02 | 1.19e-01 | 1.04e-01 |
HYALURONAN UPTAKE AND DEGRADATION | 11 | 4.95e-01 | 1.19e-01 | 7.44e-01 |
NUCLEOTIDE EXCISION REPAIR | 109 | 3.28e-02 | -1.18e-01 | 1.53e-01 |
KERATAN SULFATE BIOSYNTHESIS | 25 | 3.09e-01 | 1.17e-01 | 5.75e-01 |
ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | 291 | 5.84e-04 | -1.17e-01 | 9.06e-03 |
GRB2 EVENTS IN ERBB2 SIGNALING | 15 | 4.32e-01 | -1.17e-01 | 6.89e-01 |
GLYCOGEN SYNTHESIS | 14 | 4.48e-01 | -1.17e-01 | 7.05e-01 |
MRNA SPLICING MINOR PATHWAY | 52 | 1.45e-01 | -1.17e-01 | 3.72e-01 |
EPHA MEDIATED GROWTH CONE COLLAPSE | 29 | 2.76e-01 | 1.17e-01 | 5.46e-01 |
REGULATION OF LIPID METABOLISM BY PPARALPHA | 107 | 3.71e-02 | 1.17e-01 | 1.63e-01 |
L1CAM INTERACTIONS | 107 | 3.76e-02 | 1.16e-01 | 1.64e-01 |
TELOMERE C STRAND LAGGING STRAND SYNTHESIS | 33 | 2.49e-01 | -1.16e-01 | 5.06e-01 |
INHIBITION OF DNA RECOMBINATION AT TELOMERE | 34 | 2.43e-01 | -1.16e-01 | 5.00e-01 |
WNT LIGAND BIOGENESIS AND TRAFFICKING | 19 | 3.84e-01 | -1.15e-01 | 6.41e-01 |
PREGNENOLONE BIOSYNTHESIS | 12 | 4.91e-01 | -1.15e-01 | 7.41e-01 |
KERATAN SULFATE KERATIN METABOLISM | 31 | 2.69e-01 | 1.15e-01 | 5.36e-01 |
RNA POLYMERASE II TRANSCRIPTION TERMINATION | 65 | 1.11e-01 | -1.14e-01 | 3.18e-01 |
PYRIMIDINE SALVAGE | 10 | 5.32e-01 | 1.14e-01 | 7.71e-01 |
SIGNALING BY NODAL | 15 | 4.45e-01 | 1.14e-01 | 7.02e-01 |
TERMINATION OF TRANSLESION DNA SYNTHESIS | 30 | 2.82e-01 | -1.14e-01 | 5.50e-01 |
RAP1 SIGNALLING | 15 | 4.49e-01 | -1.13e-01 | 7.05e-01 |
RESPONSE OF EIF2AK1 HRI TO HEME DEFICIENCY | 15 | 4.52e-01 | -1.12e-01 | 7.06e-01 |
NON INTEGRIN MEMBRANE ECM INTERACTIONS | 56 | 1.47e-01 | 1.12e-01 | 3.74e-01 |
TNFR2 NON CANONICAL NF KB PATHWAY | 84 | 7.58e-02 | -1.12e-01 | 2.54e-01 |
UCH PROTEINASES | 91 | 6.60e-02 | -1.12e-01 | 2.37e-01 |
TELOMERE C STRAND SYNTHESIS INITIATION | 13 | 4.87e-01 | -1.11e-01 | 7.38e-01 |
MET ACTIVATES PTK2 SIGNALING | 28 | 3.08e-01 | 1.11e-01 | 5.74e-01 |
G ALPHA I SIGNALLING EVENTS | 206 | 6.03e-03 | 1.11e-01 | 5.19e-02 |
DEADENYLATION DEPENDENT MRNA DECAY | 55 | 1.55e-01 | -1.11e-01 | 3.85e-01 |
SEMA4D IN SEMAPHORIN SIGNALING | 24 | 3.47e-01 | 1.11e-01 | 6.06e-01 |
GOLGI ASSOCIATED VESICLE BIOGENESIS | 55 | 1.59e-01 | -1.10e-01 | 3.88e-01 |
APOPTOSIS | 167 | 1.44e-02 | -1.10e-01 | 9.26e-02 |
SIGNALING BY NTRK2 TRKB | 24 | 3.53e-01 | 1.09e-01 | 6.08e-01 |
SEMAPHORIN INTERACTIONS | 64 | 1.32e-01 | 1.09e-01 | 3.49e-01 |
ABC FAMILY PROTEINS MEDIATED TRANSPORT | 96 | 6.56e-02 | -1.09e-01 | 2.37e-01 |
KERATAN SULFATE DEGRADATION | 12 | 5.15e-01 | 1.09e-01 | 7.60e-01 |
APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | 34 | 2.74e-01 | 1.08e-01 | 5.43e-01 |
CREB1 PHOSPHORYLATION THROUGH THE ACTIVATION OF ADENYLATE CYCLASE | 11 | 5.34e-01 | -1.08e-01 | 7.73e-01 |
MTOR SIGNALLING | 41 | 2.30e-01 | -1.08e-01 | 4.81e-01 |
MAP2K AND MAPK ACTIVATION | 36 | 2.61e-01 | 1.08e-01 | 5.24e-01 |
PROLACTIN RECEPTOR SIGNALING | 12 | 5.17e-01 | 1.08e-01 | 7.60e-01 |
CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION | 354 | 4.99e-04 | -1.08e-01 | 8.53e-03 |
EXTRACELLULAR MATRIX ORGANIZATION | 247 | 3.54e-03 | 1.08e-01 | 3.42e-02 |
GABA RECEPTOR ACTIVATION | 55 | 1.67e-01 | 1.08e-01 | 3.98e-01 |
AQUAPORIN MEDIATED TRANSPORT | 42 | 2.27e-01 | 1.08e-01 | 4.78e-01 |
CONDENSATION OF PROPHASE CHROMOSOMES | 27 | 3.36e-01 | -1.07e-01 | 5.97e-01 |
RAS ACTIVATION UPON CA2 INFLUX THROUGH NMDA RECEPTOR | 20 | 4.07e-01 | 1.07e-01 | 6.65e-01 |
NEGATIVE REGULATION OF FGFR1 SIGNALING | 27 | 3.36e-01 | -1.07e-01 | 5.97e-01 |
PLATELET AGGREGATION PLUG FORMATION | 32 | 2.96e-01 | 1.07e-01 | 5.61e-01 |
DAP12 SIGNALING | 24 | 3.66e-01 | 1.07e-01 | 6.25e-01 |
LAGGING STRAND SYNTHESIS | 20 | 4.10e-01 | -1.07e-01 | 6.67e-01 |
RNA POLYMERASE III CHAIN ELONGATION | 18 | 4.35e-01 | -1.06e-01 | 6.91e-01 |
METABOLISM OF COFACTORS | 19 | 4.23e-01 | -1.06e-01 | 6.81e-01 |
PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | 12 | 5.24e-01 | -1.06e-01 | 7.66e-01 |
RNA POLYMERASE II TRANSCRIBES SNRNA GENES | 74 | 1.15e-01 | -1.06e-01 | 3.24e-01 |
ROS AND RNS PRODUCTION IN PHAGOCYTES | 29 | 3.26e-01 | -1.05e-01 | 5.92e-01 |
FORMATION OF THE CORNIFIED ENVELOPE | 26 | 3.53e-01 | 1.05e-01 | 6.08e-01 |
KERATINIZATION | 26 | 3.53e-01 | 1.05e-01 | 6.08e-01 |
TELOMERE MAINTENANCE | 77 | 1.13e-01 | -1.05e-01 | 3.21e-01 |
TP53 REGULATES TRANSCRIPTION OF CELL DEATH GENES | 37 | 2.73e-01 | -1.04e-01 | 5.41e-01 |
UPTAKE AND ACTIONS OF BACTERIAL TOXINS | 28 | 3.42e-01 | 1.04e-01 | 6.02e-01 |
METABOLISM OF RNA | 647 | 7.67e-06 | -1.03e-01 | 3.93e-04 |
KILLING MECHANISMS | 11 | 5.54e-01 | 1.03e-01 | 7.89e-01 |
CELL EXTRACELLULAR MATRIX INTERACTIONS | 18 | 4.50e-01 | -1.03e-01 | 7.06e-01 |
TNF RECEPTOR SUPERFAMILY TNFSF MEMBERS MEDIATING NON CANONICAL NF KB PATHWAY | 13 | 5.22e-01 | 1.03e-01 | 7.64e-01 |
INTERLEUKIN 1 FAMILY SIGNALING | 124 | 4.89e-02 | -1.02e-01 | 1.96e-01 |
FCERI MEDIATED MAPK ACTIVATION | 28 | 3.50e-01 | -1.02e-01 | 6.08e-01 |
CYTOSOLIC SULFONATION OF SMALL MOLECULES | 15 | 4.95e-01 | -1.02e-01 | 7.44e-01 |
TRANSCRIPTIONAL REGULATION BY RUNX2 | 112 | 6.28e-02 | -1.02e-01 | 2.29e-01 |
SPHINGOLIPID DE NOVO BIOSYNTHESIS | 41 | 2.62e-01 | -1.01e-01 | 5.24e-01 |
ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | 11 | 5.62e-01 | -1.01e-01 | 7.95e-01 |
COBALAMIN CBL VITAMIN B12 TRANSPORT AND METABOLISM | 14 | 5.14e-01 | -1.01e-01 | 7.60e-01 |
CA DEPENDENT EVENTS | 36 | 2.97e-01 | 1.01e-01 | 5.61e-01 |
GLYOXYLATE METABOLISM AND GLYCINE DEGRADATION | 26 | 3.75e-01 | -1.01e-01 | 6.34e-01 |
PCP CE PATHWAY | 91 | 9.78e-02 | -1.00e-01 | 2.92e-01 |
BIOLOGICAL OXIDATIONS | 125 | 5.34e-02 | -1.00e-01 | 2.07e-01 |
CELLULAR RESPONSE TO HEAT STRESS | 95 | 9.57e-02 | -9.90e-02 | 2.89e-01 |
RNA POLYMERASE III TRANSCRIPTION TERMINATION | 23 | 4.11e-01 | -9.89e-02 | 6.69e-01 |
CD28 CO STIMULATION | 31 | 3.42e-01 | -9.87e-02 | 6.02e-01 |
INTERLEUKIN 17 SIGNALING | 68 | 1.60e-01 | -9.87e-02 | 3.88e-01 |
TOLL LIKE RECEPTOR CASCADES | 141 | 4.35e-02 | -9.86e-02 | 1.80e-01 |
JOSEPHIN DOMAIN DUBS | 11 | 5.73e-01 | -9.82e-02 | 8.01e-01 |
INACTIVATION OF CSF3 G CSF SIGNALING | 24 | 4.08e-01 | -9.76e-02 | 6.65e-01 |
PURINE CATABOLISM | 16 | 5.00e-01 | -9.73e-02 | 7.50e-01 |
FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | 120 | 6.68e-02 | 9.69e-02 | 2.39e-01 |
NICOTINATE METABOLISM | 25 | 4.02e-01 | -9.69e-02 | 6.61e-01 |
SIGNALING BY CYTOSOLIC FGFR1 FUSION MUTANTS | 18 | 4.77e-01 | 9.68e-02 | 7.32e-01 |
RHO GTPASE CYCLE | 427 | 6.50e-04 | 9.65e-02 | 9.82e-03 |
RHOBTB GTPASE CYCLE | 35 | 3.24e-01 | -9.64e-02 | 5.89e-01 |
PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | 17 | 4.95e-01 | 9.57e-02 | 7.44e-01 |
SEMA3A PAK DEPENDENT AXON REPULSION | 16 | 5.08e-01 | -9.56e-02 | 7.57e-01 |
TRANS GOLGI NETWORK VESICLE BUDDING | 70 | 1.67e-01 | -9.55e-02 | 3.98e-01 |
DAP12 INTERACTIONS | 31 | 3.57e-01 | 9.55e-02 | 6.13e-01 |
PURINE SALVAGE | 12 | 5.69e-01 | -9.50e-02 | 8.00e-01 |
TOLL LIKE RECEPTOR 9 TLR9 CASCADE | 92 | 1.16e-01 | -9.50e-02 | 3.24e-01 |
ANCHORING FIBRIL FORMATION | 14 | 5.41e-01 | -9.44e-02 | 7.78e-01 |
TRANSCRIPTIONAL REGULATION BY VENTX | 35 | 3.35e-01 | 9.42e-02 | 5.97e-01 |
O LINKED GLYCOSYLATION | 87 | 1.31e-01 | 9.36e-02 | 3.49e-01 |
RAB GEFS EXCHANGE GTP FOR GDP ON RABS | 87 | 1.34e-01 | -9.29e-02 | 3.52e-01 |
P75 NTR RECEPTOR MEDIATED SIGNALLING | 95 | 1.18e-01 | 9.28e-02 | 3.28e-01 |
REGULATION OF FOXO TRANSCRIPTIONAL ACTIVITY BY ACETYLATION | 10 | 6.12e-01 | 9.27e-02 | 8.25e-01 |
COLLAGEN DEGRADATION | 51 | 2.53e-01 | -9.26e-02 | 5.12e-01 |
THE CANONICAL RETINOID CYCLE IN RODS TWILIGHT VISION | 14 | 5.49e-01 | -9.26e-02 | 7.84e-01 |
ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | 38 | 3.24e-01 | -9.26e-02 | 5.89e-01 |
ATF6 ATF6 ALPHA ACTIVATES CHAPERONES | 12 | 5.80e-01 | -9.23e-02 | 8.05e-01 |
CLEC7A DECTIN 1 INDUCES NFAT ACTIVATION | 11 | 5.98e-01 | -9.19e-02 | 8.17e-01 |
SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | 31 | 3.77e-01 | 9.17e-02 | 6.35e-01 |
VOLTAGE GATED POTASSIUM CHANNELS | 39 | 3.22e-01 | 9.17e-02 | 5.88e-01 |
POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | 61 | 2.16e-01 | -9.16e-02 | 4.71e-01 |
CELL CELL COMMUNICATION | 107 | 1.02e-01 | 9.16e-02 | 2.99e-01 |
NEGATIVE EPIGENETIC REGULATION OF RRNA EXPRESSION | 64 | 2.06e-01 | -9.14e-02 | 4.55e-01 |
INTERLEUKIN 27 SIGNALING | 10 | 6.17e-01 | 9.13e-02 | 8.31e-01 |
COSTIMULATION BY THE CD28 FAMILY | 51 | 2.61e-01 | -9.11e-02 | 5.23e-01 |
FORMATION OF FIBRIN CLOT CLOTTING CASCADE | 21 | 4.70e-01 | -9.10e-02 | 7.23e-01 |
RRNA MODIFICATION IN THE NUCLEUS AND CYTOSOL | 59 | 2.29e-01 | -9.05e-02 | 4.81e-01 |
SIGNALLING TO RAS | 20 | 4.84e-01 | 9.05e-02 | 7.35e-01 |
IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | 22 | 4.63e-01 | -9.03e-02 | 7.16e-01 |
FORMATION OF THE EARLY ELONGATION COMPLEX | 33 | 3.70e-01 | -9.01e-02 | 6.29e-01 |
INLB MEDIATED ENTRY OF LISTERIA MONOCYTOGENES INTO HOST CELL | 15 | 5.46e-01 | -9.01e-02 | 7.82e-01 |
LYSOSOME VESICLE BIOGENESIS | 33 | 3.75e-01 | -8.92e-02 | 6.34e-01 |
ANTIGEN ACTIVATES B CELL RECEPTOR BCR LEADING TO GENERATION OF SECOND MESSENGERS | 26 | 4.32e-01 | 8.91e-02 | 6.89e-01 |
REGULATION OF EXPRESSION OF SLITS AND ROBOS | 166 | 4.80e-02 | -8.90e-02 | 1.94e-01 |
RIP MEDIATED NFKB ACTIVATION VIA ZBP1 | 15 | 5.51e-01 | 8.89e-02 | 7.86e-01 |
THE PHOTOTRANSDUCTION CASCADE | 21 | 4.81e-01 | 8.89e-02 | 7.34e-01 |
ACTIVATION OF MATRIX METALLOPROTEINASES | 14 | 5.65e-01 | -8.88e-02 | 7.97e-01 |
UNFOLDED PROTEIN RESPONSE UPR | 85 | 1.57e-01 | 8.88e-02 | 3.87e-01 |
DOWNSTREAM SIGNALING OF ACTIVATED FGFR4 | 19 | 5.03e-01 | 8.87e-02 | 7.52e-01 |
METABOLISM OF FOLATE AND PTERINES | 15 | 5.52e-01 | -8.87e-02 | 7.86e-01 |
PLASMA LIPOPROTEIN CLEARANCE | 27 | 4.26e-01 | 8.86e-02 | 6.84e-01 |
HS GAG BIOSYNTHESIS | 30 | 4.03e-01 | 8.82e-02 | 6.62e-01 |
CAMK IV MEDIATED PHOSPHORYLATION OF CREB | 10 | 6.30e-01 | -8.81e-02 | 8.31e-01 |
SLC TRANSPORTER DISORDERS | 78 | 1.79e-01 | 8.80e-02 | 4.16e-01 |
EXTENSION OF TELOMERES | 49 | 2.88e-01 | -8.78e-02 | 5.55e-01 |
TRNA MODIFICATION IN THE NUCLEUS AND CYTOSOL | 43 | 3.20e-01 | -8.77e-02 | 5.86e-01 |
CELLULAR RESPONSES TO EXTERNAL STIMULI | 604 | 2.45e-04 | -8.77e-02 | 5.02e-03 |
INCRETIN SYNTHESIS SECRETION AND INACTIVATION | 14 | 5.71e-01 | -8.75e-02 | 8.00e-01 |
OLFACTORY SIGNALING PATHWAY | 31 | 4.00e-01 | 8.74e-02 | 6.59e-01 |
OPIOID SIGNALLING | 87 | 1.59e-01 | 8.74e-02 | 3.88e-01 |
HIV TRANSCRIPTION ELONGATION | 42 | 3.32e-01 | -8.65e-02 | 5.95e-01 |
RECEPTOR TYPE TYROSINE PROTEIN PHOSPHATASES | 20 | 5.04e-01 | 8.62e-02 | 7.53e-01 |
DNA REPAIR | 289 | 1.18e-02 | -8.62e-02 | 8.09e-02 |
FERTILIZATION | 13 | 5.91e-01 | 8.61e-02 | 8.13e-01 |
INTRINSIC PATHWAY OF FIBRIN CLOT FORMATION | 13 | 5.92e-01 | -8.59e-02 | 8.13e-01 |
PHOSPHOLIPID METABOLISM | 187 | 4.31e-02 | 8.58e-02 | 1.79e-01 |
MYOGENESIS | 25 | 4.58e-01 | 8.58e-02 | 7.09e-01 |
AMINO ACIDS REGULATE MTORC1 | 51 | 2.90e-01 | -8.57e-02 | 5.58e-01 |
SIGNALING BY NOTCH4 | 83 | 1.78e-01 | -8.56e-02 | 4.13e-01 |
DNA STRAND ELONGATION | 32 | 4.02e-01 | -8.56e-02 | 6.61e-01 |
TRANSCRIPTIONAL REGULATION BY TP53 | 347 | 6.41e-03 | -8.53e-02 | 5.39e-02 |
MEIOTIC RECOMBINATION | 36 | 3.76e-01 | -8.52e-02 | 6.35e-01 |
FGFR1 MUTANT RECEPTOR ACTIVATION | 26 | 4.52e-01 | 8.51e-02 | 7.06e-01 |
ADAPTIVE IMMUNE SYSTEM | 617 | 3.22e-04 | -8.51e-02 | 6.32e-03 |
CARGO TRAFFICKING TO THE PERICILIARY MEMBRANE | 49 | 3.04e-01 | -8.49e-02 | 5.70e-01 |
DISEASES OF METABOLISM | 200 | 3.92e-02 | 8.47e-02 | 1.68e-01 |
INSULIN RECEPTOR SIGNALLING CASCADE | 45 | 3.29e-01 | -8.40e-02 | 5.94e-01 |
GENERATION OF SECOND MESSENGER MOLECULES | 20 | 5.16e-01 | -8.38e-02 | 7.60e-01 |
PLATELET HOMEOSTASIS | 77 | 2.04e-01 | 8.37e-02 | 4.54e-01 |
TRNA AMINOACYLATION | 42 | 3.48e-01 | -8.37e-02 | 6.07e-01 |
SUMOYLATION OF IMMUNE RESPONSE PROTEINS | 11 | 6.32e-01 | 8.34e-02 | 8.32e-01 |
DNA DAMAGE RECOGNITION IN GG NER | 38 | 3.75e-01 | -8.32e-02 | 6.34e-01 |
NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | 13 | 6.04e-01 | -8.30e-02 | 8.23e-01 |
ATF6 ATF6 ALPHA ACTIVATES CHAPERONE GENES | 10 | 6.50e-01 | -8.30e-02 | 8.41e-01 |
NEUROTRANSMITTER RECEPTORS AND POSTSYNAPTIC SIGNAL TRANSMISSION | 183 | 5.32e-02 | 8.29e-02 | 2.07e-01 |
MRNA SPLICING | 188 | 5.06e-02 | -8.28e-02 | 2.02e-01 |
SIGNALING BY MODERATE KINASE ACTIVITY BRAF MUTANTS | 41 | 3.60e-01 | 8.26e-02 | 6.16e-01 |
ZINC TRANSPORTERS | 16 | 5.71e-01 | 8.19e-02 | 8.00e-01 |
DEREGULATED CDK5 TRIGGERS MULTIPLE NEURODEGENERATIVE PATHWAYS IN ALZHEIMER S DISEASE MODELS | 19 | 5.37e-01 | -8.18e-02 | 7.75e-01 |
METABOLISM OF NUCLEOTIDES | 92 | 1.75e-01 | -8.18e-02 | 4.10e-01 |
RHO GTPASE EFFECTORS | 252 | 2.57e-02 | -8.17e-02 | 1.30e-01 |
SYNTHESIS OF IP2 IP AND INS IN THE CYTOSOL | 13 | 6.10e-01 | 8.17e-02 | 8.25e-01 |
RUNX2 REGULATES OSTEOBLAST DIFFERENTIATION | 23 | 4.98e-01 | 8.16e-02 | 7.47e-01 |
DOWNSTREAM SIGNALING OF ACTIVATED FGFR3 | 20 | 5.28e-01 | 8.15e-02 | 7.69e-01 |
FGFR2 ALTERNATIVE SPLICING | 25 | 4.80e-01 | -8.15e-02 | 7.34e-01 |
CTLA4 INHIBITORY SIGNALING | 20 | 5.28e-01 | -8.15e-02 | 7.69e-01 |
NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | 58 | 2.86e-01 | -8.10e-02 | 5.54e-01 |
B WICH COMPLEX POSITIVELY REGULATES RRNA EXPRESSION | 46 | 3.42e-01 | -8.10e-02 | 6.02e-01 |
TP53 REGULATES TRANSCRIPTION OF CELL CYCLE GENES | 46 | 3.43e-01 | -8.09e-02 | 6.02e-01 |
EPH EPHRIN MEDIATED REPULSION OF CELLS | 51 | 3.19e-01 | 8.07e-02 | 5.84e-01 |
CIRCADIAN CLOCK | 68 | 2.51e-01 | 8.04e-02 | 5.10e-01 |
TRP CHANNELS | 20 | 5.35e-01 | 8.01e-02 | 7.74e-01 |
GAP FILLING DNA REPAIR SYNTHESIS AND LIGATION IN GG NER | 24 | 5.02e-01 | -7.92e-02 | 7.51e-01 |
SELECTIVE AUTOPHAGY | 73 | 2.43e-01 | -7.90e-02 | 5.00e-01 |
TRANSLESION SYNTHESIS BY Y FAMILY DNA POLYMERASES BYPASSES LESIONS ON DNA TEMPLATE | 37 | 4.06e-01 | -7.89e-02 | 6.64e-01 |
REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | 15 | 5.98e-01 | -7.86e-02 | 8.17e-01 |
LEISHMANIA INFECTION | 201 | 5.51e-02 | 7.86e-02 | 2.08e-01 |
MYD88 INDEPENDENT TLR4 CASCADE | 94 | 1.90e-01 | -7.83e-02 | 4.31e-01 |
DSCAM INTERACTIONS | 11 | 6.53e-01 | -7.83e-02 | 8.42e-01 |
TOLL LIKE RECEPTOR TLR1 TLR2 CASCADE | 95 | 1.88e-01 | -7.83e-02 | 4.28e-01 |
POLYMERASE SWITCHING | 14 | 6.12e-01 | -7.82e-02 | 8.25e-01 |
INFLAMMASOMES | 18 | 5.66e-01 | -7.82e-02 | 7.97e-01 |
NUCLEAR SIGNALING BY ERBB4 | 31 | 4.52e-01 | 7.80e-02 | 7.06e-01 |
EUKARYOTIC TRANSLATION INITIATION | 115 | 1.49e-01 | -7.80e-02 | 3.77e-01 |
TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | 17 | 5.78e-01 | 7.80e-02 | 8.03e-01 |
SIGNALING BY FGFR2 | 64 | 2.82e-01 | -7.78e-02 | 5.50e-01 |
CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | 93 | 1.95e-01 | 7.78e-02 | 4.38e-01 |
COPII MEDIATED VESICLE TRANSPORT | 66 | 2.75e-01 | -7.77e-02 | 5.45e-01 |
IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | 55 | 3.21e-01 | 7.73e-02 | 5.87e-01 |
DISEASES OF PROGRAMMED CELL DEATH | 53 | 3.31e-01 | -7.73e-02 | 5.94e-01 |
PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | 237 | 4.07e-02 | -7.73e-02 | 1.72e-01 |
COOPERATION OF PDCL PHLP1 AND TRIC CCT IN G PROTEIN BETA FOLDING | 36 | 4.23e-01 | -7.73e-02 | 6.81e-01 |
SIGNALING BY NOTCH | 187 | 6.95e-02 | 7.70e-02 | 2.44e-01 |
RRNA PROCESSING | 195 | 6.42e-02 | -7.70e-02 | 2.33e-01 |
CASPASE ACTIVATION VIA DEATH RECEPTORS IN THE PRESENCE OF LIGAND | 14 | 6.19e-01 | -7.68e-02 | 8.31e-01 |
POTASSIUM CHANNELS | 91 | 2.06e-01 | 7.67e-02 | 4.55e-01 |
RHO GTPASES ACTIVATE CIT | 18 | 5.76e-01 | 7.62e-02 | 8.02e-01 |
REGULATION OF TP53 EXPRESSION AND DEGRADATION | 36 | 4.30e-01 | -7.60e-02 | 6.89e-01 |
AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | 14 | 6.23e-01 | 7.59e-02 | 8.31e-01 |
COMPLEMENT CASCADE | 28 | 4.89e-01 | 7.55e-02 | 7.40e-01 |
ACYL CHAIN REMODELLING OF PS | 14 | 6.25e-01 | -7.54e-02 | 8.31e-01 |
INTRINSIC PATHWAY FOR APOPTOSIS | 52 | 3.49e-01 | -7.51e-02 | 6.08e-01 |
PLATELET CALCIUM HOMEOSTASIS | 25 | 5.16e-01 | 7.51e-02 | 7.60e-01 |
SODIUM CALCIUM EXCHANGERS | 10 | 6.82e-01 | 7.48e-02 | 8.57e-01 |
GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | 30 | 4.78e-01 | -7.48e-02 | 7.32e-01 |
INITIAL TRIGGERING OF COMPLEMENT | 13 | 6.41e-01 | 7.48e-02 | 8.38e-01 |
LYSINE CATABOLISM | 11 | 6.69e-01 | -7.45e-02 | 8.50e-01 |
ION CHANNEL TRANSPORT | 142 | 1.26e-01 | 7.44e-02 | 3.44e-01 |
SARS COV 1 INFECTION | 48 | 3.73e-01 | -7.43e-02 | 6.33e-01 |
CHAPERONE MEDIATED AUTOPHAGY | 21 | 5.56e-01 | -7.43e-02 | 7.89e-01 |
METABOLISM OF AMINO ACIDS AND DERIVATIVES | 321 | 2.24e-02 | -7.43e-02 | 1.22e-01 |
RHO GTPASES ACTIVATE PKNS | 46 | 3.86e-01 | -7.40e-02 | 6.41e-01 |
BIOSYNTHESIS OF SPECIALIZED PRORESOLVING MEDIATORS SPMS | 12 | 6.57e-01 | -7.40e-02 | 8.44e-01 |
TP53 REGULATES TRANSCRIPTION OF GENES INVOLVED IN G2 CELL CYCLE ARREST | 16 | 6.09e-01 | 7.38e-02 | 8.25e-01 |
ASSEMBLY OF THE HIV VIRION | 16 | 6.10e-01 | -7.36e-02 | 8.25e-01 |
GAP JUNCTION TRAFFICKING AND REGULATION | 33 | 4.66e-01 | -7.33e-02 | 7.18e-01 |
SUMOYLATION OF INTRACELLULAR RECEPTORS | 27 | 5.10e-01 | -7.33e-02 | 7.57e-01 |
SIGNALING BY RETINOIC ACID | 34 | 4.60e-01 | -7.32e-02 | 7.12e-01 |
AUTOPHAGY | 140 | 1.35e-01 | -7.32e-02 | 3.53e-01 |
SIGNALING BY SCF KIT | 41 | 4.18e-01 | 7.32e-02 | 6.75e-01 |
RETROGRADE TRANSPORT AT THE TRANS GOLGI NETWORK | 48 | 3.82e-01 | -7.29e-02 | 6.39e-01 |
INFECTION WITH MYCOBACTERIUM TUBERCULOSIS | 24 | 5.37e-01 | -7.29e-02 | 7.75e-01 |
TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | 13 | 6.51e-01 | -7.25e-02 | 8.41e-01 |
DUAL INCISION IN GG NER | 40 | 4.29e-01 | -7.24e-02 | 6.87e-01 |
TP53 REGULATES TRANSCRIPTION OF GENES INVOLVED IN CYTOCHROME C RELEASE | 19 | 5.88e-01 | 7.19e-02 | 8.11e-01 |
HATS ACETYLATE HISTONES | 92 | 2.34e-01 | 7.19e-02 | 4.88e-01 |
DISEASES OF IMMUNE SYSTEM | 27 | 5.19e-01 | -7.17e-02 | 7.62e-01 |
FOXO MEDIATED TRANSCRIPTION | 59 | 3.43e-01 | 7.14e-02 | 6.02e-01 |
SIGNALING BY FGFR IN DISEASE | 57 | 3.53e-01 | -7.12e-02 | 6.08e-01 |
PROTEIN FOLDING | 90 | 2.44e-01 | -7.11e-02 | 5.01e-01 |
DEVELOPMENTAL BIOLOGY | 830 | 5.66e-04 | 7.08e-02 | 8.99e-03 |
SNRNP ASSEMBLY | 51 | 3.83e-01 | -7.07e-02 | 6.39e-01 |
UB SPECIFIC PROCESSING PROTEASES | 170 | 1.12e-01 | -7.07e-02 | 3.20e-01 |
SHC1 EVENTS IN EGFR SIGNALING | 11 | 6.86e-01 | -7.05e-02 | 8.59e-01 |
TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX WITHIN TLR4 COMPLEX | 16 | 6.26e-01 | -7.04e-02 | 8.31e-01 |
RIPK1 MEDIATED REGULATED NECROSIS | 25 | 5.43e-01 | -7.02e-02 | 7.80e-01 |
HSF1 DEPENDENT TRANSACTIVATION | 34 | 4.79e-01 | -7.01e-02 | 7.33e-01 |
LATE ENDOSOMAL MICROAUTOPHAGY | 32 | 4.93e-01 | -7.00e-02 | 7.43e-01 |
REGULATION OF LOCALIZATION OF FOXO TRANSCRIPTION FACTORS | 12 | 6.75e-01 | 7.00e-02 | 8.52e-01 |
DISEASES OF CARBOHYDRATE METABOLISM | 29 | 5.15e-01 | 6.99e-02 | 7.60e-01 |
CONSTITUTIVE SIGNALING BY AKT1 E17K IN CANCER | 26 | 5.38e-01 | 6.98e-02 | 7.76e-01 |
ACTIVATION OF ANTERIOR HOX GENES IN HINDBRAIN DEVELOPMENT DURING EARLY EMBRYOGENESIS | 74 | 3.03e-01 | -6.93e-02 | 5.69e-01 |
MITOTIC PROPHASE | 93 | 2.48e-01 | -6.93e-02 | 5.06e-01 |
DEADENYLATION OF MRNA | 25 | 5.49e-01 | -6.92e-02 | 7.84e-01 |
MITOCHONDRIAL TRNA AMINOACYLATION | 21 | 5.83e-01 | 6.92e-02 | 8.08e-01 |
STIMULI SENSING CHANNELS | 76 | 2.97e-01 | 6.92e-02 | 5.61e-01 |
STING MEDIATED INDUCTION OF HOST IMMUNE RESPONSES | 14 | 6.55e-01 | -6.89e-02 | 8.44e-01 |
NEGATIVE REGULATION OF FLT3 | 14 | 6.56e-01 | 6.88e-02 | 8.44e-01 |
SUMOYLATION OF DNA DAMAGE RESPONSE AND REPAIR PROTEINS | 73 | 3.15e-01 | -6.81e-02 | 5.81e-01 |
POLYMERASE SWITCHING ON THE C STRAND OF THE TELOMERE | 25 | 5.57e-01 | -6.79e-02 | 7.90e-01 |
INTERLEUKIN 4 AND INTERLEUKIN 13 SIGNALING | 79 | 2.98e-01 | 6.77e-02 | 5.62e-01 |
REGULATION OF SIGNALING BY CBL | 22 | 5.84e-01 | 6.75e-02 | 8.08e-01 |
ALPHA PROTEIN KINASE 1 SIGNALING PATHWAY | 11 | 7.00e-01 | -6.72e-02 | 8.64e-01 |
SUMOYLATION OF TRANSCRIPTION FACTORS | 18 | 6.22e-01 | -6.70e-02 | 8.31e-01 |
RAF INDEPENDENT MAPK1 3 ACTIVATION | 21 | 5.98e-01 | 6.65e-02 | 8.17e-01 |
ERBB2 REGULATES CELL MOTILITY | 14 | 6.67e-01 | -6.64e-02 | 8.49e-01 |
DEUBIQUITINATION | 244 | 7.69e-02 | -6.58e-02 | 2.55e-01 |
REGULATION OF GENE EXPRESSION BY HYPOXIA INDUCIBLE FACTOR | 10 | 7.19e-01 | 6.57e-02 | 8.77e-01 |
RHO GTPASES ACTIVATE ROCKS | 19 | 6.21e-01 | -6.55e-02 | 8.31e-01 |
METABOLISM OF NITRIC OXIDE NOS3 ACTIVATION AND REGULATION | 15 | 6.62e-01 | -6.51e-02 | 8.48e-01 |
SIGNALING BY ERBB2 | 48 | 4.37e-01 | -6.48e-02 | 6.92e-01 |
EPHB MEDIATED FORWARD SIGNALING | 42 | 4.68e-01 | -6.48e-02 | 7.20e-01 |
PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | 15 | 6.64e-01 | -6.47e-02 | 8.49e-01 |
ESTROGEN DEPENDENT NUCLEAR EVENTS DOWNSTREAM OF ESR MEMBRANE SIGNALING | 21 | 6.08e-01 | -6.47e-02 | 8.25e-01 |
MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | 15 | 6.66e-01 | -6.44e-02 | 8.49e-01 |
INSERTION OF TAIL ANCHORED PROTEINS INTO THE ENDOPLASMIC RETICULUM MEMBRANE | 22 | 6.02e-01 | -6.42e-02 | 8.21e-01 |
RNA POLYMERASE III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | 28 | 5.59e-01 | -6.39e-02 | 7.92e-01 |
GLUTAMATE AND GLUTAMINE METABOLISM | 13 | 6.90e-01 | -6.38e-02 | 8.61e-01 |
REGULATION OF FZD BY UBIQUITINATION | 19 | 6.33e-01 | 6.33e-02 | 8.32e-01 |
NEGATIVE REGULATION OF THE PI3K AKT NETWORK | 96 | 2.85e-01 | -6.32e-02 | 5.53e-01 |
ARACHIDONIC ACID METABOLISM | 40 | 4.89e-01 | -6.32e-02 | 7.40e-01 |
TRANSCRIPTIONAL REGULATION BY RUNX1 | 180 | 1.45e-01 | 6.31e-02 | 3.72e-01 |
SIGNALING BY FGFR1 IN DISEASE | 33 | 5.31e-01 | 6.30e-02 | 7.71e-01 |
ORGANELLE BIOGENESIS AND MAINTENANCE | 286 | 6.74e-02 | -6.30e-02 | 2.40e-01 |
RESOLUTION OF ABASIC SITES AP SITES | 37 | 5.09e-01 | -6.28e-02 | 7.57e-01 |
NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | 21 | 6.20e-01 | -6.25e-02 | 8.31e-01 |
POLO LIKE KINASE MEDIATED EVENTS | 13 | 6.98e-01 | -6.23e-02 | 8.63e-01 |
GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | 23 | 6.06e-01 | 6.22e-02 | 8.24e-01 |
RNA POLYMERASE II TRANSCRIPTION | 1102 | 5.41e-04 | -6.22e-02 | 8.99e-03 |
HCMV LATE EVENTS | 64 | 3.90e-01 | -6.21e-02 | 6.47e-01 |
POSTMITOTIC NUCLEAR PORE COMPLEX NPC REFORMATION | 26 | 5.84e-01 | -6.20e-02 | 8.08e-01 |
TRIGLYCERIDE CATABOLISM | 14 | 6.89e-01 | -6.19e-02 | 8.60e-01 |
SENESCENCE ASSOCIATED SECRETORY PHENOTYPE SASP | 62 | 4.04e-01 | -6.13e-02 | 6.63e-01 |
HEMOSTASIS | 475 | 2.29e-02 | 6.11e-02 | 1.22e-01 |
ACYL CHAIN REMODELLING OF PC | 17 | 6.66e-01 | 6.05e-02 | 8.49e-01 |
KSRP KHSRP BINDS AND DESTABILIZES MRNA | 16 | 6.76e-01 | -6.04e-02 | 8.52e-01 |
MET PROMOTES CELL MOTILITY | 38 | 5.22e-01 | 6.01e-02 | 7.64e-01 |
INTERFERON GAMMA SIGNALING | 80 | 3.54e-01 | 6.00e-02 | 6.08e-01 |
NICOTINAMIDE SALVAGING | 15 | 6.88e-01 | -6.00e-02 | 8.60e-01 |
NEGATIVE REGULATION OF NMDA RECEPTOR MEDIATED NEURONAL TRANSMISSION | 21 | 6.35e-01 | 5.98e-02 | 8.33e-01 |
ER TO GOLGI ANTEROGRADE TRANSPORT | 142 | 2.19e-01 | -5.98e-02 | 4.74e-01 |
SIGNALING BY ERBB4 | 57 | 4.36e-01 | 5.96e-02 | 6.92e-01 |
PHASE 4 RESTING MEMBRANE POTENTIAL | 15 | 6.90e-01 | 5.96e-02 | 8.60e-01 |
METABOLISM OF CARBOHYDRATES | 262 | 9.75e-02 | 5.96e-02 | 2.92e-01 |
ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | 74 | 3.78e-01 | -5.93e-02 | 6.35e-01 |
LAMININ INTERACTIONS | 28 | 5.88e-01 | 5.92e-02 | 8.11e-01 |
CGMP EFFECTS | 15 | 6.92e-01 | 5.91e-02 | 8.61e-01 |
CARDIAC CONDUCTION | 109 | 2.88e-01 | 5.89e-02 | 5.56e-01 |
RHOJ GTPASE CYCLE | 55 | 4.53e-01 | 5.85e-02 | 7.06e-01 |
DOWNREGULATION OF ERBB2 SIGNALING | 28 | 5.93e-01 | -5.84e-02 | 8.14e-01 |
SYNTHESIS OF PROSTAGLANDINS PG AND THROMBOXANES TX | 13 | 7.16e-01 | 5.82e-02 | 8.76e-01 |
NOTCH4 ACTIVATION AND TRANSMISSION OF SIGNAL TO THE NUCLEUS | 12 | 7.27e-01 | 5.81e-02 | 8.81e-01 |
POTENTIAL THERAPEUTICS FOR SARS | 77 | 3.81e-01 | 5.78e-02 | 6.39e-01 |
RHOD GTPASE CYCLE | 51 | 4.77e-01 | 5.75e-02 | 7.32e-01 |
SIGNALING BY FGFR1 | 44 | 5.11e-01 | -5.73e-02 | 7.58e-01 |
O LINKED GLYCOSYLATION OF MUCINS | 40 | 5.31e-01 | 5.73e-02 | 7.71e-01 |
BASIGIN INTERACTIONS | 22 | 6.43e-01 | 5.70e-02 | 8.40e-01 |
JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | 22 | 6.44e-01 | -5.69e-02 | 8.40e-01 |
INFLUENZA INFECTION | 146 | 2.41e-01 | -5.63e-02 | 4.98e-01 |
SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | 15 | 7.07e-01 | 5.62e-02 | 8.70e-01 |
TP53 REGULATES TRANSCRIPTION OF SEVERAL ADDITIONAL CELL DEATH GENES WHOSE SPECIFIC ROLES IN P53 DEPENDENT APOPTOSIS REMAIN UNCERTAIN | 12 | 7.39e-01 | -5.56e-02 | 8.83e-01 |
N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | 35 | 5.71e-01 | 5.54e-02 | 8.00e-01 |
CONSTITUTIVE SIGNALING BY OVEREXPRESSED ERBB2 | 11 | 7.51e-01 | -5.53e-02 | 8.89e-01 |
PROCESSIVE SYNTHESIS ON THE C STRAND OF THE TELOMERE | 19 | 6.76e-01 | -5.53e-02 | 8.52e-01 |
DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | 26 | 6.26e-01 | -5.53e-02 | 8.31e-01 |
INTERACTIONS OF REV WITH HOST CELLULAR PROTEINS | 35 | 5.72e-01 | -5.53e-02 | 8.00e-01 |
TIE2 SIGNALING | 17 | 6.94e-01 | -5.52e-02 | 8.61e-01 |
LISTERIA MONOCYTOGENES ENTRY INTO HOST CELLS | 20 | 6.69e-01 | 5.51e-02 | 8.50e-01 |
INNATE IMMUNE SYSTEM | 794 | 8.62e-03 | -5.51e-02 | 6.56e-02 |
IRAK1 RECRUITS IKK COMPLEX | 14 | 7.22e-01 | 5.49e-02 | 8.78e-01 |
AGGREPHAGY | 35 | 5.76e-01 | -5.46e-02 | 8.02e-01 |
ESTROGEN DEPENDENT GENE EXPRESSION | 102 | 3.42e-01 | 5.45e-02 | 6.02e-01 |
ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | 17 | 6.98e-01 | 5.43e-02 | 8.63e-01 |
ACTIVATION OF RAC1 | 13 | 7.35e-01 | -5.42e-02 | 8.83e-01 |
CYTOSOLIC IRON SULFUR CLUSTER ASSEMBLY | 13 | 7.35e-01 | 5.41e-02 | 8.83e-01 |
G BETA GAMMA SIGNALLING THROUGH CDC42 | 19 | 6.83e-01 | -5.41e-02 | 8.58e-01 |
NERVOUS SYSTEM DEVELOPMENT | 554 | 3.00e-02 | 5.41e-02 | 1.47e-01 |
HEDGEHOG ON STATE | 84 | 3.92e-01 | -5.40e-02 | 6.50e-01 |
VITAMIN B5 PANTOTHENATE METABOLISM | 15 | 7.17e-01 | -5.40e-02 | 8.76e-01 |
SHC1 EVENTS IN ERBB2 SIGNALING | 21 | 6.70e-01 | -5.36e-02 | 8.50e-01 |
POST TRANSLATIONAL PROTEIN MODIFICATION | 1226 | 2.04e-03 | -5.28e-02 | 2.25e-02 |
COPI MEDIATED ANTEROGRADE TRANSPORT | 91 | 3.85e-01 | -5.27e-02 | 6.41e-01 |
THE ROLE OF NEF IN HIV 1 REPLICATION AND DISEASE PATHOGENESIS | 28 | 6.29e-01 | -5.27e-02 | 8.31e-01 |
SIGNALING BY MET | 74 | 4.33e-01 | 5.27e-02 | 6.90e-01 |
SIGNALING BY FGFR | 75 | 4.31e-01 | -5.26e-02 | 6.89e-01 |
WNT5A DEPENDENT INTERNALIZATION OF FZD2 FZD5 AND ROR2 | 13 | 7.43e-01 | 5.25e-02 | 8.83e-01 |
P75NTR SIGNALS VIA NF KB | 16 | 7.17e-01 | 5.24e-02 | 8.76e-01 |
GLYCOGEN STORAGE DISEASES | 12 | 7.54e-01 | 5.23e-02 | 8.91e-01 |
NEUTROPHIL DEGRANULATION | 394 | 7.55e-02 | -5.23e-02 | 2.54e-01 |
TRIGLYCERIDE METABOLISM | 24 | 6.59e-01 | -5.21e-02 | 8.45e-01 |
ACTIVATION OF BH3 ONLY PROTEINS | 30 | 6.23e-01 | -5.18e-02 | 8.31e-01 |
PI 3K CASCADE FGFR4 | 12 | 7.56e-01 | 5.18e-02 | 8.91e-01 |
ROLE OF LAT2 NTAL LAB ON CALCIUM MOBILIZATION | 14 | 7.38e-01 | 5.16e-02 | 8.83e-01 |
MICRORNA MIRNA BIOGENESIS | 24 | 6.62e-01 | 5.16e-02 | 8.48e-01 |
SIGNALING BY FLT3 ITD AND TKD MUTANTS | 16 | 7.21e-01 | 5.15e-02 | 8.78e-01 |
CONSTITUTIVE SIGNALING BY EGFRVIII | 15 | 7.34e-01 | 5.07e-02 | 8.83e-01 |
CONSTITUTIVE SIGNALING BY ABERRANT PI3K IN CANCER | 63 | 4.86e-01 | -5.07e-02 | 7.38e-01 |
UNWINDING OF DNA | 12 | 7.62e-01 | -5.06e-02 | 8.92e-01 |
BASE EXCISION REPAIR | 55 | 5.17e-01 | -5.05e-02 | 7.60e-01 |
NUCLEOBASE BIOSYNTHESIS | 15 | 7.35e-01 | -5.04e-02 | 8.83e-01 |
TRANSLATION OF SARS COV 2 STRUCTURAL PROTEINS | 44 | 5.65e-01 | 5.01e-02 | 7.97e-01 |
SIGNALING BY PDGFR IN DISEASE | 20 | 6.98e-01 | 5.01e-02 | 8.63e-01 |
DNA DAMAGE TELOMERE STRESS INDUCED SENESCENCE | 42 | 5.75e-01 | -5.00e-02 | 8.02e-01 |
PTEN REGULATION | 138 | 3.12e-01 | -4.99e-02 | 5.77e-01 |
RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | 105 | 3.80e-01 | 4.96e-02 | 6.38e-01 |
IL 6 TYPE CYTOKINE RECEPTOR LIGAND INTERACTIONS | 15 | 7.40e-01 | 4.96e-02 | 8.83e-01 |
ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | 25 | 6.71e-01 | -4.90e-02 | 8.50e-01 |
TP53 REGULATES TRANSCRIPTION OF DNA REPAIR GENES | 61 | 5.09e-01 | -4.90e-02 | 7.57e-01 |
CELLULAR RESPONSE TO STARVATION | 147 | 3.10e-01 | -4.86e-02 | 5.75e-01 |
IRF3 MEDIATED INDUCTION OF TYPE I IFN | 11 | 7.82e-01 | -4.83e-02 | 8.99e-01 |
ION HOMEOSTASIS | 49 | 5.60e-01 | 4.81e-02 | 7.93e-01 |
TICAM1 DEPENDENT ACTIVATION OF IRF3 IRF7 | 12 | 7.74e-01 | -4.79e-02 | 8.97e-01 |
CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | 31 | 6.45e-01 | -4.78e-02 | 8.40e-01 |
INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | 34 | 6.30e-01 | -4.78e-02 | 8.31e-01 |
ENOS ACTIVATION | 11 | 7.87e-01 | -4.71e-02 | 9.03e-01 |
VIRAL MESSENGER RNA SYNTHESIS | 42 | 5.98e-01 | -4.70e-02 | 8.17e-01 |
PLATELET ACTIVATION SIGNALING AND AGGREGATION | 222 | 2.29e-01 | 4.69e-02 | 4.81e-01 |
SIGNALING BY ROBO RECEPTORS | 211 | 2.44e-01 | -4.66e-02 | 5.01e-01 |
INITIATION OF NUCLEAR ENVELOPE NE REFORMATION | 17 | 7.40e-01 | -4.65e-02 | 8.83e-01 |
MUSCLE CONTRACTION | 164 | 3.07e-01 | 4.62e-02 | 5.73e-01 |
OXIDATIVE STRESS INDUCED SENESCENCE | 77 | 4.83e-01 | 4.62e-02 | 7.35e-01 |
DDX58 IFIH1 MEDIATED INDUCTION OF INTERFERON ALPHA BETA | 64 | 5.23e-01 | 4.62e-02 | 7.65e-01 |
SIGNALING BY HEDGEHOG | 143 | 3.42e-01 | 4.60e-02 | 6.02e-01 |
REDUCTION OF CYTOSOLIC CA LEVELS | 11 | 7.94e-01 | -4.55e-02 | 9.08e-01 |
RAC3 GTPASE CYCLE | 91 | 4.56e-01 | 4.53e-02 | 7.08e-01 |
CALNEXIN CALRETICULIN CYCLE | 26 | 6.93e-01 | 4.47e-02 | 8.61e-01 |
TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | 43 | 6.12e-01 | 4.47e-02 | 8.25e-01 |
REGULATION OF TP53 ACTIVITY | 155 | 3.40e-01 | -4.45e-02 | 6.02e-01 |
SUMOYLATION OF DNA METHYLATION PROTEINS | 16 | 7.58e-01 | 4.44e-02 | 8.91e-01 |
INWARDLY RECTIFYING K CHANNELS | 32 | 6.66e-01 | 4.41e-02 | 8.49e-01 |
REGULATION OF GENE EXPRESSION IN BETA CELLS | 12 | 7.92e-01 | -4.40e-02 | 9.06e-01 |
SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | 11 | 8.00e-01 | -4.40e-02 | 9.11e-01 |
RAB REGULATION OF TRAFFICKING | 118 | 4.13e-01 | -4.36e-02 | 6.69e-01 |
G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | 24 | 7.11e-01 | 4.36e-02 | 8.74e-01 |
PI 3K CASCADE FGFR3 | 13 | 7.86e-01 | 4.36e-02 | 9.03e-01 |
ASPARAGINE N LINKED GLYCOSYLATION | 285 | 2.12e-01 | -4.30e-02 | 4.63e-01 |
REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | 29 | 6.89e-01 | 4.30e-02 | 8.60e-01 |
FANCONI ANEMIA PATHWAY | 36 | 6.57e-01 | -4.28e-02 | 8.44e-01 |
EXTRA NUCLEAR ESTROGEN SIGNALING | 68 | 5.47e-01 | -4.23e-02 | 7.82e-01 |
CONSTITUTIVE SIGNALING BY LIGAND RESPONSIVE EGFR CANCER VARIANTS | 19 | 7.50e-01 | 4.22e-02 | 8.89e-01 |
SIGNALING BY NUCLEAR RECEPTORS | 224 | 2.81e-01 | 4.18e-02 | 5.50e-01 |
SIGNALING BY NTRKS | 130 | 4.13e-01 | 4.16e-02 | 6.69e-01 |
ACTIVATED NTRK2 SIGNALS THROUGH FRS2 AND FRS3 | 10 | 8.22e-01 | 4.11e-02 | 9.22e-01 |
SUMOYLATION OF TRANSCRIPTION COFACTORS | 42 | 6.45e-01 | 4.11e-02 | 8.40e-01 |
VEGFR2 MEDIATED VASCULAR PERMEABILITY | 27 | 7.15e-01 | 4.06e-02 | 8.76e-01 |
SYNTHESIS OF PYROPHOSPHATES IN THE CYTOSOL | 10 | 8.24e-01 | -4.06e-02 | 9.22e-01 |
NOD1 2 SIGNALING PATHWAY | 35 | 6.80e-01 | -4.03e-02 | 8.55e-01 |
DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | 23 | 7.38e-01 | 4.03e-02 | 8.83e-01 |
P75NTR RECRUITS SIGNALLING COMPLEXES | 13 | 8.03e-01 | 4.00e-02 | 9.11e-01 |
SIGNALING BY RHO GTPASES MIRO GTPASES AND RHOBTB3 | 631 | 8.83e-02 | 3.99e-02 | 2.71e-01 |
RNA POLYMERASE III TRANSCRIPTION INITIATION FROM TYPE 1 PROMOTER | 28 | 7.16e-01 | -3.98e-02 | 8.76e-01 |
REGULATION OF IFNG SIGNALING | 13 | 8.04e-01 | -3.98e-02 | 9.11e-01 |
NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | 52 | 6.21e-01 | -3.97e-02 | 8.31e-01 |
TRANSPORT OF SMALL MOLECULES | 590 | 1.01e-01 | 3.96e-02 | 2.98e-01 |
GLUCAGON TYPE LIGAND RECEPTORS | 26 | 7.27e-01 | 3.96e-02 | 8.81e-01 |
GOLGI TO ER RETROGRADE TRANSPORT | 120 | 4.57e-01 | -3.94e-02 | 7.09e-01 |
SUMOYLATION OF RNA BINDING PROTEINS | 45 | 6.49e-01 | -3.92e-02 | 8.41e-01 |
ER QUALITY CONTROL COMPARTMENT ERQC | 21 | 7.58e-01 | 3.88e-02 | 8.91e-01 |
SIGNALING BY TYPE 1 INSULIN LIKE GROWTH FACTOR 1 RECEPTOR IGF1R | 46 | 6.50e-01 | -3.87e-02 | 8.41e-01 |
REGULATED PROTEOLYSIS OF P75NTR | 12 | 8.17e-01 | 3.86e-02 | 9.22e-01 |
CARNITINE METABOLISM | 14 | 8.03e-01 | -3.85e-02 | 9.11e-01 |
TRIGLYCERIDE BIOSYNTHESIS | 10 | 8.34e-01 | -3.84e-02 | 9.28e-01 |
DEPOLYMERISATION OF THE NUCLEAR LAMINA | 14 | 8.04e-01 | 3.83e-02 | 9.11e-01 |
LONG TERM POTENTIATION | 23 | 7.51e-01 | 3.83e-02 | 8.89e-01 |
RND1 GTPASE CYCLE | 38 | 6.84e-01 | 3.82e-02 | 8.58e-01 |
IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX | 10 | 8.35e-01 | -3.81e-02 | 9.28e-01 |
SUMOYLATION OF CHROMATIN ORGANIZATION PROTEINS | 56 | 6.27e-01 | 3.76e-02 | 8.31e-01 |
RNA POLYMERASE I TRANSCRIPTION | 66 | 6.00e-01 | -3.74e-02 | 8.18e-01 |
MISMATCH REPAIR | 15 | 8.03e-01 | -3.72e-02 | 9.11e-01 |
GPVI MEDIATED ACTIVATION CASCADE | 31 | 7.24e-01 | -3.67e-02 | 8.79e-01 |
ASSEMBLY AND CELL SURFACE PRESENTATION OF NMDA RECEPTORS | 36 | 7.04e-01 | 3.66e-02 | 8.68e-01 |
VESICLE MEDIATED TRANSPORT | 615 | 1.23e-01 | -3.66e-02 | 3.38e-01 |
PI METABOLISM | 79 | 5.75e-01 | 3.65e-02 | 8.02e-01 |
HCMV INFECTION | 102 | 5.26e-01 | -3.63e-02 | 7.68e-01 |
SIGNALING BY PDGF | 57 | 6.36e-01 | 3.63e-02 | 8.33e-01 |
MEMBRANE TRAFFICKING | 583 | 1.36e-01 | -3.62e-02 | 3.54e-01 |
SIGNALING BY ACTIVIN | 12 | 8.28e-01 | 3.61e-02 | 9.24e-01 |
INTERFERON SIGNALING | 168 | 4.24e-01 | 3.58e-02 | 6.82e-01 |
INSULIN PROCESSING | 24 | 7.62e-01 | 3.57e-02 | 8.92e-01 |
HIV ELONGATION ARREST AND RECOVERY | 32 | 7.31e-01 | 3.51e-02 | 8.83e-01 |
COLLAGEN BIOSYNTHESIS AND MODIFYING ENZYMES | 64 | 6.28e-01 | -3.51e-02 | 8.31e-01 |
METABOLISM OF LIPIDS | 615 | 1.44e-01 | -3.46e-02 | 3.72e-01 |
MEIOSIS | 63 | 6.35e-01 | -3.46e-02 | 8.33e-01 |
RHOQ GTPASE CYCLE | 59 | 6.47e-01 | -3.45e-02 | 8.41e-01 |
PLATELET SENSITIZATION BY LDL | 15 | 8.22e-01 | -3.36e-02 | 9.22e-01 |
SMOOTH MUSCLE CONTRACTION | 33 | 7.43e-01 | -3.30e-02 | 8.83e-01 |
MAP3K8 TPL2 DEPENDENT MAPK1 3 ACTIVATION | 16 | 8.20e-01 | -3.28e-02 | 9.22e-01 |
ANCHORING OF THE BASAL BODY TO THE PLASMA MEMBRANE | 97 | 5.81e-01 | -3.24e-02 | 8.06e-01 |
SURFACTANT METABOLISM | 16 | 8.22e-01 | 3.24e-02 | 9.22e-01 |
ACTIVATION OF NMDA RECEPTORS AND POSTSYNAPTIC EVENTS | 85 | 6.08e-01 | -3.22e-02 | 8.25e-01 |
RHO GTPASES ACTIVATE PAKS | 21 | 7.99e-01 | 3.21e-02 | 9.11e-01 |
TRANSCRIPTIONAL REGULATION BY THE AP 2 TFAP2 FAMILY OF TRANSCRIPTION FACTORS | 32 | 7.56e-01 | 3.17e-02 | 8.91e-01 |
RETROGRADE NEUROTROPHIN SIGNALLING | 14 | 8.38e-01 | 3.16e-02 | 9.28e-01 |
DNA DOUBLE STRAND BREAK RESPONSE | 51 | 6.98e-01 | 3.14e-02 | 8.63e-01 |
G PROTEIN BETA GAMMA SIGNALLING | 31 | 7.62e-01 | 3.14e-02 | 8.92e-01 |
INFECTIOUS DISEASE | 737 | 1.51e-01 | -3.12e-02 | 3.79e-01 |
TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | 79 | 6.32e-01 | -3.12e-02 | 8.32e-01 |
SIGNALING BY INTERLEUKINS | 355 | 3.17e-01 | -3.10e-02 | 5.83e-01 |
CREB1 PHOSPHORYLATION THROUGH NMDA RECEPTOR MEDIATED ACTIVATION OF RAS SIGNALING | 28 | 7.78e-01 | 3.08e-02 | 8.97e-01 |
TELOMERE EXTENSION BY TELOMERASE | 22 | 8.03e-01 | -3.08e-02 | 9.11e-01 |
TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | 30 | 7.73e-01 | 3.04e-02 | 8.97e-01 |
EXPORT OF VIRAL RIBONUCLEOPROTEINS FROM NUCLEUS | 31 | 7.71e-01 | -3.02e-02 | 8.97e-01 |
SIGNALLING TO ERKS | 34 | 7.66e-01 | -2.96e-02 | 8.94e-01 |
CELLULAR SENESCENCE | 140 | 5.47e-01 | 2.95e-02 | 7.82e-01 |
NGF STIMULATED TRANSCRIPTION | 36 | 7.61e-01 | -2.93e-02 | 8.92e-01 |
NUCLEAR IMPORT OF REV PROTEIN | 32 | 7.74e-01 | -2.93e-02 | 8.97e-01 |
P38MAPK EVENTS | 13 | 8.56e-01 | -2.92e-02 | 9.37e-01 |
PLATELET ADHESION TO EXPOSED COLLAGEN | 12 | 8.62e-01 | -2.90e-02 | 9.39e-01 |
RESPONSE OF EIF2AK4 GCN2 TO AMINO ACID DEFICIENCY | 96 | 6.29e-01 | -2.85e-02 | 8.31e-01 |
BINDING AND UPTAKE OF LIGANDS BY SCAVENGER RECEPTORS | 34 | 7.74e-01 | -2.85e-02 | 8.97e-01 |
RHOF GTPASE CYCLE | 41 | 7.54e-01 | 2.83e-02 | 8.91e-01 |
ENDOSOMAL VACUOLAR PATHWAY | 11 | 8.72e-01 | -2.81e-02 | 9.45e-01 |
NUCLEOTIDE SALVAGE | 21 | 8.25e-01 | 2.79e-02 | 9.22e-01 |
RECOGNITION AND ASSOCIATION OF DNA GLYCOSYLASE WITH SITE CONTAINING AN AFFECTED PURINE | 21 | 8.25e-01 | -2.78e-02 | 9.22e-01 |
GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | 14 | 8.59e-01 | 2.74e-02 | 9.38e-01 |
SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | 13 | 8.66e-01 | -2.71e-02 | 9.42e-01 |
VLDLR INTERNALISATION AND DEGRADATION | 12 | 8.71e-01 | -2.71e-02 | 9.45e-01 |
GLYCOGEN METABOLISM | 25 | 8.15e-01 | 2.70e-02 | 9.21e-01 |
NS1 MEDIATED EFFECTS ON HOST PATHWAYS | 37 | 7.76e-01 | -2.70e-02 | 8.97e-01 |
GLUCOSE METABOLISM | 81 | 6.76e-01 | -2.68e-02 | 8.52e-01 |
ERYTHROPOIETIN ACTIVATES PHOSPHOINOSITIDE 3 KINASE PI3K | 11 | 8.79e-01 | 2.66e-02 | 9.50e-01 |
FORMATION OF RNA POL II ELONGATION COMPLEX | 57 | 7.29e-01 | -2.66e-02 | 8.81e-01 |
SUMOYLATION OF DNA REPLICATION PROTEINS | 42 | 7.66e-01 | -2.65e-02 | 8.94e-01 |
OVARIAN TUMOR DOMAIN PROTEASES | 37 | 7.81e-01 | 2.64e-02 | 8.99e-01 |
SIGNALING BY ERBB2 IN CANCER | 25 | 8.20e-01 | -2.63e-02 | 9.22e-01 |
ERYTHROPOIETIN ACTIVATES RAS | 13 | 8.74e-01 | 2.54e-02 | 9.46e-01 |
NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | 45 | 7.69e-01 | 2.53e-02 | 8.96e-01 |
PEPTIDE HORMONE METABOLISM | 60 | 7.35e-01 | 2.53e-02 | 8.83e-01 |
SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | 107 | 6.52e-01 | -2.53e-02 | 8.41e-01 |
ACYL CHAIN REMODELLING OF PE | 17 | 8.57e-01 | -2.53e-02 | 9.37e-01 |
CHEMOKINE RECEPTORS BIND CHEMOKINES | 19 | 8.49e-01 | -2.52e-02 | 9.35e-01 |
RHOG GTPASE CYCLE | 74 | 7.08e-01 | 2.52e-02 | 8.72e-01 |
GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | 16 | 8.63e-01 | -2.49e-02 | 9.40e-01 |
SIGNALING BY FGFR3 | 35 | 8.01e-01 | 2.46e-02 | 9.11e-01 |
METABOLISM OF ANGIOTENSINOGEN TO ANGIOTENSINS | 10 | 8.94e-01 | -2.44e-02 | 9.58e-01 |
INTEGRIN CELL SURFACE INTERACTIONS | 74 | 7.21e-01 | -2.40e-02 | 8.78e-01 |
RESPONSE OF MTB TO PHAGOCYTOSIS | 21 | 8.49e-01 | -2.40e-02 | 9.35e-01 |
EPH EPHRIN SIGNALING | 92 | 6.92e-01 | 2.39e-02 | 8.61e-01 |
SYNTHESIS OF LEUKOTRIENES LT AND EOXINS EX | 12 | 8.86e-01 | -2.39e-02 | 9.56e-01 |
SELENOAMINO ACID METABOLISM | 110 | 6.68e-01 | -2.37e-02 | 8.49e-01 |
ERBB2 ACTIVATES PTK6 SIGNALING | 11 | 8.92e-01 | -2.36e-02 | 9.58e-01 |
TBC RABGAPS | 43 | 7.92e-01 | -2.33e-02 | 9.06e-01 |
SIGNALING BY FGFR4 | 33 | 8.19e-01 | 2.30e-02 | 9.22e-01 |
CELL CELL JUNCTION ORGANIZATION | 49 | 7.81e-01 | 2.29e-02 | 8.99e-01 |
APOPTOTIC EXECUTION PHASE | 45 | 7.97e-01 | -2.22e-02 | 9.11e-01 |
PARASITE INFECTION | 55 | 7.78e-01 | -2.20e-02 | 8.97e-01 |
REGULATION OF INNATE IMMUNE RESPONSES TO CYTOSOLIC DNA | 13 | 8.91e-01 | 2.19e-02 | 9.58e-01 |
FCERI MEDIATED CA 2 MOBILIZATION | 26 | 8.47e-01 | -2.19e-02 | 9.34e-01 |
SIGNALING BY CSF3 G CSF | 29 | 8.39e-01 | -2.18e-02 | 9.28e-01 |
TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | 171 | 6.33e-01 | -2.12e-02 | 8.32e-01 |
AKT PHOSPHORYLATES TARGETS IN THE NUCLEUS | 10 | 9.09e-01 | 2.09e-02 | 9.65e-01 |
ESR MEDIATED SIGNALING | 166 | 6.49e-01 | 2.05e-02 | 8.41e-01 |
SYNTHESIS OF PC | 27 | 8.54e-01 | 2.05e-02 | 9.37e-01 |
PI3K AKT SIGNALING IN CANCER | 90 | 7.41e-01 | -2.02e-02 | 8.83e-01 |
GAP JUNCTION DEGRADATION | 11 | 9.08e-01 | 2.01e-02 | 9.65e-01 |
TCF DEPENDENT SIGNALING IN RESPONSE TO WNT | 177 | 6.46e-01 | -2.01e-02 | 8.40e-01 |
BILE ACID AND BILE SALT METABOLISM | 24 | 8.67e-01 | 1.97e-02 | 9.42e-01 |
ABC TRANSPORTERS IN LIPID HOMEOSTASIS | 13 | 9.04e-01 | 1.94e-02 | 9.65e-01 |
SIGNALING BY VEGF | 104 | 7.36e-01 | -1.92e-02 | 8.83e-01 |
NUCLEAR ENVELOPE BREAKDOWN | 49 | 8.21e-01 | 1.86e-02 | 9.22e-01 |
DISEASES OF SIGNAL TRANSDUCTION BY GROWTH FACTOR RECEPTORS AND SECOND MESSENGERS | 369 | 5.40e-01 | 1.86e-02 | 7.77e-01 |
DISEASES OF DNA REPAIR | 11 | 9.15e-01 | -1.85e-02 | 9.70e-01 |
INTRACELLULAR SIGNALING BY SECOND MESSENGERS | 288 | 5.90e-01 | -1.85e-02 | 8.13e-01 |
DEGRADATION OF THE EXTRACELLULAR MATRIX | 108 | 7.40e-01 | -1.85e-02 | 8.83e-01 |
SUMOYLATION OF SUMOYLATION PROTEINS | 33 | 8.55e-01 | -1.84e-02 | 9.37e-01 |
COLLAGEN FORMATION | 81 | 7.77e-01 | -1.82e-02 | 8.97e-01 |
FRS MEDIATED FGFR4 SIGNALING | 14 | 9.06e-01 | 1.82e-02 | 9.65e-01 |
ACTIVATED PKN1 STIMULATES TRANSCRIPTION OF AR ANDROGEN RECEPTOR REGULATED GENES KLK2 AND KLK3 | 20 | 8.89e-01 | 1.80e-02 | 9.57e-01 |
SARS COV INFECTIONS | 140 | 7.14e-01 | 1.80e-02 | 8.76e-01 |
CELL JUNCTION ORGANIZATION | 74 | 7.90e-01 | 1.79e-02 | 9.06e-01 |
RECYCLING PATHWAY OF L1 | 40 | 8.46e-01 | -1.78e-02 | 9.34e-01 |
HEDGEHOG OFF STATE | 108 | 7.51e-01 | -1.77e-02 | 8.89e-01 |
CILIUM ASSEMBLY | 193 | 6.75e-01 | -1.75e-02 | 8.52e-01 |
METABOLISM OF VITAMINS AND COFACTORS | 153 | 7.10e-01 | 1.75e-02 | 8.72e-01 |
CARBOXYTERMINAL POST TRANSLATIONAL MODIFICATIONS OF TUBULIN | 36 | 8.59e-01 | -1.71e-02 | 9.38e-01 |
BETA CATENIN INDEPENDENT WNT SIGNALING | 141 | 7.27e-01 | 1.70e-02 | 8.81e-01 |
MAPK FAMILY SIGNALING CASCADES | 290 | 6.20e-01 | -1.70e-02 | 8.31e-01 |
MISCELLANEOUS TRANSPORT AND BINDING EVENTS | 21 | 8.93e-01 | 1.69e-02 | 9.58e-01 |
SIGNALING BY PTK6 | 50 | 8.36e-01 | 1.69e-02 | 9.28e-01 |
METABOLISM OF STEROIDS | 114 | 7.61e-01 | -1.65e-02 | 8.92e-01 |
PI3K EVENTS IN ERBB2 SIGNALING | 15 | 9.12e-01 | -1.65e-02 | 9.68e-01 |
TFAP2 AP 2 FAMILY REGULATES TRANSCRIPTION OF GROWTH FACTORS AND THEIR RECEPTORS | 11 | 9.25e-01 | -1.65e-02 | 9.76e-01 |
NEGATIVE REGULATION OF FGFR3 SIGNALING | 24 | 8.89e-01 | -1.64e-02 | 9.57e-01 |
INTRAFLAGELLAR TRANSPORT | 52 | 8.44e-01 | 1.58e-02 | 9.33e-01 |
NUCLEOTIDE LIKE PURINERGIC RECEPTORS | 13 | 9.22e-01 | -1.56e-02 | 9.75e-01 |
STRIATED MUSCLE CONTRACTION | 28 | 8.87e-01 | 1.55e-02 | 9.56e-01 |
SIGNALING BY ERBB2 ECD MUTANTS | 16 | 9.16e-01 | 1.53e-02 | 9.70e-01 |
SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | 52 | 8.51e-01 | 1.51e-02 | 9.36e-01 |
SIGNALING BY TGF BETA RECEPTOR COMPLEX | 72 | 8.27e-01 | -1.49e-02 | 9.23e-01 |
CASPASE ACTIVATION VIA EXTRINSIC APOPTOTIC SIGNALLING PATHWAY | 24 | 9.00e-01 | 1.49e-02 | 9.62e-01 |
SYNTHESIS OF BILE ACIDS AND BILE SALTS | 21 | 9.07e-01 | -1.48e-02 | 9.65e-01 |
NUCLEAR PORE COMPLEX NPC DISASSEMBLY | 32 | 8.85e-01 | -1.48e-02 | 9.56e-01 |
CLATHRIN MEDIATED ENDOCYTOSIS | 134 | 7.68e-01 | -1.48e-02 | 8.96e-01 |
NEGATIVE REGULATION OF FGFR4 SIGNALING | 23 | 9.03e-01 | -1.47e-02 | 9.65e-01 |
RNA POLYMERASE I TRANSCRIPTION INITIATION | 47 | 8.62e-01 | -1.47e-02 | 9.39e-01 |
ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | 23 | 9.06e-01 | 1.43e-02 | 9.65e-01 |
INTRA GOLGI AND RETROGRADE GOLGI TO ER TRAFFIC | 186 | 7.43e-01 | -1.40e-02 | 8.83e-01 |
REPRODUCTION | 76 | 8.34e-01 | -1.39e-02 | 9.28e-01 |
DISORDERS OF TRANSMEMBRANE TRANSPORTERS | 149 | 7.71e-01 | -1.38e-02 | 8.97e-01 |
HCMV EARLY EVENTS | 79 | 8.37e-01 | 1.34e-02 | 9.28e-01 |
FRS MEDIATED FGFR3 SIGNALING | 15 | 9.29e-01 | 1.33e-02 | 9.78e-01 |
GENE SILENCING BY RNA | 81 | 8.37e-01 | 1.33e-02 | 9.28e-01 |
SIGNALING BY FGFR3 FUSIONS IN CANCER | 10 | 9.43e-01 | -1.30e-02 | 9.85e-01 |
GLYCOLYSIS | 67 | 8.54e-01 | -1.30e-02 | 9.37e-01 |
DNA METHYLATION | 19 | 9.24e-01 | -1.26e-02 | 9.76e-01 |
INTRA GOLGI TRAFFIC | 43 | 8.97e-01 | 1.14e-02 | 9.60e-01 |
EPIGENETIC REGULATION OF GENE EXPRESSION | 102 | 8.43e-01 | 1.14e-02 | 9.32e-01 |
SIGNALING BY PDGFRA TRANSMEMBRANE JUXTAMEMBRANE AND KINASE DOMAIN MUTANTS | 12 | 9.46e-01 | 1.13e-02 | 9.85e-01 |
SIGNALING BY WNT | 267 | 7.55e-01 | 1.11e-02 | 8.91e-01 |
REGULATION OF TP53 ACTIVITY THROUGH METHYLATION | 18 | 9.36e-01 | 1.09e-02 | 9.80e-01 |
RNA POLYMERASE III TRANSCRIPTION | 41 | 9.05e-01 | -1.08e-02 | 9.65e-01 |
POSITIVE EPIGENETIC REGULATION OF RRNA EXPRESSION | 61 | 8.85e-01 | 1.07e-02 | 9.56e-01 |
VXPX CARGO TARGETING TO CILIUM | 19 | 9.36e-01 | 1.06e-02 | 9.80e-01 |
UNBLOCKING OF NMDA RECEPTORS GLUTAMATE BINDING AND ACTIVATION | 21 | 9.34e-01 | 1.04e-02 | 9.80e-01 |
METABOLISM OF WATER SOLUBLE VITAMINS AND COFACTORS | 103 | 8.57e-01 | -1.03e-02 | 9.37e-01 |
TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | 16 | 9.46e-01 | -9.83e-03 | 9.85e-01 |
SIGNALING BY TGFB FAMILY MEMBERS | 97 | 8.71e-01 | 9.58e-03 | 9.45e-01 |
NEGATIVE REGULATION OF MET ACTIVITY | 20 | 9.48e-01 | -8.46e-03 | 9.85e-01 |
COMMON PATHWAY OF FIBRIN CLOT FORMATION | 11 | 9.63e-01 | 8.04e-03 | 9.97e-01 |
MEIOTIC SYNAPSIS | 40 | 9.31e-01 | 7.95e-03 | 9.78e-01 |
LDL CLEARANCE | 16 | 9.57e-01 | 7.77e-03 | 9.93e-01 |
PHASE I FUNCTIONALIZATION OF COMPOUNDS | 59 | 9.20e-01 | 7.57e-03 | 9.74e-01 |
BASE EXCISION REPAIR AP SITE FORMATION | 28 | 9.45e-01 | 7.49e-03 | 9.85e-01 |
EGFR DOWNREGULATION | 28 | 9.46e-01 | -7.34e-03 | 9.85e-01 |
PRC2 METHYLATES HISTONES AND DNA | 28 | 9.51e-01 | -6.72e-03 | 9.88e-01 |
SARS COV 2 INFECTION | 65 | 9.30e-01 | -6.29e-03 | 9.78e-01 |
SIGNALING BY RECEPTOR TYROSINE KINASES | 467 | 8.21e-01 | 6.12e-03 | 9.22e-01 |
CYTOKINE SIGNALING IN IMMUNE SYSTEM | 558 | 8.07e-01 | -6.08e-03 | 9.13e-01 |
CYTOSOLIC SENSORS OF PATHOGEN ASSOCIATED DNA | 59 | 9.36e-01 | 6.08e-03 | 9.80e-01 |
SIGNAL TRANSDUCTION BY L1 | 21 | 9.62e-01 | 6.01e-03 | 9.97e-01 |
TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | 10 | 9.75e-01 | 5.73e-03 | 9.99e-01 |
TRANSCRIPTIONAL REGULATION BY RUNX3 | 94 | 9.30e-01 | 5.25e-03 | 9.78e-01 |
CROSSLINKING OF COLLAGEN FIBRILS | 16 | 9.72e-01 | -5.14e-03 | 9.99e-01 |
FOXO MEDIATED TRANSCRIPTION OF CELL CYCLE GENES | 16 | 9.72e-01 | 5.11e-03 | 9.99e-01 |
NONSENSE MEDIATED DECAY NMD | 110 | 9.29e-01 | -4.93e-03 | 9.78e-01 |
FCGAMMA RECEPTOR FCGR DEPENDENT PHAGOCYTOSIS | 82 | 9.42e-01 | -4.64e-03 | 9.85e-01 |
NEGATIVE REGULATORS OF DDX58 IFIH1 SIGNALING | 34 | 9.65e-01 | 4.31e-03 | 9.97e-01 |
ADP SIGNALLING THROUGH P2Y PURINOCEPTOR 12 | 20 | 9.74e-01 | 4.27e-03 | 9.99e-01 |
WNT5A DEPENDENT INTERNALIZATION OF FZD4 | 15 | 9.78e-01 | -4.18e-03 | 9.99e-01 |
CARGO RECOGNITION FOR CLATHRIN MEDIATED ENDOCYTOSIS | 94 | 9.45e-01 | 4.12e-03 | 9.85e-01 |
SIGNALING BY KIT IN DISEASE | 20 | 9.78e-01 | 3.61e-03 | 9.99e-01 |
SIGNALING BY HIPPO | 20 | 9.78e-01 | 3.53e-03 | 9.99e-01 |
CD28 DEPENDENT PI3K AKT SIGNALING | 21 | 9.79e-01 | 3.36e-03 | 9.99e-01 |
DEFECTS IN VITAMIN AND COFACTOR METABOLISM | 21 | 9.79e-01 | 3.32e-03 | 9.99e-01 |
AMYLOID FIBER FORMATION | 56 | 9.66e-01 | 3.30e-03 | 9.97e-01 |
SPRY REGULATION OF FGF SIGNALING | 16 | 9.82e-01 | 3.23e-03 | 9.99e-01 |
ENDOGENOUS STEROLS | 20 | 9.80e-01 | -3.23e-03 | 9.99e-01 |
SHC MEDIATED CASCADE FGFR4 | 12 | 9.85e-01 | 3.16e-03 | 1.00e+00 |
RAC2 GTPASE CYCLE | 88 | 9.61e-01 | 3.00e-03 | 9.97e-01 |
SUMOYLATION OF UBIQUITINYLATION PROTEINS | 37 | 9.76e-01 | 2.89e-03 | 9.99e-01 |
HEME SIGNALING | 45 | 9.75e-01 | 2.75e-03 | 9.99e-01 |
TRANSPORT OF MATURE MRNAS DERIVED FROM INTRONLESS TRANSCRIPTS | 41 | 9.76e-01 | -2.71e-03 | 9.99e-01 |
COPI DEPENDENT GOLGI TO ER RETROGRADE TRAFFIC | 87 | 9.66e-01 | -2.68e-03 | 9.97e-01 |
NUCLEOBASE CATABOLISM | 31 | 9.80e-01 | 2.55e-03 | 9.99e-01 |
RHOH GTPASE CYCLE | 37 | 9.81e-01 | 2.27e-03 | 9.99e-01 |
TRANSCRIPTIONAL REGULATION BY SMALL RNAS | 60 | 9.78e-01 | -2.03e-03 | 9.99e-01 |
SIGNALING BY EGFR IN CANCER | 22 | 9.88e-01 | 1.91e-03 | 1.00e+00 |
TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | 32 | 9.86e-01 | 1.81e-03 | 1.00e+00 |
TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | 32 | 9.86e-01 | -1.79e-03 | 1.00e+00 |
DOWNSTREAM SIGNALING OF ACTIVATED FGFR1 | 26 | 9.90e-01 | -1.49e-03 | 1.00e+00 |
TRANSLATION OF SARS COV 1 STRUCTURAL PROTEINS | 28 | 9.90e-01 | -1.42e-03 | 1.00e+00 |
ABORTIVE ELONGATION OF HIV 1 TRANSCRIPT IN THE ABSENCE OF TAT | 23 | 9.91e-01 | 1.31e-03 | 1.00e+00 |
SHC MEDIATED CASCADE FGFR3 | 13 | 9.93e-01 | -1.31e-03 | 1.00e+00 |
PD 1 SIGNALING | 10 | 9.95e-01 | 1.23e-03 | 1.00e+00 |
SIGNALING BY FGFR4 IN DISEASE | 11 | 9.95e-01 | -1.12e-03 | 1.00e+00 |
SIGNALING BY WNT IN CANCER | 31 | 9.93e-01 | 9.62e-04 | 1.00e+00 |
CARGO CONCENTRATION IN THE ER | 31 | 9.95e-01 | -6.72e-04 | 1.00e+00 |
RETINOID CYCLE DISEASE EVENTS | 10 | 9.97e-01 | -6.68e-04 | 1.00e+00 |
EUKARYOTIC TRANSLATION ELONGATION | 88 | 9.94e-01 | -5.01e-04 | 1.00e+00 |
SCAVENGING BY CLASS A RECEPTORS | 14 | 9.98e-01 | -4.69e-04 | 1.00e+00 |
REGULATION OF PTEN GENE TRANSCRIPTION | 60 | 9.96e-01 | -4.20e-04 | 1.00e+00 |
TRANSCRIPTIONAL ACTIVATION OF MITOCHONDRIAL BIOGENESIS | 54 | 9.96e-01 | 3.55e-04 | 1.00e+00 |
SUMOYLATION | 163 | 9.98e-01 | 9.95e-05 | 1.00e+00 |
TRANSPORT OF THE SLBP DEPENDANT MATURE MRNA | 34 | 9.99e-01 | 9.16e-05 | 1.00e+00 |
CD209 DC SIGN SIGNALING | 18 | 1.00e+00 | 3.20e-05 | 1.00e+00 |
REGULATION OF RUNX1 EXPRESSION AND ACTIVITY
818 | |
---|---|
set | REGULATION OF RUNX1 EXPRESSION AND ACTIVITY |
setSize | 17 |
pANOVA | 1.27e-05 |
s.dist | 0.611 |
p.adjustANOVA | 0.000557 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Ptpn11 | 9216 |
Ago2 | 8780 |
Mov10 | 8721 |
Src | 8029 |
Tnrc6b | 7816 |
Ago3 | 7792 |
Ago1 | 7427 |
Pml | 7388 |
Runx1 | 7134 |
Ccnd2 | 6910 |
Cdk6 | 5283 |
Ccnd3 | 5010 |
Tnrc6c | 4966 |
Tnrc6a | 4639 |
Ago4 | 3109 |
Cbfb | -1400 |
Ccnd1 | -1417 |
GeneID | Gene Rank |
---|---|
Ptpn11 | 9216 |
Ago2 | 8780 |
Mov10 | 8721 |
Src | 8029 |
Tnrc6b | 7816 |
Ago3 | 7792 |
Ago1 | 7427 |
Pml | 7388 |
Runx1 | 7134 |
Ccnd2 | 6910 |
Cdk6 | 5283 |
Ccnd3 | 5010 |
Tnrc6c | 4966 |
Tnrc6a | 4639 |
Ago4 | 3109 |
Cbfb | -1400 |
Ccnd1 | -1417 |
ERYTHROCYTES TAKE UP CARBON DIOXIDE AND RELEASE OXYGEN
299 | |
---|---|
set | ERYTHROCYTES TAKE UP CARBON DIOXIDE AND RELEASE OXYGEN |
setSize | 10 |
pANOVA | 0.00198 |
s.dist | -0.565 |
p.adjustANOVA | 0.0221 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Cyb5r1 | -7231 |
Hbb-bt | -6892 |
Cyb5r4 | -6626 |
Car2 | -6572 |
Cyb5r2 | -6023 |
Hba-a1 | -5814 |
Hba-a2 | -4802 |
Car4 | -2794 |
Aqp1 | -2553 |
Cyb5rl | 5706 |
GeneID | Gene Rank |
---|---|
Cyb5r1 | -7231 |
Hbb-bt | -6892 |
Cyb5r4 | -6626 |
Car2 | -6572 |
Cyb5r2 | -6023 |
Hba-a1 | -5814 |
Hba-a2 | -4802 |
Car4 | -2794 |
Aqp1 | -2553 |
Cyb5rl | 5706 |
NOTCH2 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION
638 | |
---|---|
set | NOTCH2 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION |
setSize | 11 |
pANOVA | 0.00397 |
s.dist | 0.502 |
p.adjustANOVA | 0.0377 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Hes5 | 8725 |
Notch2 | 8640 |
Mamld1 | 7114 |
Maml2 | 6126 |
Hes1 | 5678 |
Maml3 | 5247 |
Maml1 | 4758 |
Ep300 | 3948 |
Rbpj | 2968 |
Fcer2a | 2926 |
Creb1 | -2266 |
GeneID | Gene Rank |
---|---|
Hes5 | 8725 |
Notch2 | 8640 |
Mamld1 | 7114 |
Maml2 | 6126 |
Hes1 | 5678 |
Maml3 | 5247 |
Maml1 | 4758 |
Ep300 | 3948 |
Rbpj | 2968 |
Fcer2a | 2926 |
Creb1 | -2266 |
TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR
1106 | |
---|---|
set | TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR |
setSize | 11 |
pANOVA | 0.0047 |
s.dist | -0.492 |
p.adjustANOVA | 0.0429 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Tlr3 | -8114 |
Ctsk | -6498 |
Lgmn | -6322 |
Hsp90b1 | -6219 |
Ctss | -4519 |
Tlr7 | -4011 |
Tlr9 | -2782 |
Ctsb | -2221 |
Ctsl | -2109 |
Unc93b1 | -1345 |
Cnpy3 | 3105 |
GeneID | Gene Rank |
---|---|
Tlr3 | -8114 |
Ctsk | -6498 |
Lgmn | -6322 |
Hsp90b1 | -6219 |
Ctss | -4519 |
Tlr7 | -4011 |
Tlr9 | -2782 |
Ctsb | -2221 |
Ctsl | -2109 |
Unc93b1 | -1345 |
Cnpy3 | 3105 |
ADENYLATE CYCLASE ACTIVATING PATHWAY
36 | |
---|---|
set | ADENYLATE CYCLASE ACTIVATING PATHWAY |
setSize | 10 |
pANOVA | 0.00794 |
s.dist | 0.485 |
p.adjustANOVA | 0.0624 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Adcy6 | 8821 |
Adcy5 | 8012 |
Adcy4 | 7917 |
Adcy2 | 7682 |
Adcy3 | 4776 |
Adcy7 | 4456 |
Adcy9 | 3934 |
Adcy8 | 3828 |
Adcy1 | -373 |
Gnal | -1542 |
GeneID | Gene Rank |
---|---|
Adcy6 | 8821 |
Adcy5 | 8012 |
Adcy4 | 7917 |
Adcy2 | 7682 |
Adcy3 | 4776 |
Adcy7 | 4456 |
Adcy9 | 3934 |
Adcy8 | 3828 |
Adcy1 | -373 |
Gnal | -1542 |
NOTCH4 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION
642 | |
---|---|
set | NOTCH4 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION |
setSize | 20 |
pANOVA | 0.000238 |
s.dist | 0.475 |
p.adjustANOVA | 0.00502 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Notch1 | 8999 |
Hes5 | 8725 |
Notch4 | 8676 |
Notch2 | 8640 |
Crebbp | 7942 |
Mamld1 | 7114 |
Hey2 | 6505 |
Flt4 | 6174 |
Maml2 | 6126 |
Hes1 | 5678 |
Smad3 | 5361 |
Maml3 | 5247 |
Maml1 | 4758 |
Ep300 | 3948 |
Hey1 | 2985 |
Rbpj | 2968 |
Snw1 | 1230 |
Kat2a | -241 |
Acta2 | -2738 |
Kat2b | -4896 |
GeneID | Gene Rank |
---|---|
Notch1 | 8999 |
Hes5 | 8725 |
Notch4 | 8676 |
Notch2 | 8640 |
Crebbp | 7942 |
Mamld1 | 7114 |
Hey2 | 6505 |
Flt4 | 6174 |
Maml2 | 6126 |
Hes1 | 5678 |
Smad3 | 5361 |
Maml3 | 5247 |
Maml1 | 4758 |
Ep300 | 3948 |
Hey1 | 2985 |
Rbpj | 2968 |
Snw1 | 1230 |
Kat2a | -241 |
Acta2 | -2738 |
Kat2b | -4896 |
ACETYLCHOLINE REGULATES INSULIN SECRETION
10 | |
---|---|
set | ACETYLCHOLINE REGULATES INSULIN SECRETION |
setSize | 10 |
pANOVA | 0.00956 |
s.dist | 0.473 |
p.adjustANOVA | 0.0712 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Gna11 | 9159 |
Gna15 | 8747 |
Gnaq | 8708 |
Plcb3 | 7955 |
Plcb2 | 5794 |
Marcks | 4849 |
Prkca | 3936 |
Plcb1 | 775 |
Chrm3 | -764 |
Gna14 | -2654 |
GeneID | Gene Rank |
---|---|
Gna11 | 9159 |
Gna15 | 8747 |
Gnaq | 8708 |
Plcb3 | 7955 |
Plcb2 | 5794 |
Marcks | 4849 |
Prkca | 3936 |
Plcb1 | 775 |
Chrm3 | -764 |
Gna14 | -2654 |
A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS
1 | |
---|---|
set | A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS |
setSize | 26 |
pANOVA | 6.9e-05 |
s.dist | 0.451 |
p.adjustANOVA | 0.00209 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Gpc3 | 9164 |
Sdc4 | 9051 |
Ncan | 8843 |
Cspg4 | 8709 |
Xylt2 | 8160 |
Gpc4 | 7880 |
Hspg2 | 7534 |
B4galt7 | 7465 |
B3gat2 | 6157 |
Sdc3 | 6007 |
Gpc5 | 5911 |
B3gat1 | 5345 |
Dcn | 5141 |
Vcan | 4229 |
Cspg5 | 4159 |
Xylt1 | 3986 |
B3galt6 | 3903 |
Gpc1 | 3237 |
Agrn | 2428 |
Bgn | 1800 |
GeneID | Gene Rank |
---|---|
Gpc3 | 9164 |
Sdc4 | 9051 |
Ncan | 8843 |
Cspg4 | 8709 |
Xylt2 | 8160 |
Gpc4 | 7880 |
Hspg2 | 7534 |
B4galt7 | 7465 |
B3gat2 | 6157 |
Sdc3 | 6007 |
Gpc5 | 5911 |
B3gat1 | 5345 |
Dcn | 5141 |
Vcan | 4229 |
Cspg5 | 4159 |
Xylt1 | 3986 |
B3galt6 | 3903 |
Gpc1 | 3237 |
Agrn | 2428 |
Bgn | 1800 |
Gpc2 | 1789 |
B3gat3 | 63 |
Bcan | -609 |
Sdc2 | -743 |
Sdc1 | -1206 |
Gpc6 | -2624 |
RUNX3 REGULATES NOTCH SIGNALING
904 | |
---|---|
set | RUNX3 REGULATES NOTCH SIGNALING |
setSize | 13 |
pANOVA | 0.00489 |
s.dist | 0.451 |
p.adjustANOVA | 0.044 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Jag1 | 9047 |
Notch1 | 8999 |
Crebbp | 7942 |
Mamld1 | 7114 |
Maml2 | 6126 |
Hes1 | 5678 |
Maml3 | 5247 |
Maml1 | 4758 |
Ep300 | 3948 |
Rbpj | 2968 |
Snw1 | 1230 |
Kat2a | -241 |
Kat2b | -4896 |
GeneID | Gene Rank |
---|---|
Jag1 | 9047 |
Notch1 | 8999 |
Crebbp | 7942 |
Mamld1 | 7114 |
Maml2 | 6126 |
Hes1 | 5678 |
Maml3 | 5247 |
Maml1 | 4758 |
Ep300 | 3948 |
Rbpj | 2968 |
Snw1 | 1230 |
Kat2a | -241 |
Kat2b | -4896 |
DEFECTIVE B4GALT7 CAUSES EDS PROGEROID TYPE
216 | |
---|---|
set | DEFECTIVE B4GALT7 CAUSES EDS PROGEROID TYPE |
setSize | 20 |
pANOVA | 0.000561 |
s.dist | 0.446 |
p.adjustANOVA | 0.00899 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Gpc3 | 9164 |
Sdc4 | 9051 |
Ncan | 8843 |
Cspg4 | 8709 |
Gpc4 | 7880 |
Hspg2 | 7534 |
B4galt7 | 7465 |
Sdc3 | 6007 |
Gpc5 | 5911 |
Dcn | 5141 |
Vcan | 4229 |
Cspg5 | 4159 |
Gpc1 | 3237 |
Agrn | 2428 |
Bgn | 1800 |
Gpc2 | 1789 |
Bcan | -609 |
Sdc2 | -743 |
Sdc1 | -1206 |
Gpc6 | -2624 |
GeneID | Gene Rank |
---|---|
Gpc3 | 9164 |
Sdc4 | 9051 |
Ncan | 8843 |
Cspg4 | 8709 |
Gpc4 | 7880 |
Hspg2 | 7534 |
B4galt7 | 7465 |
Sdc3 | 6007 |
Gpc5 | 5911 |
Dcn | 5141 |
Vcan | 4229 |
Cspg5 | 4159 |
Gpc1 | 3237 |
Agrn | 2428 |
Bgn | 1800 |
Gpc2 | 1789 |
Bcan | -609 |
Sdc2 | -743 |
Sdc1 | -1206 |
Gpc6 | -2624 |
NOTCH HLH TRANSCRIPTION PATHWAY
635 | |
---|---|
set | NOTCH HLH TRANSCRIPTION PATHWAY |
setSize | 28 |
pANOVA | 5.01e-05 |
s.dist | 0.443 |
p.adjustANOVA | 0.00164 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Hdac5 | 9081 |
Notch1 | 8999 |
Ncor2 | 8830 |
Ncor1 | 8766 |
Notch3 | 8739 |
Notch4 | 8676 |
Notch2 | 8640 |
Hdac8 | 8624 |
Hdac4 | 8280 |
Hdac11 | 7987 |
Crebbp | 7942 |
Hdac6 | 7800 |
Mamld1 | 7114 |
Maml2 | 6126 |
Maml3 | 5247 |
Maml1 | 4758 |
Hdac10 | 4673 |
Rbpj | 2968 |
Tbl1x | 2490 |
Hdac1 | 1732 |
GeneID | Gene Rank |
---|---|
Hdac5 | 9081 |
Notch1 | 8999 |
Ncor2 | 8830 |
Ncor1 | 8766 |
Notch3 | 8739 |
Notch4 | 8676 |
Notch2 | 8640 |
Hdac8 | 8624 |
Hdac4 | 8280 |
Hdac11 | 7987 |
Crebbp | 7942 |
Hdac6 | 7800 |
Mamld1 | 7114 |
Maml2 | 6126 |
Maml3 | 5247 |
Maml1 | 4758 |
Hdac10 | 4673 |
Rbpj | 2968 |
Tbl1x | 2490 |
Hdac1 | 1732 |
Hdac7 | 1610 |
Snw1 | 1230 |
Hdac9 | 590 |
Tbl1xr1 | 124 |
Kat2a | -241 |
Kat2b | -4896 |
Hdac3 | -6297 |
Hdac2 | -6904 |
REGULATION OF COMMISSURAL AXON PATHFINDING BY SLIT AND ROBO
792 | |
---|---|
set | REGULATION OF COMMISSURAL AXON PATHFINDING BY SLIT AND ROBO |
setSize | 10 |
pANOVA | 0.017 |
s.dist | 0.436 |
p.adjustANOVA | 0.102 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Dcc | 8033 |
Src | 8029 |
Slit1 | 7348 |
Ntn1 | 7135 |
Slit2 | 5401 |
Robo3 | 4617 |
Nell2 | 4191 |
Robo1 | 3856 |
Robo2 | -1332 |
Slit3 | -4016 |
GeneID | Gene Rank |
---|---|
Dcc | 8033 |
Src | 8029 |
Slit1 | 7348 |
Ntn1 | 7135 |
Slit2 | 5401 |
Robo3 | 4617 |
Nell2 | 4191 |
Robo1 | 3856 |
Robo2 | -1332 |
Slit3 | -4016 |
NOTCH3 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION
640 | |
---|---|
set | NOTCH3 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION |
setSize | 23 |
pANOVA | 0.000347 |
s.dist | 0.431 |
p.adjustANOVA | 0.00645 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Notch1 | 8999 |
Notch3 | 8739 |
Hes5 | 8725 |
Pbx1 | 8385 |
Crebbp | 7942 |
Ikzf1 | 7835 |
Mamld1 | 7114 |
Heyl | 6800 |
Wwc1 | 6734 |
Hey2 | 6505 |
Maml2 | 6126 |
Hes1 | 5678 |
Maml3 | 5247 |
Plxnd1 | 4926 |
Maml1 | 4758 |
Ep300 | 3948 |
Hey1 | 2985 |
Rbpj | 2968 |
Snw1 | 1230 |
Kat2a | -241 |
GeneID | Gene Rank |
---|---|
Notch1 | 8999 |
Notch3 | 8739 |
Hes5 | 8725 |
Pbx1 | 8385 |
Crebbp | 7942 |
Ikzf1 | 7835 |
Mamld1 | 7114 |
Heyl | 6800 |
Wwc1 | 6734 |
Hey2 | 6505 |
Maml2 | 6126 |
Hes1 | 5678 |
Maml3 | 5247 |
Plxnd1 | 4926 |
Maml1 | 4758 |
Ep300 | 3948 |
Hey1 | 2985 |
Rbpj | 2968 |
Snw1 | 1230 |
Kat2a | -241 |
Kat2b | -4896 |
Stat1 | -5672 |
Fabp7 | -6388 |
MITOCHONDRIAL TRANSLATION
571 | |
---|---|
set | MITOCHONDRIAL TRANSLATION |
setSize | 93 |
pANOVA | 7.3e-13 |
s.dist | -0.43 |
p.adjustANOVA | 4.3e-10 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Ptcd3 | -7941 |
Mtif2 | -7708 |
Mrpl47 | -7703 |
Mrps2 | -7665 |
Mrpl32 | -7484 |
Mrpl42 | -7442 |
Mrpl1 | -7429 |
Mrpl3 | -7425 |
Mrps30 | -7389 |
Mrpl16 | -7244 |
Mrps22 | -7208 |
Mrpl50 | -7045 |
Mrpl18 | -6985 |
Mrps31 | -6813 |
Mrrf | -6752 |
Mrpl22 | -6694 |
Mrpl40 | -6637 |
Chchd1 | -6048 |
Mrps14 | -6016 |
Mrpl10 | -5932 |
GeneID | Gene Rank |
---|---|
Ptcd3 | -7941 |
Mtif2 | -7708 |
Mrpl47 | -7703 |
Mrps2 | -7665 |
Mrpl32 | -7484 |
Mrpl42 | -7442 |
Mrpl1 | -7429 |
Mrpl3 | -7425 |
Mrps30 | -7389 |
Mrpl16 | -7244 |
Mrps22 | -7208 |
Mrpl50 | -7045 |
Mrpl18 | -6985 |
Mrps31 | -6813 |
Mrrf | -6752 |
Mrpl22 | -6694 |
Mrpl40 | -6637 |
Chchd1 | -6048 |
Mrps14 | -6016 |
Mrpl10 | -5932 |
Mrpl15 | -5922 |
Mrpl35 | -5803 |
Mrps23 | -5679 |
Mrpl34 | -5571 |
Mrpl11 | -5416 |
Mrpl13 | -5399 |
Mrps36 | -5049 |
Mrpl21 | -4899 |
Mrpl48 | -4798 |
Gfm1 | -4708 |
Mrpl51 | -4678 |
Mrpl30 | -4671 |
Mrpl12 | -4670 |
Mrpl46 | -4653 |
Mrpl39 | -4580 |
Mrpl36 | -4538 |
Mrps33 | -4467 |
Mrps35 | -4398 |
Mrps18a | -4382 |
Mrps27 | -4337 |
Mrps18c | -4305 |
Mrpl33 | -4190 |
Mrpl43 | -3987 |
Mrps12 | -3766 |
Mrps18b | -3656 |
Mrpl27 | -3604 |
Mrpl49 | -3507 |
Mrpl20 | -3440 |
Mrpl37 | -3396 |
Mrps10 | -3264 |
Gfm2 | -3139 |
Mrps9 | -2999 |
Mrps21 | -2985 |
Mrpl54 | -2907 |
Mrpl17 | -2833 |
Oxa1l | -2550 |
Mrpl28 | -2389 |
Gadd45gip1 | -2281 |
Mrps7 | -2248 |
Mrpl44 | -2112 |
Mrpl19 | -1978 |
Mrpl55 | -1854 |
Mrpl53 | -1766 |
Mrps24 | -1707 |
Mrpl9 | -1683 |
Mrpl57 | -1563 |
Mrps11 | -1388 |
Mrpl4 | -1331 |
Mrps25 | -1217 |
Mrpl52 | -971 |
Tsfm | -833 |
Mrps16 | -822 |
Mrpl58 | -789 |
Mrpl24 | -682 |
Mrps17 | -544 |
Mrpl41 | -518 |
Mrps15 | -423 |
Aurkaip1 | -327 |
Mtif3 | -259 |
Mrpl23 | -195 |
Mrps28 | -146 |
Tufm | 588 |
Mtfmt | 650 |
Mrps6 | 973 |
Mrps26 | 978 |
Mrpl2 | 1103 |
Mrps5 | 1311 |
Mrpl14 | 1675 |
Mrps34 | 1923 |
Mrpl38 | 4193 |
Eral1 | 4336 |
Dap3 | 5241 |
Mtrf1l | 6440 |
SYNTHESIS OF ACTIVE UBIQUITIN ROLES OF E1 AND E2 ENZYMES
1036 | |
---|---|
set | SYNTHESIS OF ACTIVE UBIQUITIN ROLES OF E1 AND E2 ENZYMES |
setSize | 29 |
pANOVA | 6.19e-05 |
s.dist | -0.43 |
p.adjustANOVA | 0.00192 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Ube2b | -8104 |
Ube2w | -8063 |
Ube2a | -8007 |
Ube2g1 | -8005 |
Uchl3 | -7908 |
Ube2l3 | -7759 |
Ube2d1 | -7672 |
Ube2e1 | -7614 |
Ube2d2a | -7380 |
Ube2e3 | -7216 |
Ube2k | -7089 |
Uba6 | -6485 |
Ube2t | -6180 |
Ube2q2 | -6095 |
Cdc34 | -5028 |
Ube2s | -3423 |
Usp9x | -2842 |
Ube2r2 | -2055 |
Ubb | -2020 |
Rps27a | -1712 |
GeneID | Gene Rank |
---|---|
Ube2b | -8104 |
Ube2w | -8063 |
Ube2a | -8007 |
Ube2g1 | -8005 |
Uchl3 | -7908 |
Ube2l3 | -7759 |
Ube2d1 | -7672 |
Ube2e1 | -7614 |
Ube2d2a | -7380 |
Ube2e3 | -7216 |
Ube2k | -7089 |
Uba6 | -6485 |
Ube2t | -6180 |
Ube2q2 | -6095 |
Cdc34 | -5028 |
Ube2s | -3423 |
Usp9x | -2842 |
Ube2r2 | -2055 |
Ubb | -2020 |
Rps27a | -1712 |
Usp7 | -1294 |
Otulin | 779 |
Ubc | 798 |
Uba1 | 2534 |
Ube2z | 3122 |
Usp5 | 3548 |
Uba52 | 5450 |
Ube2g2 | 6056 |
Ube2h | 7329 |
P75NTR REGULATES AXONOGENESIS
679 | |
---|---|
set | P75NTR REGULATES AXONOGENESIS |
setSize | 10 |
pANOVA | 0.0196 |
s.dist | -0.426 |
p.adjustANOVA | 0.113 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Mcf2 | -8127 |
Omg | -7605 |
Rtn4 | -5975 |
Ngf | -5721 |
Rhoa | -5052 |
Rtn4r | -4845 |
Mag | -3666 |
Lingo1 | 242 |
Ngfr | 781 |
Arhgdia | 8393 |
GeneID | Gene Rank |
---|---|
Mcf2 | -8127 |
Omg | -7605 |
Rtn4 | -5975 |
Ngf | -5721 |
Rhoa | -5052 |
Rtn4r | -4845 |
Mag | -3666 |
Lingo1 | 242 |
Ngfr | 781 |
Arhgdia | 8393 |
TRANSCRIPTIONAL REGULATION OF PLURIPOTENT STEM CELLS
1126 | |
---|---|
set | TRANSCRIPTIONAL REGULATION OF PLURIPOTENT STEM CELLS |
setSize | 19 |
pANOVA | 0.00133 |
s.dist | 0.425 |
p.adjustANOVA | 0.0165 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Epas1 | 9187 |
Stat3 | 8846 |
Nr5a1 | 8816 |
Hif3a | 8481 |
Fgf2 | 8388 |
Pbx1 | 8385 |
Epha1 | 6596 |
Sall1 | 6236 |
Klf4 | 4296 |
Nr6a1 | 4080 |
Foxp1 | 3744 |
Sox2 | 3502 |
Foxd3 | 2754 |
Smad4 | 2273 |
Smad2 | 403 |
Hhex | 341 |
Eomes | -1674 |
Zic3 | -1748 |
Tsc22d1 | -2502 |
GeneID | Gene Rank |
---|---|
Epas1 | 9187 |
Stat3 | 8846 |
Nr5a1 | 8816 |
Hif3a | 8481 |
Fgf2 | 8388 |
Pbx1 | 8385 |
Epha1 | 6596 |
Sall1 | 6236 |
Klf4 | 4296 |
Nr6a1 | 4080 |
Foxp1 | 3744 |
Sox2 | 3502 |
Foxd3 | 2754 |
Smad4 | 2273 |
Smad2 | 403 |
Hhex | 341 |
Eomes | -1674 |
Zic3 | -1748 |
Tsc22d1 | -2502 |
YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION
1176 | |
---|---|
set | YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION |
setSize | 12 |
pANOVA | 0.0141 |
s.dist | 0.409 |
p.adjustANOVA | 0.0916 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Hipk1 | 9090 |
Hipk2 | 9003 |
Tead2 | 8425 |
Tead3 | 7940 |
Tead1 | 7354 |
Yap1 | 6916 |
Runx2 | 6638 |
Tead4 | 5835 |
Ccn2 | 3389 |
Nppa | -3843 |
Kat2b | -4896 |
Wwtr1 | -6715 |
GeneID | Gene Rank |
---|---|
Hipk1 | 9090 |
Hipk2 | 9003 |
Tead2 | 8425 |
Tead3 | 7940 |
Tead1 | 7354 |
Yap1 | 6916 |
Runx2 | 6638 |
Tead4 | 5835 |
Ccn2 | 3389 |
Nppa | -3843 |
Kat2b | -4896 |
Wwtr1 | -6715 |
CRISTAE FORMATION
188 | |
---|---|
set | CRISTAE FORMATION |
setSize | 31 |
pANOVA | 8.21e-05 |
s.dist | -0.409 |
p.adjustANOVA | 0.00231 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Apoo | -8125 |
Dmac2l | -7964 |
Atp5c1 | -7957 |
Mtx2 | -7801 |
Atp5pb | -7747 |
Apool | -6642 |
Atp5o | -6216 |
Atp5l | -6120 |
Atp5h | -5525 |
Atp5b | -5442 |
Chchd3 | -5369 |
Immt | -5216 |
mt-Atp6 | -4706 |
Micos10 | -4068 |
Atp5g3 | -3711 |
Atp5a1 | -3490 |
Micos13 | -2872 |
Hspa9 | -2568 |
Atp5j2 | -2335 |
Tmem11 | -2123 |
GeneID | Gene Rank |
---|---|
Apoo | -8125 |
Dmac2l | -7964 |
Atp5c1 | -7957 |
Mtx2 | -7801 |
Atp5pb | -7747 |
Apool | -6642 |
Atp5o | -6216 |
Atp5l | -6120 |
Atp5h | -5525 |
Atp5b | -5442 |
Chchd3 | -5369 |
Immt | -5216 |
mt-Atp6 | -4706 |
Micos10 | -4068 |
Atp5g3 | -3711 |
Atp5a1 | -3490 |
Micos13 | -2872 |
Hspa9 | -2568 |
Atp5j2 | -2335 |
Tmem11 | -2123 |
Atp5d | -1654 |
Atp5j | -1396 |
Chchd6 | -299 |
Samm50 | 145 |
Mtx1 | 280 |
Atp5g1 | 398 |
Atp5g2 | 801 |
Atp5e | 1074 |
Atp5k | 2318 |
Dnajc11 | 2937 |
mt-Atp8 | 8362 |
REGULATION OF GENE EXPRESSION IN LATE STAGE BRANCHING MORPHOGENESIS PANCREATIC BUD PRECURSOR CELLS
798 | |
---|---|
set | REGULATION OF GENE EXPRESSION IN LATE STAGE BRANCHING MORPHOGENESIS PANCREATIC BUD PRECURSOR CELLS |
setSize | 15 |
pANOVA | 0.00628 |
s.dist | 0.408 |
p.adjustANOVA | 0.0533 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Notch1 | 8999 |
Crebbp | 7942 |
Mamld1 | 7114 |
Maml2 | 6126 |
Onecut1 | 6083 |
Hes1 | 5678 |
Maml3 | 5247 |
Maml1 | 4758 |
Ep300 | 3948 |
Onecut3 | 3418 |
Rbpj | 2968 |
Hnf1b | 2818 |
Snw1 | 1230 |
Kat2a | -241 |
Kat2b | -4896 |
GeneID | Gene Rank |
---|---|
Notch1 | 8999 |
Crebbp | 7942 |
Mamld1 | 7114 |
Maml2 | 6126 |
Onecut1 | 6083 |
Hes1 | 5678 |
Maml3 | 5247 |
Maml1 | 4758 |
Ep300 | 3948 |
Onecut3 | 3418 |
Rbpj | 2968 |
Hnf1b | 2818 |
Snw1 | 1230 |
Kat2a | -241 |
Kat2b | -4896 |
FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC
340 | |
---|---|
set | FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC |
setSize | 19 |
pANOVA | 0.00253 |
s.dist | -0.4 |
p.adjustANOVA | 0.0269 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Tuba8 | -7123 |
Cct6a | -6799 |
Tcp1 | -6717 |
Tuba4a | -6704 |
Cct4 | -6509 |
Tubb4b | -6350 |
Tuba1b | -5485 |
Cct7 | -5438 |
Cct2 | -5394 |
Tuba1c | -4834 |
Cct8 | -4490 |
Tubb3 | -3833 |
Cct5 | -3393 |
Cct3 | -1065 |
Tuba1a | 675 |
Tubb4a | 976 |
Tubb6 | 5057 |
Tubb2a | 5530 |
Tubb2b | 6231 |
GeneID | Gene Rank |
---|---|
Tuba8 | -7123 |
Cct6a | -6799 |
Tcp1 | -6717 |
Tuba4a | -6704 |
Cct4 | -6509 |
Tubb4b | -6350 |
Tuba1b | -5485 |
Cct7 | -5438 |
Cct2 | -5394 |
Tuba1c | -4834 |
Cct8 | -4490 |
Tubb3 | -3833 |
Cct5 | -3393 |
Cct3 | -1065 |
Tuba1a | 675 |
Tubb4a | 976 |
Tubb6 | 5057 |
Tubb2a | 5530 |
Tubb2b | 6231 |
SIGNALING BY LEPTIN
968 | |
---|---|
set | SIGNALING BY LEPTIN |
setSize | 10 |
pANOVA | 0.0284 |
s.dist | 0.4 |
p.adjustANOVA | 0.143 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Ptpn11 | 9216 |
Stat3 | 8846 |
Stat5b | 8264 |
Sh2b1 | 8203 |
Irs2 | 2951 |
Irs1 | 1960 |
Socs3 | 1333 |
Jak2 | 418 |
Lepr | 33 |
Stat5a | -1061 |
GeneID | Gene Rank |
---|---|
Ptpn11 | 9216 |
Stat3 | 8846 |
Stat5b | 8264 |
Sh2b1 | 8203 |
Irs2 | 2951 |
Irs1 | 1960 |
Socs3 | 1333 |
Jak2 | 418 |
Lepr | 33 |
Stat5a | -1061 |
NR1H2 AND NR1H3 MEDIATED SIGNALING
643 | |
---|---|
set | NR1H2 AND NR1H3 MEDIATED SIGNALING |
setSize | 38 |
pANOVA | 2.41e-05 |
s.dist | 0.396 |
p.adjustANOVA | 0.000948 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Rxra | 9068 |
Srebf1 | 8892 |
Ncor2 | 8830 |
Ago2 | 8780 |
Ncor1 | 8766 |
Mov10 | 8721 |
Kdm4a | 8056 |
Tnrc6b | 7816 |
Ago3 | 7792 |
Ago1 | 7427 |
Fasn | 7242 |
Apoe | 6650 |
Scd2 | 6102 |
Gps2 | 6003 |
Scd1 | 5868 |
Pltp | 5735 |
Abca1 | 5679 |
Abcg1 | 5249 |
Tnrc6c | 4966 |
Tnrc6a | 4639 |
GeneID | Gene Rank |
---|---|
Rxra | 9068 |
Srebf1 | 8892 |
Ncor2 | 8830 |
Ago2 | 8780 |
Ncor1 | 8766 |
Mov10 | 8721 |
Kdm4a | 8056 |
Tnrc6b | 7816 |
Ago3 | 7792 |
Ago1 | 7427 |
Fasn | 7242 |
Apoe | 6650 |
Scd2 | 6102 |
Gps2 | 6003 |
Scd1 | 5868 |
Pltp | 5735 |
Abca1 | 5679 |
Abcg1 | 5249 |
Tnrc6c | 4966 |
Tnrc6a | 4639 |
Eepd1 | 3995 |
Ep300 | 3948 |
Nr1h3 | 3739 |
Kdm3a | 3241 |
Ago4 | 3109 |
Ncoa1 | 2648 |
Rxrb | 2496 |
Tbl1x | 2490 |
Mylip | 1690 |
Kdm1b | 492 |
Tbl1xr1 | 124 |
Nr1h2 | -29 |
Kdm1a | -812 |
Apoc1 | -835 |
Arl4c | -2397 |
Apod | -3647 |
Nrip1 | -5244 |
Hdac3 | -6297 |
NR1H3 NR1H2 REGULATE GENE EXPRESSION LINKED TO CHOLESTEROL TRANSPORT AND EFFLUX
644 | |
---|---|
set | NR1H3 NR1H2 REGULATE GENE EXPRESSION LINKED TO CHOLESTEROL TRANSPORT AND EFFLUX |
setSize | 32 |
pANOVA | 0.000118 |
s.dist | 0.393 |
p.adjustANOVA | 0.00317 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Rxra | 9068 |
Ncor2 | 8830 |
Ago2 | 8780 |
Ncor1 | 8766 |
Mov10 | 8721 |
Kdm4a | 8056 |
Tnrc6b | 7816 |
Ago3 | 7792 |
Ago1 | 7427 |
Apoe | 6650 |
Gps2 | 6003 |
Pltp | 5735 |
Abca1 | 5679 |
Abcg1 | 5249 |
Tnrc6c | 4966 |
Tnrc6a | 4639 |
Eepd1 | 3995 |
Ep300 | 3948 |
Nr1h3 | 3739 |
Kdm3a | 3241 |
GeneID | Gene Rank |
---|---|
Rxra | 9068 |
Ncor2 | 8830 |
Ago2 | 8780 |
Ncor1 | 8766 |
Mov10 | 8721 |
Kdm4a | 8056 |
Tnrc6b | 7816 |
Ago3 | 7792 |
Ago1 | 7427 |
Apoe | 6650 |
Gps2 | 6003 |
Pltp | 5735 |
Abca1 | 5679 |
Abcg1 | 5249 |
Tnrc6c | 4966 |
Tnrc6a | 4639 |
Eepd1 | 3995 |
Ep300 | 3948 |
Nr1h3 | 3739 |
Kdm3a | 3241 |
Ago4 | 3109 |
Ncoa1 | 2648 |
Rxrb | 2496 |
Tbl1x | 2490 |
Kdm1b | 492 |
Tbl1xr1 | 124 |
Nr1h2 | -29 |
Kdm1a | -812 |
Apoc1 | -835 |
Arl4c | -2397 |
Apod | -3647 |
Hdac3 | -6297 |
INTERLEUKIN 6 SIGNALING
483 | |
---|---|
set | INTERLEUKIN 6 SIGNALING |
setSize | 10 |
pANOVA | 0.0318 |
s.dist | 0.392 |
p.adjustANOVA | 0.151 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Ptpn11 | 9216 |
Stat3 | 8846 |
Il6st | 8446 |
Cbl | 8343 |
Il6ra | 6903 |
Tyk2 | 5685 |
Socs3 | 1333 |
Jak2 | 418 |
Jak1 | -4063 |
Stat1 | -5672 |
GeneID | Gene Rank |
---|---|
Ptpn11 | 9216 |
Stat3 | 8846 |
Il6st | 8446 |
Cbl | 8343 |
Il6ra | 6903 |
Tyk2 | 5685 |
Socs3 | 1333 |
Jak2 | 418 |
Jak1 | -4063 |
Stat1 | -5672 |
FORMATION OF ATP BY CHEMIOSMOTIC COUPLING
331 | |
---|---|
set | FORMATION OF ATP BY CHEMIOSMOTIC COUPLING |
setSize | 18 |
pANOVA | 0.00408 |
s.dist | -0.391 |
p.adjustANOVA | 0.0384 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Dmac2l | -7964 |
Atp5c1 | -7957 |
Atp5pb | -7747 |
Atp5o | -6216 |
Atp5l | -6120 |
Atp5h | -5525 |
Atp5b | -5442 |
mt-Atp6 | -4706 |
Atp5g3 | -3711 |
Atp5a1 | -3490 |
Atp5j2 | -2335 |
Atp5d | -1654 |
Atp5j | -1396 |
Atp5g1 | 398 |
Atp5g2 | 801 |
Atp5e | 1074 |
Atp5k | 2318 |
mt-Atp8 | 8362 |
GeneID | Gene Rank |
---|---|
Dmac2l | -7964 |
Atp5c1 | -7957 |
Atp5pb | -7747 |
Atp5o | -6216 |
Atp5l | -6120 |
Atp5h | -5525 |
Atp5b | -5442 |
mt-Atp6 | -4706 |
Atp5g3 | -3711 |
Atp5a1 | -3490 |
Atp5j2 | -2335 |
Atp5d | -1654 |
Atp5j | -1396 |
Atp5g1 | 398 |
Atp5g2 | 801 |
Atp5e | 1074 |
Atp5k | 2318 |
mt-Atp8 | 8362 |
APOPTOSIS INDUCED DNA FRAGMENTATION
67 | |
---|---|
set | APOPTOSIS INDUCED DNA FRAGMENTATION |
setSize | 10 |
pANOVA | 0.0348 |
s.dist | -0.386 |
p.adjustANOVA | 0.156 |
Top enriched genes
GeneID | Gene Rank |
---|---|
H1f0 | -7563 |
Kpna1 | -6673 |
Hmgb1 | -5673 |
H1f2 | -3903 |
Hmgb2 | -3802 |
Dffb | -3575 |
Dffa | -3400 |
Casp3 | -1258 |
H1f4 | 3449 |
Kpnb1 | 4352 |
GeneID | Gene Rank |
---|---|
H1f0 | -7563 |
Kpna1 | -6673 |
Hmgb1 | -5673 |
H1f2 | -3903 |
Hmgb2 | -3802 |
Dffb | -3575 |
Dffa | -3400 |
Casp3 | -1258 |
H1f4 | 3449 |
Kpnb1 | 4352 |
E2F MEDIATED REGULATION OF DNA REPLICATION
272 | |
---|---|
set | E2F MEDIATED REGULATION OF DNA REPLICATION |
setSize | 20 |
pANOVA | 0.0031 |
s.dist | -0.382 |
p.adjustANOVA | 0.0312 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Ppp2cb | -8037 |
Orc5 | -8018 |
Orc4 | -8011 |
Orc6 | -7649 |
Prim1 | -7142 |
Ppp2ca | -6584 |
Rb1 | -5019 |
Orc3 | -4888 |
Cdk1 | -4536 |
Pola2 | -4310 |
Orc2 | -3311 |
Tfdp2 | -2762 |
Ppp2r1a | -1577 |
Pola1 | -566 |
E2f1 | -285 |
Mcm8 | 1092 |
Tfdp1 | 3188 |
Prim2 | 3596 |
Ppp2r1b | 4009 |
Ppp2r3d | 5360 |
GeneID | Gene Rank |
---|---|
Ppp2cb | -8037 |
Orc5 | -8018 |
Orc4 | -8011 |
Orc6 | -7649 |
Prim1 | -7142 |
Ppp2ca | -6584 |
Rb1 | -5019 |
Orc3 | -4888 |
Cdk1 | -4536 |
Pola2 | -4310 |
Orc2 | -3311 |
Tfdp2 | -2762 |
Ppp2r1a | -1577 |
Pola1 | -566 |
E2f1 | -285 |
Mcm8 | 1092 |
Tfdp1 | 3188 |
Prim2 | 3596 |
Ppp2r1b | 4009 |
Ppp2r3d | 5360 |
RESPIRATORY ELECTRON TRANSPORT
837 | |
---|---|
set | RESPIRATORY ELECTRON TRANSPORT |
setSize | 102 |
pANOVA | 2.96e-11 |
s.dist | -0.381 |
p.adjustANOVA | 8.73e-09 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Cycs | -8030 |
Ndufaf4 | -7868 |
mt-Co2 | -7681 |
Ndufv2 | -7655 |
Ndufaf1 | -7468 |
Cox16 | -7132 |
Ndufaf5 | -7081 |
Uqcrc2 | -6943 |
Ndufa10 | -6619 |
Ndufs8 | -6345 |
Etfa | -6344 |
Ndufb5 | -6246 |
Uqcrfs1 | -6241 |
Coq10b | -6236 |
Sco1 | -6172 |
Sdhb | -6139 |
Ndufs4 | -5999 |
Ndufab1 | -5905 |
Ndufaf2 | -5869 |
Cox5a | -5846 |
GeneID | Gene Rank |
---|---|
Cycs | -8030 |
Ndufaf4 | -7868 |
mt-Co2 | -7681 |
Ndufv2 | -7655 |
Ndufaf1 | -7468 |
Cox16 | -7132 |
Ndufaf5 | -7081 |
Uqcrc2 | -6943 |
Ndufa10 | -6619 |
Ndufs8 | -6345 |
Etfa | -6344 |
Ndufb5 | -6246 |
Uqcrfs1 | -6241 |
Coq10b | -6236 |
Sco1 | -6172 |
Sdhb | -6139 |
Ndufs4 | -5999 |
Ndufab1 | -5905 |
Ndufaf2 | -5869 |
Cox5a | -5846 |
Ndufc2 | -5705 |
mt-Nd6 | -5660 |
Ndufs1 | -5653 |
Ndufaf6 | -5591 |
Cox7b | -5575 |
Ndufb6 | -5470 |
mt-Co3 | -5278 |
Ndufb10 | -5235 |
Ndufs3 | -5121 |
Etfdh | -4903 |
mt-Nd1 | -4841 |
mt-Nd2 | -4778 |
Ndufb11 | -4770 |
Ndufa11 | -4641 |
Cyc1 | -4446 |
Ndufs5 | -4410 |
Cox6b1 | -4379 |
Ndufa4 | -4295 |
Cox14 | -4207 |
Nubpl | -4193 |
Ndufa9 | -4086 |
Coq10a | -4066 |
mt-Nd4 | -3963 |
Uqcrh | -3952 |
Ndufb2 | -3708 |
Uqcrb | -3699 |
Ndufb8 | -3626 |
mt-Cytb | -3522 |
Ndufb3 | -3470 |
Ndufb9 | -3215 |
Ndufc1 | -3161 |
Surf1 | -3104 |
Ndufa5 | -2847 |
Sdhd | -2733 |
Acad9 | -2498 |
Tmem126b | -2434 |
Cox7a2l | -2392 |
Cox6a1 | -2387 |
mt-Co1 | -2372 |
Taco1 | -2352 |
Lrpprc | -2265 |
Uqcrc1 | -2162 |
Cox4i1 | -2089 |
Cox7c | -2026 |
Ndufv1 | -1901 |
mt-Nd5 | -1898 |
Ndufb4 | -1842 |
Sdhc | -1458 |
Cox20 | -1000 |
Cox6c | -980 |
Ndufa1 | -976 |
Ndufa8 | -890 |
Cox11 | -886 |
Trap1 | -876 |
Ecsit | -798 |
Ndufa6 | -729 |
Ndufs2 | -313 |
Uqcrq | -45 |
Sco2 | -39 |
Timmdc1 | 127 |
Ndufa2 | 192 |
Ndufb1 | 287 |
Ndufb7 | 525 |
Ndufv3 | 527 |
Ndufs7 | 539 |
Ndufa7 | 676 |
Ndufa12 | 817 |
Etfb | 928 |
Ndufs6 | 970 |
Uqcr10 | 1018 |
Uqcr11 | 1032 |
Cox19 | 1233 |
Cox5b | 1282 |
Sdha | 1613 |
Ndufaf3 | 1638 |
Cox18 | 1693 |
Ndufa3 | 2455 |
Cox8a | 2984 |
Ndufa13 | 3395 |
Ndufaf7 | 4174 |
mt-Nd3 | 4615 |
Tmem186 | 6796 |
CHK1 CHK2 CDS1 MEDIATED INACTIVATION OF CYCLIN B CDK1 COMPLEX
146 | |
---|---|
set | CHK1 CHK2 CDS1 MEDIATED INACTIVATION OF CYCLIN B CDK1 COMPLEX |
setSize | 11 |
pANOVA | 0.029 |
s.dist | -0.38 |
p.adjustANOVA | 0.145 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Ywhaq | -7491 |
Chek1 | -6893 |
Ywhab | -5368 |
Ywhah | -4971 |
Cdk1 | -4536 |
Wee1 | -3597 |
Ywhae | -3459 |
Ywhaz | -2939 |
Chek2 | -1869 |
Ywhag | 3508 |
Sfn | 7281 |
GeneID | Gene Rank |
---|---|
Ywhaq | -7491 |
Chek1 | -6893 |
Ywhab | -5368 |
Ywhah | -4971 |
Cdk1 | -4536 |
Wee1 | -3597 |
Ywhae | -3459 |
Ywhaz | -2939 |
Chek2 | -1869 |
Ywhag | 3508 |
Sfn | 7281 |
ASPARTATE AND ASPARAGINE METABOLISM
74 | |
---|---|
set | ASPARTATE AND ASPARAGINE METABOLISM |
setSize | 11 |
pANOVA | 0.0292 |
s.dist | -0.38 |
p.adjustANOVA | 0.145 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Aspa | -7826 |
Folh1 | -6996 |
Asns | -6372 |
Slc25a13 | -5107 |
Got1 | -4038 |
Got2 | -3411 |
Gadl1 | -1112 |
Nat8l | -570 |
Slc25a12 | 1 |
Naalad2 | 1185 |
Aspg | 3947 |
GeneID | Gene Rank |
---|---|
Aspa | -7826 |
Folh1 | -6996 |
Asns | -6372 |
Slc25a13 | -5107 |
Got1 | -4038 |
Got2 | -3411 |
Gadl1 | -1112 |
Nat8l | -570 |
Slc25a12 | 1 |
Naalad2 | 1185 |
Aspg | 3947 |
PHASE 2 PLATEAU PHASE
694 | |
---|---|
set | PHASE 2 PLATEAU PHASE |
setSize | 12 |
pANOVA | 0.0228 |
s.dist | 0.38 |
p.adjustANOVA | 0.122 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Cacng4 | 9124 |
Kcne4 | 8639 |
Cacng8 | 8295 |
Akap9 | 8138 |
Cacna1c | 6955 |
Cacnb1 | 6814 |
Cacna2d2 | 3392 |
Cacng7 | 2830 |
Kcne1l | 1055 |
Cacnb2 | 336 |
Kcne2 | -3117 |
Kcnq1 | -6399 |
GeneID | Gene Rank |
---|---|
Cacng4 | 9124 |
Kcne4 | 8639 |
Cacng8 | 8295 |
Akap9 | 8138 |
Cacna1c | 6955 |
Cacnb1 | 6814 |
Cacna2d2 | 3392 |
Cacng7 | 2830 |
Kcne1l | 1055 |
Cacnb2 | 336 |
Kcne2 | -3117 |
Kcnq1 | -6399 |
COOPERATION OF PREFOLDIN AND TRIC CCT IN ACTIN AND TUBULIN FOLDING
180 | |
---|---|
set | COOPERATION OF PREFOLDIN AND TRIC CCT IN ACTIN AND TUBULIN FOLDING |
setSize | 26 |
pANOVA | 0.00098 |
s.dist | -0.373 |
p.adjustANOVA | 0.0133 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Vbp1 | -7976 |
Pfdn4 | -7847 |
Tuba8 | -7123 |
Cct6a | -6799 |
Tcp1 | -6717 |
Tuba4a | -6704 |
Cct4 | -6509 |
Tubb4b | -6350 |
Tuba1b | -5485 |
Cct7 | -5438 |
Cct2 | -5394 |
Tuba1c | -4834 |
Cct8 | -4490 |
Tubb3 | -3833 |
Pfdn1 | -3798 |
Cct5 | -3393 |
Pfdn6 | -1704 |
Cct3 | -1065 |
Tuba1a | 675 |
Tubb4a | 976 |
GeneID | Gene Rank |
---|---|
Vbp1 | -7976 |
Pfdn4 | -7847 |
Tuba8 | -7123 |
Cct6a | -6799 |
Tcp1 | -6717 |
Tuba4a | -6704 |
Cct4 | -6509 |
Tubb4b | -6350 |
Tuba1b | -5485 |
Cct7 | -5438 |
Cct2 | -5394 |
Tuba1c | -4834 |
Cct8 | -4490 |
Tubb3 | -3833 |
Pfdn1 | -3798 |
Cct5 | -3393 |
Pfdn6 | -1704 |
Cct3 | -1065 |
Tuba1a | 675 |
Tubb4a | 976 |
Pfdn5 | 1529 |
Actb | 1819 |
Pfdn2 | 3530 |
Tubb6 | 5057 |
Tubb2a | 5530 |
Tubb2b | 6231 |
COMPLEX I BIOGENESIS
171 | |
---|---|
set | COMPLEX I BIOGENESIS |
setSize | 56 |
pANOVA | 1.98e-06 |
s.dist | -0.367 |
p.adjustANOVA | 0.000117 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Ndufaf4 | -7868 |
Ndufv2 | -7655 |
Ndufaf1 | -7468 |
Ndufaf5 | -7081 |
Ndufa10 | -6619 |
Ndufs8 | -6345 |
Ndufb5 | -6246 |
Ndufs4 | -5999 |
Ndufab1 | -5905 |
Ndufaf2 | -5869 |
Ndufc2 | -5705 |
mt-Nd6 | -5660 |
Ndufs1 | -5653 |
Ndufaf6 | -5591 |
Ndufb6 | -5470 |
Ndufb10 | -5235 |
Ndufs3 | -5121 |
mt-Nd1 | -4841 |
mt-Nd2 | -4778 |
Ndufb11 | -4770 |
GeneID | Gene Rank |
---|---|
Ndufaf4 | -7868 |
Ndufv2 | -7655 |
Ndufaf1 | -7468 |
Ndufaf5 | -7081 |
Ndufa10 | -6619 |
Ndufs8 | -6345 |
Ndufb5 | -6246 |
Ndufs4 | -5999 |
Ndufab1 | -5905 |
Ndufaf2 | -5869 |
Ndufc2 | -5705 |
mt-Nd6 | -5660 |
Ndufs1 | -5653 |
Ndufaf6 | -5591 |
Ndufb6 | -5470 |
Ndufb10 | -5235 |
Ndufs3 | -5121 |
mt-Nd1 | -4841 |
mt-Nd2 | -4778 |
Ndufb11 | -4770 |
Ndufa11 | -4641 |
Ndufs5 | -4410 |
Nubpl | -4193 |
Ndufa9 | -4086 |
mt-Nd4 | -3963 |
Ndufb2 | -3708 |
Ndufb8 | -3626 |
Ndufb3 | -3470 |
Ndufb9 | -3215 |
Ndufc1 | -3161 |
Ndufa5 | -2847 |
Acad9 | -2498 |
Tmem126b | -2434 |
Ndufv1 | -1901 |
mt-Nd5 | -1898 |
Ndufb4 | -1842 |
Ndufa1 | -976 |
Ndufa8 | -890 |
Ecsit | -798 |
Ndufa6 | -729 |
Ndufs2 | -313 |
Timmdc1 | 127 |
Ndufa2 | 192 |
Ndufb1 | 287 |
Ndufb7 | 525 |
Ndufv3 | 527 |
Ndufs7 | 539 |
Ndufa7 | 676 |
Ndufa12 | 817 |
Ndufs6 | 970 |
Ndufaf3 | 1638 |
Ndufa3 | 2455 |
Ndufa13 | 3395 |
Ndufaf7 | 4174 |
mt-Nd3 | 4615 |
Tmem186 | 6796 |
DEFECTIVE EXT2 CAUSES EXOSTOSES 2
218 | |
---|---|
set | DEFECTIVE EXT2 CAUSES EXOSTOSES 2 |
setSize | 14 |
pANOVA | 0.0175 |
s.dist | 0.367 |
p.adjustANOVA | 0.103 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Gpc3 | 9164 |
Sdc4 | 9051 |
Gpc4 | 7880 |
Hspg2 | 7534 |
Sdc3 | 6007 |
Gpc5 | 5911 |
Ext2 | 4928 |
Gpc1 | 3237 |
Agrn | 2428 |
Gpc2 | 1789 |
Sdc2 | -743 |
Ext1 | -1182 |
Sdc1 | -1206 |
Gpc6 | -2624 |
GeneID | Gene Rank |
---|---|
Gpc3 | 9164 |
Sdc4 | 9051 |
Gpc4 | 7880 |
Hspg2 | 7534 |
Sdc3 | 6007 |
Gpc5 | 5911 |
Ext2 | 4928 |
Gpc1 | 3237 |
Agrn | 2428 |
Gpc2 | 1789 |
Sdc2 | -743 |
Ext1 | -1182 |
Sdc1 | -1206 |
Gpc6 | -2624 |
ACTIVATION OF SMO
27 | |
---|---|
set | ACTIVATION OF SMO |
setSize | 16 |
pANOVA | 0.0113 |
s.dist | 0.366 |
p.adjustANOVA | 0.0788 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Arrb1 | 9183 |
Evc | 8993 |
Gas8 | 8538 |
Smo | 7048 |
Iqce | 6496 |
Ptch1 | 6098 |
Kif3a | 6075 |
Cdon | 4380 |
Arrb2 | 3721 |
Evc2 | 3417 |
Grk2 | 2586 |
Efcab7 | 272 |
Boc | -49 |
Gas1 | -76 |
Shh | -767 |
Csnk1a1 | -6441 |
GeneID | Gene Rank |
---|---|
Arrb1 | 9183 |
Evc | 8993 |
Gas8 | 8538 |
Smo | 7048 |
Iqce | 6496 |
Ptch1 | 6098 |
Kif3a | 6075 |
Cdon | 4380 |
Arrb2 | 3721 |
Evc2 | 3417 |
Grk2 | 2586 |
Efcab7 | 272 |
Boc | -49 |
Gas1 | -76 |
Shh | -767 |
Csnk1a1 | -6441 |
TRAF3 DEPENDENT IRF ACTIVATION PATHWAY
1101 | |
---|---|
set | TRAF3 DEPENDENT IRF ACTIVATION PATHWAY |
setSize | 13 |
pANOVA | 0.0228 |
s.dist | 0.365 |
p.adjustANOVA | 0.122 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Traf3 | 8935 |
Mavs | 8896 |
Crebbp | 7942 |
Irf3 | 6741 |
Sike1 | 6195 |
Ikbke | 5562 |
Ep300 | 3948 |
Ddx58 | 2906 |
Rnf135 | 1572 |
Ifih1 | 1500 |
Irf7 | 442 |
Trim25 | -926 |
Tbk1 | -5507 |
GeneID | Gene Rank |
---|---|
Traf3 | 8935 |
Mavs | 8896 |
Crebbp | 7942 |
Irf3 | 6741 |
Sike1 | 6195 |
Ikbke | 5562 |
Ep300 | 3948 |
Ddx58 | 2906 |
Rnf135 | 1572 |
Ifih1 | 1500 |
Irf7 | 442 |
Trim25 | -926 |
Tbk1 | -5507 |
INTERACTION BETWEEN L1 AND ANKYRINS
462 | |
---|---|
set | INTERACTION BETWEEN L1 AND ANKYRINS |
setSize | 27 |
pANOVA | 0.00104 |
s.dist | 0.365 |
p.adjustANOVA | 0.0137 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Scn5a | 8330 |
Sptbn4 | 8118 |
Sptbn5 | 7957 |
Scn2b | 7941 |
Sptbn1 | 7674 |
Scn3b | 7515 |
Scn3a | 7338 |
Nfasc | 7214 |
Ank2 | 7085 |
Kcnq2 | 7046 |
Kcnq3 | 6351 |
Sptbn2 | 6241 |
L1cam | 5044 |
Scn7a | 4955 |
Sptan1 | 4939 |
Scn2a | 4473 |
Sptb | 4393 |
Scn9a | 2520 |
Actb | 1819 |
Ank3 | 1757 |
GeneID | Gene Rank |
---|---|
Scn5a | 8330 |
Sptbn4 | 8118 |
Sptbn5 | 7957 |
Scn2b | 7941 |
Sptbn1 | 7674 |
Scn3b | 7515 |
Scn3a | 7338 |
Nfasc | 7214 |
Ank2 | 7085 |
Kcnq2 | 7046 |
Kcnq3 | 6351 |
Sptbn2 | 6241 |
L1cam | 5044 |
Scn7a | 4955 |
Sptan1 | 4939 |
Scn2a | 4473 |
Sptb | 4393 |
Scn9a | 2520 |
Actb | 1819 |
Ank3 | 1757 |
Scn8a | 875 |
Nrcam | 500 |
Ank1 | 291 |
Scn4b | -4559 |
Actg1 | -4823 |
Scn1a | -5327 |
Scn1b | -5618 |
NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS
596 | |
---|---|
set | NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS |
setSize | 15 |
pANOVA | 0.0151 |
s.dist | 0.362 |
p.adjustANOVA | 0.0954 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Slc6a7 | 9086 |
Slc6a6 | 8801 |
Slc6a11 | 8629 |
Slc6a9 | 8019 |
Slc6a1 | 7336 |
Slc22a2 | 6592 |
Slc18a2 | 5632 |
Slc6a2 | 5066 |
Slc6a20a | 3305 |
Slc6a19 | 2351 |
Slc6a13 | 1499 |
Slc6a3 | 1455 |
Slc6a12 | -2737 |
Slc6a15 | -3630 |
Slc6a5 | -6079 |
GeneID | Gene Rank |
---|---|
Slc6a7 | 9086 |
Slc6a6 | 8801 |
Slc6a11 | 8629 |
Slc6a9 | 8019 |
Slc6a1 | 7336 |
Slc22a2 | 6592 |
Slc18a2 | 5632 |
Slc6a2 | 5066 |
Slc6a20a | 3305 |
Slc6a19 | 2351 |
Slc6a13 | 1499 |
Slc6a3 | 1455 |
Slc6a12 | -2737 |
Slc6a15 | -3630 |
Slc6a5 | -6079 |
RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS
838 | |
---|---|
set | RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS |
setSize | 125 |
pANOVA | 2.83e-12 |
s.dist | -0.362 |
p.adjustANOVA | 1.11e-09 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Cycs | -8030 |
Dmac2l | -7964 |
Atp5c1 | -7957 |
Ndufaf4 | -7868 |
Atp5pb | -7747 |
mt-Co2 | -7681 |
Ndufv2 | -7655 |
Ndufaf1 | -7468 |
Cox16 | -7132 |
Ndufaf5 | -7081 |
Uqcrc2 | -6943 |
Ndufa10 | -6619 |
Ndufs8 | -6345 |
Etfa | -6344 |
Ndufb5 | -6246 |
Uqcrfs1 | -6241 |
Coq10b | -6236 |
Atp5o | -6216 |
Sco1 | -6172 |
Sdhb | -6139 |
GeneID | Gene Rank |
---|---|
Cycs | -8030 |
Dmac2l | -7964 |
Atp5c1 | -7957 |
Ndufaf4 | -7868 |
Atp5pb | -7747 |
mt-Co2 | -7681 |
Ndufv2 | -7655 |
Ndufaf1 | -7468 |
Cox16 | -7132 |
Ndufaf5 | -7081 |
Uqcrc2 | -6943 |
Ndufa10 | -6619 |
Ndufs8 | -6345 |
Etfa | -6344 |
Ndufb5 | -6246 |
Uqcrfs1 | -6241 |
Coq10b | -6236 |
Atp5o | -6216 |
Sco1 | -6172 |
Sdhb | -6139 |
Atp5l | -6120 |
Ndufs4 | -5999 |
Ndufab1 | -5905 |
Ndufaf2 | -5869 |
Cox5a | -5846 |
Ndufc2 | -5705 |
mt-Nd6 | -5660 |
Ndufs1 | -5653 |
Ndufaf6 | -5591 |
Cox7b | -5575 |
Atp5h | -5525 |
Ndufb6 | -5470 |
Atp5b | -5442 |
mt-Co3 | -5278 |
Ndufb10 | -5235 |
Ndufs3 | -5121 |
Etfdh | -4903 |
mt-Nd1 | -4841 |
mt-Nd2 | -4778 |
Ndufb11 | -4770 |
Ucp3 | -4764 |
mt-Atp6 | -4706 |
Ndufa11 | -4641 |
Cyc1 | -4446 |
Ndufs5 | -4410 |
Cox6b1 | -4379 |
Ndufa4 | -4295 |
Cox14 | -4207 |
Nubpl | -4193 |
Ndufa9 | -4086 |
Coq10a | -4066 |
mt-Nd4 | -3963 |
Uqcrh | -3952 |
Atp5g3 | -3711 |
Ndufb2 | -3708 |
Uqcrb | -3699 |
Ndufb8 | -3626 |
mt-Cytb | -3522 |
Atp5a1 | -3490 |
Ndufb3 | -3470 |
Ndufb9 | -3215 |
Ndufc1 | -3161 |
Surf1 | -3104 |
Ndufa5 | -2847 |
Sdhd | -2733 |
Acad9 | -2498 |
Tmem126b | -2434 |
Cox7a2l | -2392 |
Cox6a1 | -2387 |
mt-Co1 | -2372 |
Taco1 | -2352 |
Atp5j2 | -2335 |
Lrpprc | -2265 |
Uqcrc1 | -2162 |
Cox4i1 | -2089 |
Cox7c | -2026 |
Ndufv1 | -1901 |
mt-Nd5 | -1898 |
Ndufb4 | -1842 |
Atp5d | -1654 |
Sdhc | -1458 |
Atp5j | -1396 |
Cox20 | -1000 |
Cox6c | -980 |
Ndufa1 | -976 |
Ndufa8 | -890 |
Cox11 | -886 |
Trap1 | -876 |
Ecsit | -798 |
Ndufa6 | -729 |
Ndufs2 | -313 |
Uqcrq | -45 |
Sco2 | -39 |
Timmdc1 | 127 |
Ndufa2 | 192 |
Ndufb1 | 287 |
Atp5g1 | 398 |
Ndufb7 | 525 |
Ndufv3 | 527 |
Ndufs7 | 539 |
Ndufa7 | 676 |
Atp5g2 | 801 |
Ndufa12 | 817 |
Etfb | 928 |
Ndufs6 | 970 |
Slc25a14 | 1016 |
Uqcr10 | 1018 |
Uqcr11 | 1032 |
Atp5e | 1074 |
Cox19 | 1233 |
Cox5b | 1282 |
Sdha | 1613 |
Ndufaf3 | 1638 |
Cox18 | 1693 |
Slc25a27 | 1706 |
Atp5k | 2318 |
Ndufa3 | 2455 |
Pm20d1 | 2517 |
Cox8a | 2984 |
Ndufa13 | 3395 |
Ndufaf7 | 4174 |
mt-Nd3 | 4615 |
Tmem186 | 6796 |
mt-Atp8 | 8362 |
Ucp2 | 8829 |
CITRIC ACID CYCLE TCA CYCLE
154 | |
---|---|
set | CITRIC ACID CYCLE TCA CYCLE |
setSize | 22 |
pANOVA | 0.0034 |
s.dist | -0.361 |
p.adjustANOVA | 0.0331 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Dld | -8061 |
Sucla2 | -7990 |
Fahd1 | -7791 |
Me3 | -7329 |
Suclg1 | -6600 |
Idh3a | -6468 |
Sdhb | -6139 |
Idh3g | -6105 |
Fh1 | -4681 |
Mdh2 | -4198 |
Aco2 | -3962 |
Idh3b | -3767 |
Sdhd | -2733 |
Me2 | -2243 |
Sdhc | -1458 |
Cs | -689 |
Nnt | 958 |
Sdha | 1613 |
Dlst | 2214 |
Ogdh | 2892 |
GeneID | Gene Rank |
---|---|
Dld | -8061 |
Sucla2 | -7990 |
Fahd1 | -7791 |
Me3 | -7329 |
Suclg1 | -6600 |
Idh3a | -6468 |
Sdhb | -6139 |
Idh3g | -6105 |
Fh1 | -4681 |
Mdh2 | -4198 |
Aco2 | -3962 |
Idh3b | -3767 |
Sdhd | -2733 |
Me2 | -2243 |
Sdhc | -1458 |
Cs | -689 |
Nnt | 958 |
Sdha | 1613 |
Dlst | 2214 |
Ogdh | 2892 |
Suclg2 | 6469 |
Idh2 | 9145 |
MITOCHONDRIAL PROTEIN IMPORT
570 | |
---|---|
set | MITOCHONDRIAL PROTEIN IMPORT |
setSize | 63 |
pANOVA | 7.97e-07 |
s.dist | -0.36 |
p.adjustANOVA | 6.26e-05 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Mtx2 | -7801 |
Timm8a1 | -7662 |
Cmc4 | -7636 |
Timm21 | -7062 |
Tomm70a | -7009 |
Pmpcb | -6783 |
Timm23 | -6713 |
Slc25a4 | -6586 |
Chchd5 | -6361 |
Cmc2 | -6357 |
Idh3g | -6105 |
Hspd1 | -5886 |
Timm44 | -5756 |
Chchd7 | -5498 |
Atp5b | -5442 |
Chchd3 | -5369 |
Chchd2 | -5111 |
Slc25a13 | -5107 |
Grpel2 | -5016 |
Tomm22 | -4986 |
GeneID | Gene Rank |
---|---|
Mtx2 | -7801 |
Timm8a1 | -7662 |
Cmc4 | -7636 |
Timm21 | -7062 |
Tomm70a | -7009 |
Pmpcb | -6783 |
Timm23 | -6713 |
Slc25a4 | -6586 |
Chchd5 | -6361 |
Cmc2 | -6357 |
Idh3g | -6105 |
Hspd1 | -5886 |
Timm44 | -5756 |
Chchd7 | -5498 |
Atp5b | -5442 |
Chchd3 | -5369 |
Chchd2 | -5111 |
Slc25a13 | -5107 |
Grpel2 | -5016 |
Tomm22 | -4986 |
Timm9 | -4937 |
Cyc1 | -4446 |
Fxn | -4392 |
Vdac1 | -4135 |
Aco2 | -3962 |
Tomm20 | -3686 |
Ndufb8 | -3626 |
Atp5a1 | -3490 |
Timm50 | -3352 |
Taz | -2875 |
Hspa9 | -2568 |
Timm10b | -2323 |
Chchd4 | -2298 |
Dnajc19 | -2238 |
Timm8b | -2171 |
Ldhd | -2168 |
Pitrm1 | -1889 |
Pmpca | -1849 |
Chchd10 | -1806 |
Tomm5 | -1781 |
Timm17a | -1444 |
Tomm7 | -721 |
Cs | -689 |
Timm10 | -414 |
Hscb | -401 |
Coa6 | -389 |
Slc25a12 | 1 |
Grpel1 | 11 |
Samm50 | 145 |
Mtx1 | 280 |
Atp5g1 | 398 |
Gfer | 415 |
Pam16 | 912 |
Coa4 | 923 |
Timm17b | 1088 |
Cox17 | 1172 |
Cox19 | 1233 |
Timm13 | 1374 |
Timm22 | 2588 |
Tomm6 | 2820 |
Bcs1l | 3575 |
Coq2 | 3973 |
Tomm40 | 5499 |
ORGANIC CATION ANION ZWITTERION TRANSPORT
670 | |
---|---|
set | ORGANIC CATION ANION ZWITTERION TRANSPORT |
setSize | 12 |
pANOVA | 0.0322 |
s.dist | 0.357 |
p.adjustANOVA | 0.152 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Slc22a18 | 8860 |
Runx1 | 7134 |
Slc22a12 | 7133 |
Slc22a3 | 6810 |
Slc22a2 | 6592 |
Rsc1a1 | 4896 |
Slc22a6 | 3767 |
Slc22a4 | 2861 |
Slc22a7 | 2693 |
Slc22a15 | -10 |
Slc22a8 | -3395 |
Slc22a5 | -3627 |
GeneID | Gene Rank |
---|---|
Slc22a18 | 8860 |
Runx1 | 7134 |
Slc22a12 | 7133 |
Slc22a3 | 6810 |
Slc22a2 | 6592 |
Rsc1a1 | 4896 |
Slc22a6 | 3767 |
Slc22a4 | 2861 |
Slc22a7 | 2693 |
Slc22a15 | -10 |
Slc22a8 | -3395 |
Slc22a5 | -3627 |
CHOLESTEROL BIOSYNTHESIS
147 | |
---|---|
set | CHOLESTEROL BIOSYNTHESIS |
setSize | 24 |
pANOVA | 0.00249 |
s.dist | -0.357 |
p.adjustANOVA | 0.0267 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Idi1 | -8021 |
Ggps1 | -7744 |
Msmo1 | -7742 |
Hsd17b7 | -7406 |
Nsdhl | -7281 |
Cyp51 | -7217 |
Plpp6 | -6287 |
Hmgcs1 | -5833 |
Fdft1 | -5530 |
Sqle | -3976 |
Ebp | -3120 |
Dhcr7 | -3051 |
Mvd | -3001 |
Fdps | -2857 |
Lbr | -2856 |
Acat3 | -1840 |
Hmgcr | -872 |
Arv1 | 648 |
Pmvk | 1853 |
Sc5d | 2342 |
GeneID | Gene Rank |
---|---|
Idi1 | -8021 |
Ggps1 | -7744 |
Msmo1 | -7742 |
Hsd17b7 | -7406 |
Nsdhl | -7281 |
Cyp51 | -7217 |
Plpp6 | -6287 |
Hmgcs1 | -5833 |
Fdft1 | -5530 |
Sqle | -3976 |
Ebp | -3120 |
Dhcr7 | -3051 |
Mvd | -3001 |
Fdps | -2857 |
Lbr | -2856 |
Acat3 | -1840 |
Hmgcr | -872 |
Arv1 | 648 |
Pmvk | 1853 |
Sc5d | 2342 |
Tm7sf2 | 3669 |
Mvk | 4049 |
Lss | 4547 |
Dhcr24 | 6308 |
TNFR1 INDUCED PROAPOPTOTIC SIGNALING
1085 | |
---|---|
set | TNFR1 INDUCED PROAPOPTOTIC SIGNALING |
setSize | 12 |
pANOVA | 0.033 |
s.dist | 0.356 |
p.adjustANOVA | 0.153 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Otud7b | 8178 |
Ripk1 | 7898 |
Usp2 | 7736 |
Cyld | 5832 |
Usp21 | 5544 |
Fadd | 4418 |
Tnfaip3 | 3424 |
Tnfrsf1a | 3382 |
Usp4 | 2900 |
Traf2 | 1889 |
Casp8 | -3463 |
Tradd | -4194 |
GeneID | Gene Rank |
---|---|
Otud7b | 8178 |
Ripk1 | 7898 |
Usp2 | 7736 |
Cyld | 5832 |
Usp21 | 5544 |
Fadd | 4418 |
Tnfaip3 | 3424 |
Tnfrsf1a | 3382 |
Usp4 | 2900 |
Traf2 | 1889 |
Casp8 | -3463 |
Tradd | -4194 |
SIGNALING BY NOTCH1 HD DOMAIN MUTANTS IN CANCER
974 | |
---|---|
set | SIGNALING BY NOTCH1 HD DOMAIN MUTANTS IN CANCER |
setSize | 15 |
pANOVA | 0.0173 |
s.dist | 0.355 |
p.adjustANOVA | 0.103 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Mib2 | 9212 |
Jag2 | 9163 |
Jag1 | 9047 |
Notch1 | 8999 |
Neurl1b | 7247 |
Uba52 | 5450 |
Adam17 | 5067 |
Dll1 | 3321 |
Mib1 | 1763 |
Ubc | 798 |
Adam10 | 27 |
Neurl1a | -825 |
Dll4 | -1180 |
Rps27a | -1712 |
Ubb | -2020 |
GeneID | Gene Rank |
---|---|
Mib2 | 9212 |
Jag2 | 9163 |
Jag1 | 9047 |
Notch1 | 8999 |
Neurl1b | 7247 |
Uba52 | 5450 |
Adam17 | 5067 |
Dll1 | 3321 |
Mib1 | 1763 |
Ubc | 798 |
Adam10 | 27 |
Neurl1a | -825 |
Dll4 | -1180 |
Rps27a | -1712 |
Ubb | -2020 |
AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE
50 | |
---|---|
set | AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE |
setSize | 27 |
pANOVA | 0.00152 |
s.dist | 0.353 |
p.adjustANOVA | 0.0181 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Slc7a2 | 8957 |
Slc6a6 | 8801 |
Slc36a2 | 8668 |
Slc7a5 | 8536 |
Slc7a7 | 8460 |
Slc7a3 | 7879 |
Slc43a2 | 6724 |
Slc1a5 | 6648 |
Slc38a1 | 6593 |
Slc3a2 | 6446 |
Slc7a11 | 6116 |
Slc7a8 | 5850 |
Slc1a4 | 5829 |
Slc7a1 | 5812 |
Slc25a29 | 4349 |
Slc38a2 | 3373 |
Slc36a1 | 3366 |
Slc6a20a | 3305 |
Slc6a19 | 2351 |
Slc7a10 | -463 |
GeneID | Gene Rank |
---|---|
Slc7a2 | 8957 |
Slc6a6 | 8801 |
Slc36a2 | 8668 |
Slc7a5 | 8536 |
Slc7a7 | 8460 |
Slc7a3 | 7879 |
Slc43a2 | 6724 |
Slc1a5 | 6648 |
Slc38a1 | 6593 |
Slc3a2 | 6446 |
Slc7a11 | 6116 |
Slc7a8 | 5850 |
Slc1a4 | 5829 |
Slc7a1 | 5812 |
Slc25a29 | 4349 |
Slc38a2 | 3373 |
Slc36a1 | 3366 |
Slc6a20a | 3305 |
Slc6a19 | 2351 |
Slc7a10 | -463 |
Slc38a3 | -732 |
Slc7a6 | -883 |
Slc36a4 | -957 |
Slc6a12 | -2737 |
Slc6a15 | -3630 |
Slc16a10 | -5299 |
Slc38a5 | -6146 |
PENTOSE PHOSPHATE PATHWAY
686 | |
---|---|
set | PENTOSE PHOSPHATE PATHWAY |
setSize | 13 |
pANOVA | 0.0285 |
s.dist | -0.351 |
p.adjustANOVA | 0.143 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Rpe | -7664 |
Rbks | -7342 |
Prps2 | -6922 |
Pgm2 | -5824 |
Shpk | -5730 |
Taldo1 | -4832 |
Dera | -4718 |
G6pdx | -2577 |
Rpia | -680 |
Tkt | 1010 |
Prps1 | 1285 |
Pgls | 4033 |
Pgd | 7422 |
GeneID | Gene Rank |
---|---|
Rpe | -7664 |
Rbks | -7342 |
Prps2 | -6922 |
Pgm2 | -5824 |
Shpk | -5730 |
Taldo1 | -4832 |
Dera | -4718 |
G6pdx | -2577 |
Rpia | -680 |
Tkt | 1010 |
Prps1 | 1285 |
Pgls | 4033 |
Pgd | 7422 |
PKA ACTIVATION IN GLUCAGON SIGNALLING
710 | |
---|---|
set | PKA ACTIVATION IN GLUCAGON SIGNALLING |
setSize | 16 |
pANOVA | 0.0152 |
s.dist | 0.351 |
p.adjustANOVA | 0.0954 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Adcy6 | 8821 |
Adcy5 | 8012 |
Adcy4 | 7917 |
Adcy2 | 7682 |
Prkaca | 5534 |
Adcy3 | 4776 |
Adcy7 | 4456 |
Gnas | 4019 |
Adcy9 | 3934 |
Adcy8 | 3828 |
Prkar2a | 2314 |
Prkar2b | 738 |
Prkar1b | 586 |
Adcy1 | -373 |
Prkacb | -1783 |
Prkar1a | -3106 |
GeneID | Gene Rank |
---|---|
Adcy6 | 8821 |
Adcy5 | 8012 |
Adcy4 | 7917 |
Adcy2 | 7682 |
Prkaca | 5534 |
Adcy3 | 4776 |
Adcy7 | 4456 |
Gnas | 4019 |
Adcy9 | 3934 |
Adcy8 | 3828 |
Prkar2a | 2314 |
Prkar2b | 738 |
Prkar1b | 586 |
Adcy1 | -373 |
Prkacb | -1783 |
Prkar1a | -3106 |
ADENYLATE CYCLASE INHIBITORY PATHWAY
37 | |
---|---|
set | ADENYLATE CYCLASE INHIBITORY PATHWAY |
setSize | 13 |
pANOVA | 0.0292 |
s.dist | 0.349 |
p.adjustANOVA | 0.145 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Adcy6 | 8821 |
Gnai2 | 8537 |
Adcy5 | 8012 |
Adcy4 | 7917 |
Adcy2 | 7682 |
Adcy3 | 4776 |
Adcy7 | 4456 |
Adcy9 | 3934 |
Adcy8 | 3828 |
Adcy1 | -373 |
Gnal | -1542 |
Gnai3 | -4516 |
Gnai1 | -5063 |
GeneID | Gene Rank |
---|---|
Adcy6 | 8821 |
Gnai2 | 8537 |
Adcy5 | 8012 |
Adcy4 | 7917 |
Adcy2 | 7682 |
Adcy3 | 4776 |
Adcy7 | 4456 |
Adcy9 | 3934 |
Adcy8 | 3828 |
Adcy1 | -373 |
Gnal | -1542 |
Gnai3 | -4516 |
Gnai1 | -5063 |
Here is the session info with all the versions of packages used.
sessionInfo()
## R version 4.3.1 (2023-06-16)
## Platform: x86_64-pc-linux-gnu (64-bit)
## Running under: Ubuntu 22.04.3 LTS
##
## Matrix products: default
## BLAS: /usr/lib/x86_64-linux-gnu/openblas-pthread/libblas.so.3
## LAPACK: /usr/lib/x86_64-linux-gnu/openblas-pthread/libopenblasp-r0.3.20.so; LAPACK version 3.10.0
##
## locale:
## [1] LC_CTYPE=en_AU.UTF-8 LC_NUMERIC=C
## [3] LC_TIME=en_AU.UTF-8 LC_COLLATE=en_AU.UTF-8
## [5] LC_MONETARY=en_AU.UTF-8 LC_MESSAGES=en_AU.UTF-8
## [7] LC_PAPER=en_AU.UTF-8 LC_NAME=C
## [9] LC_ADDRESS=C LC_TELEPHONE=C
## [11] LC_MEASUREMENT=en_AU.UTF-8 LC_IDENTIFICATION=C
##
## time zone: /usr/share/zoneinfo/Australia/Melbourne
## tzcode source: system (glibc)
##
## attached base packages:
## [1] stats4 stats graphics grDevices utils datasets methods
## [8] base
##
## other attached packages:
## [1] GGally_2.1.2 gtools_3.9.4
## [3] echarts4r_0.4.5 beeswarm_0.4.0
## [5] pkgload_1.3.2.1 vioplot_0.4.0
## [7] sm_2.2-5.7.1 kableExtra_1.3.4
## [9] topconfects_1.16.0 limma_3.56.2
## [11] eulerr_7.0.0 mitch_1.12.0
## [13] MASS_7.3-60 fgsea_1.26.0
## [15] gplots_3.1.3 DESeq2_1.40.2
## [17] SummarizedExperiment_1.30.2 Biobase_2.60.0
## [19] MatrixGenerics_1.12.3 matrixStats_1.0.0
## [21] GenomicRanges_1.52.0 GenomeInfoDb_1.36.2
## [23] IRanges_2.34.1 S4Vectors_0.38.1
## [25] BiocGenerics_0.46.0 reshape2_1.4.4
## [27] lubridate_1.9.2 forcats_1.0.0
## [29] stringr_1.5.0 dplyr_1.1.2
## [31] purrr_1.0.2 readr_2.1.4
## [33] tidyr_1.3.0 tibble_3.2.1
## [35] ggplot2_3.4.3 tidyverse_2.0.0
## [37] zoo_1.8-12
##
## loaded via a namespace (and not attached):
## [1] bitops_1.0-7 gridExtra_2.3 rlang_1.1.1
## [4] magrittr_2.0.3 compiler_4.3.1 polylabelr_0.2.0
## [7] systemfonts_1.0.4 vctrs_0.6.3 rvest_1.0.3
## [10] pkgconfig_2.0.3 crayon_1.5.2 fastmap_1.1.1
## [13] XVector_0.40.0 ellipsis_0.3.2 labeling_0.4.2
## [16] caTools_1.18.2 utf8_1.2.3 promises_1.2.1
## [19] rmarkdown_2.24 tzdb_0.4.0 xfun_0.40
## [22] zlibbioc_1.46.0 cachem_1.0.8 jsonlite_1.8.7
## [25] highr_0.10 later_1.3.1 DelayedArray_0.26.7
## [28] reshape_0.8.9 BiocParallel_1.34.2 parallel_4.3.1
## [31] R6_2.5.1 bslib_0.5.1 stringi_1.7.12
## [34] RColorBrewer_1.1-3 jquerylib_0.1.4 assertthat_0.2.1
## [37] Rcpp_1.0.11 knitr_1.43 httpuv_1.6.11
## [40] Matrix_1.6-1 timechange_0.2.0 tidyselect_1.2.0
## [43] rstudioapi_0.15.0 abind_1.4-5 yaml_2.3.7
## [46] codetools_0.2-19 lattice_0.21-8 plyr_1.8.8
## [49] shiny_1.7.5 withr_2.5.0 evaluate_0.21
## [52] polyclip_1.10-4 xml2_1.3.5 pillar_1.9.0
## [55] KernSmooth_2.23-22 generics_0.1.3 RCurl_1.98-1.12
## [58] hms_1.1.3 munsell_0.5.0 scales_1.2.1
## [61] xtable_1.8-4 glue_1.6.2 tools_4.3.1
## [64] data.table_1.14.8 webshot_0.5.5 locfit_1.5-9.8
## [67] fastmatch_1.1-4 cowplot_1.1.1 grid_4.3.1
## [70] colorspace_2.1-0 GenomeInfoDbData_1.2.10 cli_3.6.1
## [73] fansi_1.0.4 viridisLite_0.4.2 S4Arrays_1.0.5
## [76] svglite_2.1.1 gtable_0.3.4 sass_0.4.7
## [79] digest_0.6.33 farver_2.1.1 htmlwidgets_1.6.2
## [82] htmltools_0.5.6 lifecycle_1.0.3 httr_1.4.7
## [85] mime_0.12
END of report